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Abstract 
A heterogeneous population of apical membrane chloride channels is responsible 
for transepithelial secretion of chloride ions in the small intestine, thereby providing a 
driving force for fluid secretion into the intestinal lumen. Previous experimental 
characterization of one of these pathways led to the selection of a monoclonal antibody 
capable of significantly inhibiting conductive chloride uptake into ileal apical membrane 
vesicles. 
This antibody was used to isolate a 0.94 kb cDNA clone, PG33, from a porcine 
intestinal expression library. A labeled probe constructed From this sequence identified a 
2.7 kb band in a Northern blot of porcine parotid gland mRNA. Further clones were 
isolated through conventional oligonucleotide screening of the porcine library, as well as 
PCR-based screening of the porcine library and a human intestinal cDNA library. The 
total sequence cloned to date includes 2.3 kb, encoding a 679-amino acid translation 
product. The primary sequence bears significant homology to only two known genes: 
Ca-CC, a calcium-regulated chloride channel expressed in bovine tracheal epithelium, 
and Lu-ECAM-I, a lung endothelial cell adhesion molecule. 
Expression of PG33 rnRNA was detected by reverse transcriptase PCR in several 
porcine secretory epithelial tissues, including ileum, trachea, and the major salivary 
glands (parotid, submandibular, and sublingual). In situ hybridization studies confirmed 
the ileal and tracheal expression. In porcine ileal mucosa, PG33 mRNA was detected in 
both the crypt and villus epithelial regions, while in the trachea, expression was observed 
both in the surface epithelium and the submucosal glands. 
Reverse transcriptase PCR studies demonstrated that the tissue expression of 
PG33 mRNA is distinct from that of the bovine chloride channel Ca-CC. Expression of 
Ca-CC appears restricted to bovine tracheal epithelium, and could not be detected in 
bovine ileum or parotid gland, nor in porcine trachea, ileum, or parotid gland. PG33 
gene expression could not be detected in bovine tissues, though both PG33 and Ca-CC 
mRNA were detected in the human intestinal cell line T84 and the human airway cell line 
HBE-I. Expression of the PG33 and Ca-CC genes in these two lines may depend upon 
the differentiation status of the cell. 
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1.0 Introduction 
The ability to control fluid movement fi-om intracellular to extracellular 
compartments is determined by the type and location of ion channels in the plasma 
membrane. In secretory epithelia such as the proximal small intestine, apical membrane 
chloride channels allow the movement of chloride into the gut lumen in response to 
events which increase the intracellular chloride concentration above its equilibrium 
point. 
While it has been clear for some time that several different intracellular 
signalling mechanisms control the exit of chloride ions, the identity of the channel or 
channels responsible for the majority of the chloride secretory response has been a 
matter of much debate. In the past decade. a number of chloride channels have been 
characterised in intestinal epithelia, including the cystic fibrosis transmembrane 
conductance regulator (CFTR), the outwardly rectifying chloride channel (ORCC), and 
CIC-2. it is not currently known, however, precisely how many chloride channels exist 
in the brush-border apical membrane, nor exactly how their activity is coordinated to 
ensure that the amount of chloride secretion is appropriate to the circumstances. 
One particular conductive chloride pathway has been under investigation in this 
laboratory for some time. Studies involving a number of experimental approaches have 
tentatively identified a 90 kDa brush-border protein as a candidate protein for this 
chloride channel (Racette et al., 1996). The kinetics of this pathway have been shown 
to be samrable (Forsyth & Gabriel, 1988), and the activity of the putative channel is 
sensitive to inhibition by a-phenylcinnamate (Forsyth & Gabriel. 1989b), though it is 
relatively insensitive to typical chloride channel blockers such as SITS or anthracene-9- 
carboxylate (Forsyth & Gabriel, 1988). 
Since the purification of single proteins from membrane preparations is often 
technically extremely difficult, a homogenous preparation of this candidate protein had 
not been obtained. In order to ascertain its actual role in chloride conductance, a 
molecular biological approach was therefore undertaken. 
The major aim of this project was to identi@, through the use of an antibody 
inhibitory for small intestinal chloriCe conductance, the gene responsible for encoding 
the candidate protein. This part of the project was intended to provide a pure source of 
protein for tests of its functional abilities as a chloride channel. As well, the tissue 
expression of this gene was to be investigated, both to compare its expression with that 
of known chloride channels, and to correlate the expression of the specific message with 
the location of the antigen against which the anti-chloride conductive antibody had been 
raised. 
2.0 Literature Review 
2.1 Morphology of the Small Intestine 
The mammalian small intestine functions as both a secretory and as an 
absorptive organ in order to meet the demands placed upon it by widely varying daily 
fluid loads. Normally, the absorptive aspect predominates: though nearly ten litres of 
fluid pass through the average human small intestine each day, only approximately one 
litre enters the large intestine fiom the ileum. The secretory ability of the small 
intestine, while less dramatic, is also critical, as it contributes to the osmotic 
environment required for intestinal digestion and absorption of nutrients. The 
importance of fluid secretion in the gut is illustrated by the pathological consequences 
of its excess, which occurs in secretory diarrhea, or its insufficiency, which occurs in 
cystic fibrosis. 
The secretory and absorptive capacities of the small intestine appear to be 
divided both histologically and anatomically. Both are a function of the mucosal layer 
of the intestinal wall. The rnucosa consists of the surface epithelium, which is exposed 
to the contents of the lumen, along with an underlying layer of connective tissue called 
the lamina propria, and a thin layer of smooth muscle, the muscularis mucosae. The 
surface epithelial layer is functionally divided into crypts, which originate deep in the 
intestinal wall, and villi, which are fingerlike projections extending outwards into the 
lumen. Secretion is held to be a function of newly-produced epithelial cells in the 
crypts (Welsh el al., 1982); these cells differentiate into absorptive cells as they migrate 
upwards before they arc eventually sloughed off fiom the villus tip into the intestinal 
lumen. As well, while the proximal regions of the small intestine such as the duodenum 
are predominantly secretory, more distal regions such as the ileum appear to act in a 
predominantly absorptive fashion. 
The key to these secretory and absorptive abilities lies in the polarized 
organization of the epithelial cells lining the intestinal wall. In a polarized cell, the 
protein and even the lipid compositions of the apical membrane are different from that 
of the basolateral membrane (Handler, 1989). As a result, some functions of the cell, 
especially transport functions, are segregated to the parts of the plasma membrane 
containing the appropriate proteins. In the case of ion transport, the proteins responsible 
for the movement of electrolytes are differentially targeted to the apical and basolateral 
membranes, and then restricted to their respective membrane domains by interactions 
with cytoskeletal elements and by the banier formed by intercellular tight junctions 
(Handler, 1989; Rodriguez-Boulan & Salas, 1989). This inequai distribution of 
transport molecules between the apical and basolateral merrlbranes is responsible for the 
vectorial movement of electrolytes across epithelial cclls. Depending on the membrane 
distribution of transport proteins, movement may be either serosal-to-mucosal or 
mucosal-to-serosal. In the first instance, the cell is acting in a secretory manner; in the 
second, it is absorptive. 
The electrical driving force for this vectorial movement in polarized cells is 
established by the actions of the basolateral Nat/K+ ATPase, which couples the inward 
transport of K'  and the outward transport of Na' to the hydrolysis of ATP (see Figure 
2.1). This results in an inwardly-directed Na' concentration gradient, which the 
basolaterall y-located Na-K-2Cl cotramporter uses to move Na', K', and Cl- into the cell 
from the extracellular fluid in an electrically neutral fashion. KT leaves the cell 
passively through basolateral K' channels while C1' exits through apical membrane 
channels along its electrochemical gradient. The lumen-negative transepithelial 
potential thus generated provides an electromotive force for serosal-to-mucosal Na+ 
movement through a paracell ular path way. 
2.2 Basolateral Membrane Transporters In Secretory Epithelia 
2.2.1 Na/K ATPase 
The Nan< ATPase, also called the N a K  pump, is a ubiquitous protein that helps 
preserve transmembrane ionic gradients by simultaneously regulating both the 
Figure 2.1 Selected ion transport mechanisms in a secretory cell. Tight junctions are 
indicated by shaded boxes. The activity of the Na0/K' pump requires ATP hydrolysis 
(-9. 
intracellular and extraccl lular levels of sodium and potassium. The transport of these 
ions against their concentration gradients is carried out through the expenditure of 
chemical energy in the form of ATP hydrolysis. In this manner, for each molecule of 
ATP split, 3 Na' can be transported out of the cell, and 2 K'  can bc transported into the 
cell. This results in the creation of a high intracellular and a low extracellular K'  
concentration, and a high extracellular and low intracellular Na' concentration. Thc 
movement of more positively charged ions out of the cell than into the cell with each 
ATP hydrolyzed results in the accumulation of a net negative charge on the interior of 
the cell membrane. This charge imbalance helps establish what is known as the 
membrane potential, which is essentially the potential energy due to the separation of 
positive and negative charges on either side of the plasma membrane. In epithelia1 cells, 
the membrane potential is usually between -35 and -40 mV. 
The electrochemical gradient generated by the NdK pump allows a number of 
energetically unfavourable transport processes to be linked to the movement of sodium 
ions without requiring direct ATP hydrolysis by the protein transporters. This process is 
known as secondary active transport, and includes thc sodium-linked cotransport of 
nutrients such as glucose or amino acids as well as cotransport of other electrolyte 
species such as Kt, C1-. and H'. Preservation of the electrochemical gradient may 
require anywhere from 5 to 40% of the available energy of a cell, depending on the 
metabolic activity level of that cell (Ismail-Beigi & Edelman, 197 1 ; Ewart & Klip, 
1995). 
The N a K  pump is an integral membrane protein consisting of two joined 
subunits. The 1 12 kDa a subunit is the catalytic subunit and contains a number of 
membrane-spanning domains (Skou, 1992; Ewart & Klip, 1995). Contained within the 
a subunit are the binding sites for Na', Kt, Mg2+ ATP, and the inhibitory cardiac 
glycoside ouabain (Geering, 1991 ; Ewart & Klip, 1995). Kt and ouabain bind on the 
extracelIular side of the a subunit, while Na' and MgATP bind on the cytoplasmic 
surface of the subunit. The smaller, associated P subunit has a single transmembrane 
domain with a glycosyiated extracellular portion (Gecring, 1991 ; Farnbrough et ul.. 
1994)). The molecular mass of the P subunit varies depending on the amount of 
glycosylation present, but the mass of the core protein is approximately 35 kDa (Skou, 
1992; Ewart & Klip, 1995). The precise function of the P subunit is not currently 
known, though assembly of the two subunits appears to be required for protein 
maturation, transport to the plasma membrane, and subsequent enzyme activity 
(Geering, 1 99 1). Each of the subunits occurs in a number of isoforrns, the distribution 
of which is tissue-specific; the most commonly occurring form of the enzyme, however, 
is an a$, association (Sweadner, 1989; Ewan & Klip, 1995) 
Regulation of N a K  pump activity can be divided into acute and long-term 
phases. Acute or short-term regulation generally refen to transient changes in the 
activity of existing pump units, while long-term regulation usually involves an increase 
in the synthetic rate of the Na/K pump due to a stimulation of transcriptional and 
translational events, as well as changes in the stability of pump subunit transcripts 
(Jorgensen, 1986; Ewart & Klip, 1995). 
Acute regulation of Nan< ATPase activity has traditionally been considered to 
reflect the intracellular levels of Na+ (Jorgensen, 1986), which is the rate-limiting 
species for the pump. More recently, receptor-mediated increases in a number of 
intracellular second messengers such as CAMP, diacylglycerol (DAG), and arachidonic 
acid have also been implicated in short-term pump regulation (Bertorello & Katz, 1993; 
Bertorello 8c Katz, 1995; Ewart & Klip, 1995). The actions of these messengers appear 
to vary depending on the tissue studied (Bertorello & Katz, 1993; Bertorello & Katz, 
1995; Ewart & Klip, 1995); consequently, the final effect on pump activity may bc 
stirnulatory or inhibitory. Finally, cytoskeletal elements have also bcen shown to 
influence Na/K pump activity, in that G, or monomeric, actin can stimulate pump 
activity, while F, or filamentous, actin cannot (Bertorello & Cantiello, 1992). Possible 
interactions between actin, cellular protein kinases such as PKA and PKC. and the Na/K 
pump are still unclear (Bertorello & Katz, 1995). 
2.2.2 Na-K-2CI Cotransporter 
Sodium-linked cotransport of chloride ions provides a mechanism for increasing 
the intracellular level of chloride above its electrochemical equilibrium without 
requiring additional energy beyond that expended by the Na/K AT13ase. The 
electrochemical gradient in turn determines the direction of chloride movement from the 
cell; in the case of secretory epithelia, chloride ions exit through apically-located 
chloride channels. 
Electroneutral cotransporters include the Na-Cl cotransporter, the Na-K-2CI 
cotransporter, and the K-CI cotransporter (Haas, 1994). Of these, the Na-K-2CI 
cotransporter is the best characterised cotransporter in secretory epithelia. This 
cotransporter binds Na' , K', and CI- in an interdependent fashion, in that all three ions 
must be present and bound to the cotransporter before the transport process can occur 
(Lytle & McManus, 1986). The stoichiometry for nearly all such cotransporters is 
1 Na': 1 K' : X I -  (O'Grady et al., 1986; O'Grady el al., 1987). Another characteristic of 
the Na-K-2CI cotransporters is their sensitivity to loop diuretics, or sulfarnoylbenzoic 
acid derivatives such as furosemide and bumetanide (O'Grady et a l ,  1987; Haas 1994). 
Loop diuretics have been hypothesized to inhibit cotransport by preventing the 
interaction of the final chloride with its binding site on the protein, thereby blocking the 
ability of the cotransporter to undergo the necessary conformational change for ion 
transport (Hedge & Palfrey, 1 992). 
The driving force for ion cotransport is established by the sum of the chemical 
gradients of all the electroiyte species involved (Haas, 1994). In other words, the 
direction and amount okotransport is dictated by the chemical gradients for Na', K', 
and CI-. The sodium and chloride gradients are inwardly directed, while the potassium 
gradient is outwardly directed; as a result, because two chloride ions are transported for 
each sodium and potassium, the effects of the chloride gradient predominate in 
determining the direction of ion transport. 
A variety of Na-K-2CI cotransporter isoforms have been characterised in 
epithelial tissues, and can be categorized as either members of apical absorptive or 
basolateral secretory families (Payne & Forbush, 1995). Members of the basolateral 
secretory family are all homologous to a cotransporter originally identified in shark 
rectal gland (SRG), NKCC-1 (Xu et al., 1994; Payne & Forbush, 1995); this isoform 
has a wide tissue distribution, including intestinal epithelium (Xu et al., 1994). The 
apical absorptive isoform, on the other hand, appears to be restricted to epithelial cells 
of the kidney (Payne & Forbush, 1994). 
The protein structure for NKCC-1 has been deduced from the SRG cDNA 
encoding this protein (Xu et al., 1994). The mass of the core protein is roughly I30 
kDa, while the mass of the fully glycosylated mature protein varies depending on the 
tissue and species. Based on amino acid sequence, the NKCC proteins are all predicted 
to contain large cytosolic N- and C-terminal domains flanking 12 putative membrane- 
spanning segments (Xu et a/. , 1 994; Haas, 1994; Payne & Forbush. 1 995). Several 
consensus sequences for N-linked glycosylation have been identified on one of the 
extracellular loops between transmembrane segments (Xu et a/. , 1994). 
Activity of the Na-K-XI cotransporter is subject to a number of regulatory 
influences. These influences may either directly affect cotransporter activity, or they 
may be secondary to some event that activates apical chloride channels and therefore 
requires an increased basolateral chloride influx (Haas et al., 1993: Haas. 1994). In 
many cases, it is difficult to distinguish the two. 
Elevation of intracellular CAMP, and therefore activation of PKA. has been 
associated with increased cotransporter activity (Dharmsathaphorn et ul.. 1985; Lytle & 
Forbush. 1992; Haas er d.. 1993; Haas. 1994: Payne & Forbush. 1995). It is not 
currently clear whether the activation due to PKA is due to a direct kinase action upon 
the cotransporter, or whether PKA activates some other regulatory component that in 
turn activates the cotransporter (Haas, 1994; Payne & Forbush, 1995). 
Cytoskeletal elements have also been implicated in the regulation of the Na-K- 
2Cl cotransporter (Haas, 1994; Payne & Forbush, 1995). Reagents that maintain actin 
in monomeric or short filamentous form appear to activate the cotransporter, while 
compounds that block actin disassembly from the longer F-actin form inhibit 
cotransporter activity (Matthews et al.. 1994; Matthews et a/. , 1997) . 
2.2.3 K Channels 
The basolateral K' conductance performs a number of functions in secretory 
epithelia. This pathway permits exit of the Kt brought into the cell by the NdK ATPase 
and the Na-K-2CI cotransporter. Upregulation of K' conductance hyperpolarizes the 
cell, increasing the stimulus for Cl- exit via apical chloride channels. Many 
secretagogues that increase free cytosolic Ca2+ levels. for example, stimulate net 
chloride secretion by stimulating the K+ conductive pathway. The potassium channel 
blocker barium (Ba) prevents chloride secretion, on the other hand, by inhibiting K' exit 
from the cell through Kv channels (Welsh, 1983; Smith & Frizzell. 1984). 
Coordination of potassium movement with chloride exit from epithelial cells is 
essential during salt secretion in order to maintain the balance of charge and mass 
within the cell, thereby keeping cell volume constant (Dawson & Richards, 1990). For 
each cycle of the N d K  ATPase, six chloride ions can be secreted at the apical 
membrane (see Figure 2.1 for stoichiometry). In this simplified model, the sodium ions 
entering via the cotransporter are recycled by the N a K  pump. For each ATP 
hydrolyzed, only two K' are brought in while 3 Na' are transported out of the cell; as a 
result, if all of the chloride ions entering the cell are secreted at the apical membrane, 
charge balance can only be preserved if the remaining h e  potassium ions exit via 
basolateral channels. 
If chloride secretion and potassium conduction are linked, then. stimuli which 
cause an increase in net chloride secretion should also activate potassium channels. 
These Kt channels may be classified as either channels which respond to increases in 
cytosolic free C$+ or those which activate in response to increases in cyclic nucleotides 
such as cAMP (Dawson & Richards, 1990; Barrett, 1993; Breitwieser, 1996). cAMP 
and CaL+ being two of the major intracellular messengers for chloride secretagogues. In 
fact. calcium-linked chloride secretion has traditionally been held to be driven primarily 
by the activation of basolaterd calcium-regulated potassium channels (Barrett, 1993). 
The identity of these K+ channels has been complicated by the technical 
difficulty of obtaining eIectrophysiologicaI records of channels in the basolateral 
membrane (Dawson et al., 1990). A number of epithelial Kt channels have been 
characterised, however, based on measurable biophysical properties such as single- 
channel conductance, sensitivity to common potassium channel blockers, and current- 
voltage (I-V) relationship. 
A class of large-conductance K+ channels have been identified in many secretory 
epithelial cells, including rat small intestine (Moms et al., 1986) and rabbit distal colon 
(Loo & Kaunitz, 1989). These channels tend to have very high single-channel 
conductances (between 100-300 pS in symmetrical KC1 solutions). Consequently, the 
usual descriptive term for this class of channels is "maxi" K* channels. These channels 
are also usually calcium-activated and sensitive to blockade by barium ions (Latorre & 
Miller, 1983; Morris et al., 1 986; Loo & Kaunitz, 1 989; Dawson & Richards, 1 990). 
Several groups of investigators (Devor & Frizzell, 1993; Tabcharani et aL, 
1994a; Tabcharani et al., 1994b; Roch et al., 1995) have reported the presence of 
smaller-conductance, inwardly-rectifying K+ channels in the basolateral membrane of 
T84 intestinal epithelial cells similar to a channel previously characterised in dog 
tracheal epithelial cell cultures (Welsh. 1985). In addition to the lower single-channel 
conductances, these channels are all calcium-activated and insensitive to barium 
blockade. though varying degrees of inhibition of this channel by charybdotoxin were 
reported. 
There is some debate as to whether there is overlap in the regulation of K' 
channels by cAlVP and calcium, or in other words. whether both CAMP and free 
calcium levels have the ability to control the same channel. In rabbit distal colon. the 
calcium-activated maxi-channels also responded to CAMP (Loo & Kaunitz, 1989), 
albeit with very different activation kinetics. Additionally, CAMP-associated activation 
of the smaller-conductance, inwardly-rectifying K' channels has been reported by two 
groups (Baro et al., 1994; Tabcharani et al., 1994b). In both cases, however, CAMP- 
sensitivity of the K+ channel was demonstrated only in the presence of high levels of 
free calcium (Baro rt al.. 1994: Tabcharani et al., 1994b), which led to the suggestion 
that this CAMP-associated activation is not completely independent of a calcium- 
regulated mechanism (Devor el al., 1996a; Devor ef ul., 1996b). Hence, these studies 
cannot be said to disprove earlier proposals that CAMP and Ca" regulate separate 
basolateral K conductances (McRoberts et ul., 1985; Devor ct al., 1996a; Devor er al., 
1996b). 
2.3 Apical Membrane Chloride Channels In Secretory Epithelia 
2.3.1 Cystic Fibrosis 
Cystic fibrosis (CF) is an autosomal recessive disorder affecting nearly 1 in 2000 
live births, making it one of the most common genetic disorders recognised (Welsh el 
al., 1995). The cystic fibrosis allele occurs in the Caucasian population at a frequency 
of I in 25; its frequency in black and Asian populations, and therefore the CF disease 
phenotype, is much lower (Welsh ef al., 1 995). 
CF has been traditionally identified by the production of excessively salty sweat 
in affected individuals. More seriously, CF is characterised by a high incidence of 
neonatal morbidity due to intestinal obstructions, and an extremely high childhood and 
adolescent mortality rate predominantly due to pulmonary infections. Although 
historically survival of CF individuals beyond childhood has been rare, recent 
therapeutic advances have resulted in an increase in the mean life expectancy to 29 
years (Welsh el al., 1995; Wood, 1997). 
Cystic fibrosis affects a number of epithelial tissues, many of which perform 
exocrine functions. As indicated above, increased sweat electrolyte concentration is a 
clinical diagnostic factor for CF, since the sweat glands are affected in nearly all CF 
patients (Wood, 1997). The respiratory system is also affected in the majority of CF 
patients, though the clinical severity of pulmonary symptoms may vary from mild to 
extremely severe. Common signs of CF lung disease include the production of 
abnormally thick mucus in the respiratory tract, which predisposes the individual to 
chronic and recurrent pulmonary infections, in particular with organisms such as 
Pseudomonas aeruginosa and Burkholderia cepacia (Wood, 1 997). In CF patients, 
pulmonary function may deteriorate progressively over time as a result of recurrent 
infections with these and other opportunistic organisms, often leading to end-stage lung 
disease. 
The digestive system is commonly affected, though again, the severity of the 
clinical manifestations in this system varies &om patient to patient. CF patients can be 
classified as either pancreatic sufficient (PS) or pancreatic insufficient (PI) based on the 
integrity of the exocrine pancreatic ductal structure and hence the ability to secrete 
adequate levels of digestive enzymes into the duodenum as required (Marino & 
Gorelick. 1 992). Pancreatic insufficient patients require enzyme supplements to 
properly digest nutrients. especially dietary lipids. The gastrointestinal tract itself may 
be affected: 10 to 15% of CF newborns experience a condition known as rneconium 
ileus (Marino & Gorelick, 1992). In these infants, abnormally thick mucus blocks the 
GI tract, and removal of the obstruction usually requires medical intervention (Welsh et 
al., 1995). 
Other organs commonly affected by cystic fibrosis include those of the 
reproductive system. Until recently. CF individuals rarely survived to reproductive 
maturity, and as a result infertility was not immediately seen to be an overt consequence 
of CF. With increasing survival times. however, it became apparent that over 95% of 
CF males have decreased fertility rates, and that this infertility is related to a syndrome 
known as congenital bilateral absence of the vas deferens (CBAVD) (Chillon et at., 
1995; Welsh et al., 1995; Tsui & Durie, 1997). Reproductive structures are also 
affected in CF females. resulting in low fertility rates compared to non-CF females 
(Welsh et al.. 1995). 
2.3.1.1 Celtular Basis of CF Defect 
Instances of cystic fibrosis-like disorders have been reported for several 
centuries. CF was only described as a distinct clinical syndrome, however, in 1938 
(Anderson. l938), though not until 1953 was the connection made between the presence 
of high-salt sweat and the disease cystic fibrosis (diSant'Agnese et al.. 1953). Also 
during this time interval, pedigree analysis demonstrated the autosomal recessive nature 
of CF. indicating that the disease is inherited in a single-gene or classically Mendelian 
fashion (Anderson & Hodges, 1946). 
Not until the early 1980s was the cellular defect underlying the disease 
pathology finally identified. The reabsorptive ducts of sweat glands (Quinton, 1983) 
and airway epithelial cells (Knowles & Boucher, 198 1 ) from CF patients were found to 
have greater transepithelial potential differences than those from normal subjects; the 
defect was furthermore identified as an impermeability of the epithelials cells to 
chloride ions (Quinton, 1983). More specifically, affected tissues showed an inability to 
respond to P-adrenergic stimuli (Knowles & Boucher. 1983; Sato & Sato, 1984; Welsh 
& Lietdke, 1986; Frizzell et a/. , I986), though responses to choiinergic muscarinic 
agonists. which act by increasing intracellular calcium levels, were found to be normal 
in most CF tissues (Sato & Sato, 1984; Frizzell er aL. 1986; Widdicombe, 1986; 
Boucher et al., 1989). Agonist-induced elevation of the intracellular second messenger 
CAMP was normal in CF tissues (Sato & Sato. 1984; Boucher el a[.. 1986). This 
implied that the defect might lie in the response of an ion channel to CAMP-dependent 
stimuli, rather than in the production system of this second messenger. 
The identity of this chloride channel was obvious1 y of great interest. An 
outwardly rectifying chloride channel (ORCC) had been identified in tracheal 
epithelium (Welsh, 1986) that could be stimulated by isoprenaline. a CAMP-elevating 
agent (Welsh & Lietdke. 1986). This channel was also shown to open in response to 
strong depolarizing voltages (Hwang et al., 1989). Activation in response to purified 
catalytic PKA plus ATP could consistently be demonstrated in membrane patches from 
normal airway epithelial cells, but not in patches from CF ainvay epithelia 
(Schoumacher et a l ,  1987; Li et al., 1988). though exposure of the CF patches to 
depolarizing voltages confirmed the presence of functional channels within the patches. 
Channel kinetics were identical in normal and in cystic fibrosis ainvay cells. A defect 
in this outwardly rectifying channel, therefore. was proposed to be responsible for the 
lack of chloride conductance in cystic fibrosis cells (Guggino, 1993). 
2.3.1.2 Cloning of the CF Gene 
As an autosomal recessively-inherited disease, cystic fibrosis is likely to result 
from a defect in a single gene, and hence a single protein product of such a gene. 
Because the defective protein in CF was thought to be a chloride channel, and since 
membrane proteins are notoriously difficult to purify to homogeneity, identification of 
the CF gene was undertaken in order to bypass these technical difficulties, and to allow 
the examination of the CF protein. 
The CF gene had been mapped, through large-scale linkage analysis studies, to a 
single locus on the long arm of chromosome 7 (Knowlton et al., 1985; Wainwright el 
al., 1985; White et aL, 1985). Extensive restriction mapping and cloning studies using a 
variety of techniques further narrowed the location o r  the CF locus to a 250-kb region 
between the chromosomal markers MET and D7S8 (Rommens el al., 1989; Riordan el 
al, 1989). Several overlapping cDNA clones corresponding to this gene were isolated 
from a number of epithelial cell libraries (Riordan et of., 1989), and one of these was 
used as a probe to ascertain the size of the mRNA transcript in various tissues affected 
by CF. The size of the CF transcript was 6.5 kb in ail of the tissues examined (Riordan 
et al., 1989). 
Based on the  nucleotide sequence of the cDNA, the open reading frame (ORF) 
of the CF transcript appeared to code for a protein containing 1480 amino acids. 
Hydropathy analysis of this primary amino acid sequence predicted that the CF protein 
contained two repeated motifs, each containing six hydrophobic regions that might span 
the cell membrane. In addition, each of these motifs also contained a region in which 
consensus sequences for nucleotide (ATP) binding were found. Intriguingly. the 
predicted amino acid sequence of the CF protein was highly homologous. not to 
previously identified ion channels, but to a family of proteins known as the ATP- 
binding cassette (ABC) transporter superfamily (Riordan el al. , 1989). This family 
contains proteins such as the multidrug resistance-associated P-glycoprotein and the 
yeast STE export system, and is functionally characterised by the ability of its members 
to use ATP hydrolysis to drive substrate transport across the cell membrane (Riordan et 
al., 1989). 
The amino acid sequence for the CF protein product differs in one significant 
way from other members of the ABC family, containing an additional region not found 
in any other ABC transporter. This region contains many positively and negatively 
charged amino acids, as well as a number of consensus sites for protein phosphorylation 
by kinases such as  PKA and PKC (Riordan el al., 1989). Because of these potential 
phosphoacceptor sites, this region was named the R (for regulatory) region by the 
original investigators (Riordan et al., 1989). 
Because the CF gene appeared to encode a protein more closely related to 
transporter-type proteins than to any classical ion channel, the CF protein product was 
named the cystic fibrosis transmembrane conductance regulator, abbreviated CFTR 
(Riordan et a!., 1989), until its function could be more clearly defined. 
2.3.1.3 The CF Gene Defect 
Genetic analysis of the specific mutations in a large number of CF patients 
revealed that. in the majority of cases, the CF gene defect involves the deletion of a 
codon corresponding to a phenylalanine residue at position 508 (AF508) in the CF 
protein product (Kerem et crl.. 1989). Approximately 70% of the CF chromosomes 
investigated to date bear this mutation (Kerem et c d . .  1989: Welsh et ul.. 1995). 
Haplotype analysis suggests that the widespread existence of this mutation is due to an 
original single mutational event which occurred between 50 000 and 60 000 years ago 
(Morral et al., 1994). Several hundred other mutations of the CF gene have been 
identified, all of which exist at much lower frequencies than the AF508 defect (Welsh et 
aL, 1995). These other mutations include a wide variety of gene defects, including 
missense. frameshift, and termination mutations (Welsh er al., 1995). Many CF patients 
are compound heterozygotes. bearing a different mutation on each affected chromosome 
(Kerem el al., 1989; Welsh et al., 1995). 
The functional consequences of the AF508 mutation have been studied to 
determine the nature of the CFTR defect in CAMP responsiveness. AF508 CFTR, while 
synthesized normally in the endoplasmic reticulum, does not appear in CF cells in the 
mature. fully glycosylated form (Cheng et aL, 1990). This failure to mature normally 
has been attributed to a defect in protein processing within the Golgi complex, and as a 
result, little or no AF508 CFTR appears in the cell membrane (Cheng et aL, 1990). 
However, this processing defect has been reported to be temperature-dependent. AF508 
CFTR expressed in nonepithelid cells incubated below 30°C. a lower temperature than 
normal, not only appears in the apical membrane, but also exhibits channel activity 
(Denning et al.. 1992). 
The hundreds of documented CF mutations can be classified into four or five 
categories. based on the effect of a given mutation on protein function. The first 
category, class I. describes mutations which prevent normal biosy nthesis of CFTR 
(Welsh & Smith, 1993; Zielenski & Tsui, 1995). Class I1 mutations include the AF508 
mutation. and contains all those mutants which are improperly processed (Welsh & 
Smith, 1993; Zielenski Sr Tsui, 1995). Cells with class I or I1 mutations have little or no 
CFTR in the cell membrane. Because chloride secretion is virtually absent from these 
cells, class I and class I1 mutations are generally associated with severe clinical 
syndromes (Zielenski & Tsui. 1995). 
While proteins with class 111 mutations can be detected in the plasma membrane, 
these proteins are unresponsive to regulation by intracellular ATP (Welsh & Smith. 
1993; Zielenski & Tsui. 1995). Hence, these CFTR mutants are incapable of 
functioning as chloride channeis despite their physical presence in the plasma 
membrane. 
Class IV mutants reach the cell membrane and respond normally to PKA and 
ATP stimulation, but with diminished channel conductance or altered channel gating 
(Welsh & Smith, 1993; Zielenski & Tsui, 1995). Finally, class V describes those 
mutations which result in the formation of normal CFTR, but at much lower Ievels than 
in non-CF cells (Zielenski & Tsui, 1995). 
2.3.1.4 Functions of CFTR 
2.3.1.4.1 CFTR as a Chloride Channel 
Because the predicted protein structure of CFTR appeared more closely related 
to solute pump proteins than to electrodiffisive ion channels, there was considerable 
debate as to whether CFTR could act as a chloride channel. A number of studies were 
undertaken to resolve this controversy. and within a few years of the cloning of the CF 
gene, a considerable amount of evidence had been massed to support the hypothesis 
that CFTR is, in fact, a chloride channel. 
Complementation of CF ainvay epithelial cells with a functional copy of the CF 
gene, for example, corrected the defect in the CAMP-regulated chloride conductive 
pathway (Rich el a!.. 1990) in these cells. Likewise, expreszion of the wild-type CFTR 
in a cystic fibrosis pancreatic cell line (CFPAC- I )  also corrected the chloride transport 
defect (Drumm er al., 1990). While these studies did not prove that CFTR is a chloride 
channel. they confirmed the functional association of the CF gene product with the 
cystic fibrosis conductance defect. 
Other studies were able to localise CFTR to the apical membrane of epithelial 
cells (Gregory et a!., 1990), which supports the association of CFTR with an apical 
chloride conductive pathway. Furthermore, expression of CFTR in a number of non- 
epithelial cell lines such as Chinese hamster ovary (CI-IO) cells. NIH 3T3 fibroblasts, 
and Sf9 insect cells, among other. resulted in the appearance of CAMP-regulated 
chloride currents (Anderson ef a/.. 199 1 a: Kartner et ul., 199 1 ). The biophysical 
properties of these currents in non-epithelial cells were very similar to the properties of 
a chloride current previously characterised in whole-cell recordings of intestinal and 
pancreatic epithelia (Gray et a!. , 1989; Cliff and Frizzell, 1990; Tabcharmi et a/.. 1990: 
Bear & Reyes, 1992). 
Surprisingly, these properties were very different than those which had been 
reported in previous investigations; while the protein that was thought to be defective in 
CF was outwardly rectifying, with a single-channel conductance between 30 and 50 pS 
at 0 mV, the channel that appeared in these complemented cells had a much smaller 
single-channel conduc~ance (5- 10 pS) and exhibited a linear current-voltage relationship 
(Anderson el al., 1 99 1 a; Kartner el a!., 1 99 1 ). 
Other properties characteristic of the channel appearing in CFTR expression 
systems included a halide permeability sequence of Br- > CI- > I- (Bell & Quinton, 
1992; Cliff and Frizzell, 1994) and an insensitivity to the chloride channel blocker 4,4'- 
diisothiocyanostilbene-2,2'-disulfonic acid (DIDS). This channel was, however, 
sensitive to the chloride channel blockers diphenylamine-2-carboxylate (DPC) and 
glibenclamide, and this pharmacological profile can be used to distinguish CFTR from 
other apical membrane chloride channels (Cliff & Frizzell, 1994). 
One of the studies cited as providing definitive support for the role of CFTR as a 
chloride channel involved the purification of recombinant CFTR from insect Sf9 cells in 
which CFTR had been overexpressed. The purified protein was then reconstituted into 
planar lipid bilayers, where it exhibited an anion-selective single-channel activity that 
could be stimulated by the addition of ATP along with the catalytic subunit of PKA 
(Bear et al., 1992). Hence, CFTR in the absence of any other cell-associated factors can 
indeed act as a regulated chloride channel. Furthermore, the biophysical characteristics 
of the channel studied in all of these reports were very similar, and consistent with a 
channel which is relatively quiescent in unstimulated cells, but which becomes activated 
upon exposure to CAMP agonists. This behaviour correlates with the properties of the 
chloride current originally reported to be defective in CF, and most investigators now 
accept that this small linear chloride channel corresponds to the CF gene product. 
2.3.1.4.2 CFTR as a Regulator of Other Proteins 
2.3.1 A2. l  Regulation of ORCC 
If CFTR is a small-conductance linear chloride channel, but the channel 
originally implicated in CF has a larger conductance and is outwardly rectifying, what 
then is the relationship between CFTR and this ORCC? 
Several suggestions were initially made about the nature of this relationship, 
including the hypothesis that CFTR and the ORCC may be splice variants of the same 
protein. Evidence contradicting this hypothesis includes the report that expression of 
CFTR message and the functional presence of the ORCC do not correlate in several cell 
lines, including the intestinal T84 and CaCo-2 lines, the pancreatic line PANC- I ,  and 
the airway epithelial cell line 9HTEo- (Ward ci ai., 1991). In addition. transfection of 
CF bronchial epithelial cells with the wild-type CFTR gene not only results in the 
appearance of the characteristic CFTR currents (small-conductance. with a linear 
current-voltage relationship), but also corrects the defect in CAMP sensitivity of the 
larger, outwardly-rectifying chloride channel (Egan cr al., 1992). 
Finally, separate identities for the ORCC and CFTR were definitively 
established when an animal model for CF became available. CF 'knockout' mice were 
created by replacing the wild-type CFTR gene in embryonic stem cells with a truncated 
version of the CFTR gene; these stem cells were then used to breed a population of mice 
homozygous for this defective CFTR gene (cfrr -1- mice) ( Koller el a/. , 199 1 ; 
Snouwaert ei ai., 1992). The presence of functional ORCC in CF knockout mice could 
be demonstrated by subjecting membrane patches excised from nasal epithelial cells to 
strong depolarizing voltages. These same outwardly-rectifying channels could not be 
activated by exposure to PKA and ATP, although the ORCC was responsive to PKA 
and ATP in patches from normal cells (Gabriel el aL, 1993). Hence, in the absence of 
functional CFTR, the ORCC lacks sensitivity to protein kinase A despite the physical 
presence of the channel in the membrane of CF cells. 
2.3.1.4.2.2 CFTR Regulation of ENaC 
In cystic fibrosis airway epithelial cells, although chloride conductance is lo 
than normal, the basal rate of sodium absorption across the apical membrane is greater 
than in normal cells (Knowles el al., 198 1 ; Knowles & Boucher, 1983; Boucher el 01.. 
1986; Duszyk & French, 1989; Grubb el al., 1994). This hyperabsorption appears to be 
caused by an increased sodium permeability secondary to an increase in the open 
probability of apical sodium channels (Chinet el al., 1994). Unusually for airway 
epithelia, P-adrenergic stimuli further increase sodium absorption in CF but not in 
normal cells (Boucher cr ul., 1 986). 
The sodium channels present in airway and many other epithelial cells vary in 
their exact characteristics. but are generally distinguished by their sensitivity, as a 
family, to the inhibitor miloride. These channels arc otherwise classified based on 
biophysical properties including channel kinetics, cation selectivity. and pharmacology 
(Benos et d . ,  1995). Sodium channel complexes havc been biochemically purified 
from a number of cells or tissues such as bovine renal collecting tubules, toad urinary 
bladder, and renal A6 cells (Benos el al. , 1995). An amiloride-sensitive epithelial 
sodium channel (rENaC) has also been cloned from rat distal colon (Canessa e l  a!., 
1993; Canessa et al., 1994). This channel consists of three homologous subunits (a, P, 
and y), of which the ar subunit alone is sufficient for channel activity when expressed in 
planar lipid bilayers (Canessa et of., 1993; Canessa et ul., 1994). The P and y subunits 
cannot individually act as sodium channels, but may be involved in conferring 
regulatory properties to the channel formed by the association of the three subunits 
(Benos st al., 1995; Ismailov et nl., 1997). While the main conductance state of the 
irnmunopurified bovine renal channel is 39 pS, DTT treatment reduces this conductance 
state to 13 pS, which is consistent with the single-channel conductance reported for 
rENaC (Benos et al., 1997). The suggestion has been made, therefore, that ar,P,y- 
rENaC is the core conductance unit of the native sodium channel protein complex 
(Benos el al., 1997) 
The introduction of CFTR into MDCK cells transfected with the cloned rat 
epithelial sodium channel causes a decrease in Na' current through these channels; 
furthermore, CFTR expression also alters the rENaC response to cAMP agonists in 
these cells. In the presence of CFTR, elevation of cAMP inhibits the Na' current, 
whereas in the absencc of functional CFTR, cAMP agonists stimulate the Na' current 
(Stutts et crl., 1995b). The sodium hyperabsorption in CF airways may therefore result 
from the lack of a natural inhibitor of ENaC activity, namely, the CFTR protein 
(Isrnailov er al., 1996; Stutts er al., 1997). 
The precise mechanism by which CFTR regulates the sodium channel is not 
currently known. I t  secms clear that CFTR affects ENaC at the level of single-channel 
activity, rather than by increasing the number of channel units in the membrane (Stutts 
ct al., 1995b; Ismailov er a/., 1996). The possibility exists that CFTR interacts directly 
with ENaC to inhibit channel activity: when immunopurified CFTR is coincoporated 
into planar lipid bilayers with rENaC, the single-channel activity of rENaC is decreased 
compared to rENaC activity in the absence of CFTR (Ismailov et al., 1996). CFTR has 
no effect on the channel formed by a-rENaC alone (Ismailov et al., 1997), but appears 
to require the presence of the p and the y subunits to exert its inhibitory influence on 
sodium channel activity (Ismailov el al., 1 997). 
In addition, CFTR may influence sodium channel activity through other protein 
intermediaries. Many recent reports have implicated cytoskeletal elements in the 
control of epithelial ion transport (Mills & Mandel, 1994). In particular, short actin 
filaments have been shown to increase the activity of both CFTR and ENaC; 
monomeric actin or actin in the longer filamentous (F-actin) form have no such effect 
(Cantiello, 1995; Prat er al., 1 995; Berdiev el ol., 1996). 
Short actin filaments are thought to confer PKA responsiveness to ENaC; only 
those actin filaments phosphorylated by PK A can stimulate sodium channel activity 
(Prat el al.. 1993; Cantiello, 1995; Berdiev el  al., 1996). Short actin polymers (trimers 
or tetramers) have been shown to physically interact with the a subunit of rENaC 
(Ismailov el al., 1997). The actin-mediated sensitivity of rENaC to PK A is inhibited by 
the presence of functional CFTR (Ismailov el al., 1996; Mall el al., 1996). 
Nonfunctional CFTR, such as the AF508 mutant (Mall el al., 1996) or the G55 1 D 
mutant (IsmaiIov el al., 1996), does not inhibit ENaC activity. 
Hence, in airway cells expressing both normal CFTR and these sodium 
channels, activation of I'KA may cause the simultaneous activation of chloride 
conductance and inhibition of sodium transport. In cclls either lacking CFTR or 
containing nonfunctional mutants, PKA activation would have the opposite effect: 
chloride secretion would not be elicited, but sodium transport would be upregulated. 
In summary, CFTR may exert regulatory control over arniloride-sensitive 
sodium channels in at least two ways: first, through direct protein-protein associations. 
and second, through interactions mediated by the acti n cytoskeleton. 
2.3.1.4.3 CFTR as a Potential Transporter of Other Substances 
2.3.1.43.1 CFTR-associated Bicarbonate Secretion 
The ability of the small intestine to secrete bicarbonate ions into the lumen plays 
an essential role in stabilising the pH of this extracellular compartment. This is 
particularly important in the duodenum, which is continually exposed to acidic material 
entering the gut from the stomach. While much of this duodenal bicarbonate secretion 
is electroneutral and occurs through the action of the CI- /HCOi exhanger, and some 
bicarbonate transport can be measured through the paracellular pathway, a significant 
portion occurs electrogenically (Allen el aL, 1993). cAMP agonists have been shown to 
stimulate electrogenic bicarbonate transport in the duodenum (Allen el al.. 1993) and in 
airway, biliary, and pancreatic epithelia (Illek et al., 1997). 
Because CAMP-regulated bicarbonate secretion is also defective (Smith & 
Welsh, 1992) in addition to the defective chloride conductance in CF airway epithelia, 
an interest was taken in the potential role of CFTR in the bicarbonate secretory process. 
Under basal conditions, airway epithelia secrete H' into the mucosal fluid; cAMP 
agonists prevent excess acidification of the airway fluid, presumably by stimulating 
bicarbonate secretion (Smith & Welsh, 1993). 3T3 fibroblasts or C 127i mouse 
mammary carcinoma cells transfected with AF508 CFTR, and mock-transfected cells, 
cannot modify their internal pH in response to an acid exposure (Poulsen ef a/. , 1994). 
3T3 or C127i cells transfected with wild-type CFTR, on the other hand, show an ability 
to recover rapidly from this acidification (Poulsen el ol., 1994). The CFTR-like channel 
which appeared after transfection of these cells exhibits a bicarbonate permeability, 
albeit with a quarter of its permeability to Cl- (Poulsen el al., 1994). 
Several studies have been carried out using thc CF knockout mouse to 
investigate the effects of defective CFTR on bicarbonate secretion in the small intestine. 
The consensus is that not only are basal levels of bicarbonate secretion lower in the 
duodena of cfir (-/-) mice. but the bicarbonate secretory response to cAMP agonists is 
significantly diminished compared to that of normal. cfir (+I+) liucrmates (Grubb. 1995: 
Hogan ef al., 1997a; Hogan el a/. ,  1997b). This is consistent with thc earlier 
observations that the CAMP-induced bicarbonate secretory response is defective in CF 
airway epithelia (Smith & Welsh, 1992) and pancreatic epithelia (Welsh ei al., 1995). 
Bicarbonate secretion can be stimulated by agents which increase intracellular 
cGMP production as wcll as by those which increase the production of CAMP. 
Guanylin, for example, increases electrogenic bicarbonate secretion as well as chloride 
secretion by rat duodenal mucosa, and this bicarbonate secretion can be inhibited by 
CFTR channel blockers (Guba el al., 1996). Interestingly, while cGMP agonists appear 
to increase intestinal chloride and bicarbonate secretion in a roughly equivalent fashion, 
cAMP agonists have a much greater effect on chloride secretion than on bicarbonate 
secretion (Guba ei al.. 1996; Field, 1996). 
The physiological mediator of this bicarbonate transport is still under debate. 
The demonstrated ability of CFTR to conduct bicarbonate ions. though with a much 
lower selectivity than for chloride, the absence of CAMP-induced bicarbonate secretion 
in CF epithelia, and the sensitivity of the cGMP- and CAMP-stimulated bicarbonate 
secretion to known CFTR inhibitors such as NPPB (Guba er al. , 1996), DPC, and 
glybenclamide (Illek et a!., 1997) are cited as evidence that CFTR is directly 
responsible for bicarbonate transport (Field. 1996; Guba el al., 1996; Illek ei al., 1997). 
Other investigators agree that while functional CFTR is required for normal bicarbonate 
secretion, it is not the sole candidate for the electrogenic pathway (Grubb, 1995). The 
ORCC, for example, is more permeable than CFTR to bicarbonate ions (Tabcharani el 
al., 1989). and its regulation is also defective in cystic fibrosis. Hence, while CFTR is 
definitely associated with this conductive pathway, the evidence is not yet conclusive 
that CFTR acts as the physiological mediator of epithelial bicarbonate secretion. 
2.3.1 A.3.2 CFTR-associated ATP transport 
The ability of extracellular nucleotides to stimulate ion transport has been 
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documented in a variety of epithelial cell types (Knowles el al., 1 99 1 ; Dho el uf., 
1992). The ORCC can be activated by extracellular ATP. for example. and it has been 
suggested that the regulatory effect of CFTR on the ORCC may involve autocoid 
activation by this extracellular nucleotide (Stutts ei al., 1992; Schwiebert el al., 1995b). 
This led to the speculation that CFTR might either activate a distinct ATP transport 
mechanism, or itself serve as an ATP-permeable pathway (Schwiebert cr al., 199%). 
This distinction is a critical and, currently, a controversial one. A number of 
investigators have published reports consistent with a model in which the CFTR 
molecule acts as the mediator of ATP transport across the cell membrane. Others have 
been unable to reproduce these findings, or have observed phenomena which directly 
contradict this model. 
In C127i cells, a CAMP-activated whole-cell ATP current was observed in cells 
transfected with wild-type CFTR, but not in mock-transfected cells (Reisin el of., 1994). 
This current exhibited a pattern of sensitivity to chloride channel blockers similar to that 
of the whole-cell chloride current attributable to CFTR. Measurements of the reversal 
potential indicated that the ATP- anion was the charge carrier, and no current was 
observed when ATP- was replaced with SO," (Reisin ei al., 1994) 
In the CF airway epithelial cell line IB3-1, release of 32y-ATP was only observed 
when CFTR-transfected cells were stimulated with CAMP agonists; no such release was 
seen in mock-transfectcd or unstimulated cells (Schwiebert at al., 1995b). The CFTR 
blocker glybenclamide inhibited ATP release. Both research groups furthermore 
demonstrated, in excised membrane patches, single-channel ATP currents through 
channels with biophysical properties very similar to those of CFTR (Reisin el al., 1994; 
Schwiebert et al., 1 995b). 
Other groups were unable to demonstrate ATP transport through CFTR in a 
number of experimental systems. ATP permeability could not be shown in human 
sweat duct or the Calu-3 lung cell line, both of which express CFTR endogenously 
(Reddy et al., 1996), nor was it observed in Chinese hamster ovary cells stably 
transfected with CFTR (Grygorczyk et al., 1996; Reddy et a/. , 1 996). This last study 
directly contradicts another report in which CFTR-associated ATP channels were 
observed in the plasma membrane and outer nuclear membrane of CFTR-transfec~ed 
CHO cells (Pasyk & Foskett, 1997). Two independent groups of invcstiga~ors further 
demonstrated that ATP was not transported through purified CFTR reconstituted into 
planar lipid bilayers (Li ef al., 1996a; Reddy cf al., 1996). 
Because electrophysiological studies may not be sensitive enough to record very 
smaII fluxes of ATP across membranes, ATP-release Iuminometry assays have also 
been performed on a variety of ceil types. Again, contradictory results have been 
reported. In assays performed on CFTR-transfected C 1 27i cells, CFTR expression was 
shown to correlate with CAMP-stimulated ATP transport into the extracelluar medium 
(Prat ef aL, 19%). Similar results were reported in T84 cells. and this release of ATP 
could be blocked by the introduction of antisense CFTR oligonucleotides (Abraham el 
aL, 1997). Other investigators have reported that under similar conditions T84 cells, as 
well as a number of other epithelial cell types, were not observed to release ATP into 
the extracellular medium following CAMP stimulation, though these cells often released 
ATP when subjected to mild mechanical stimuli (Grygorczyk & Hanrahan, 1997a: 
Grygorczyk & Hanrahan, 1997b). 
No consensus currently exists, therefore, concerning whether CFTR itself 
mediates ATP transport from the intracellular to the extracellular environment, or 
whether it simply activates a closely associated ATP channel. Variations in 
experimental conditions may account for some of the conflicting observations, but a 
number of reports remain to be reconciled before a workable model can be constructed 
to explain the relationship between CFTR and ATP transport. 
2.3.1.5 Regulation of CFTR Activity 
The activity of CFTR is relatively low in resting cells. In cells which have been 
stimulated by chemical or hormonal agonists, however, chloride currents attributable to 
CFTR increase greatly. Under baseline conditions, therefore, channel activity of CFTR 
must be under tight regulatory control, and this activity must have the ability to change 
depending upon the physiological status of the cell. The CFTR protein must 
consequently contain mechanisms whereby it can respond to stimuli with a change in 
channel activity. 
2.3.1.5.1 Regulation by Serine/threonine Kinases 
2.3.1.5.1.1 Regulation by CAMP-dependent Protein Kinase (PKA) 
Physiological and pharmacological agents that are classified as cAMP agonists 
act by stimulating the production of the cytosolic second messenger cAMP through the 
activation of membrane-associated adenylate cyclase. cAMP initiates a cascade of 
intracellular events by converting protein kinase A from its inactive to its active form; 
the activated kinase then modifies the activity of substrate proteins by phosphory lating 
them on serine or threonine residues. 
cAMP agonists cause an increase in the whole-cell chloride-selective current in 
cells expressing CFTR (Tabcharani el al., 1990; Cliff and Frizzell. 1 990; Kartner el al.. 
1991). The addition of the purified catalytic subunit of PKA and ATIJ to excised 
membrane patches fiom CFTR-transfected cells also results in the activation of a 
chloride-selective single-channel current (Berger el ol., 199 1 ; Tabcharani et al., 1 99 1 ). 
Moreover, purified recombinant CFTR reconstituted into planar lipid bilayers is also 
activated by the addition of PKA and ATP (Bear et al., 1992). This chloride 
conductance can be reversed by the removal of cAMP or by the addition of the Walsh 
peptide, an inhibitor of PKA (Tabcharani ef a/. , 1991). Clearly, therefore, activation of 
PKA results in increased CFTR activity. 
The protein kinase-A mediated activation of CFTR may be direct, through 
phosphorylation of CFTR itself, or indirect, through phosphorylation of other proteins 
which then act upon CFTR. Because CFTR contains ten classic consensus sites for 
PKA phosphorylation (Riordan el al., 1989), it seemed likely that CFTR was a direct 
target for kinase activity. Nine of these ten PKA consensus sites are contained within 
the R region of the CFTR protein (Riordan et al., l989), and phosphorylation of CFTR 
by PKA has been demonstrated both in vifro (Gregory et al., 1990; Cheng ef al., 199 I : 
Picciotto el al., 1992) and in vivo (Cheng el al., 199 1 ; Tabcharani el ul., 1 99 1 ; Picciotto 
e f  al., 1 992). 
Specific residues have been identified as targcts of PKA-mediated 
phosphorylation. In general, the results of the in vifro and in vivo phosphorylation 
assays correlate, in that all of the residues reported to be phosphorylated in vivo are also 
phosphorylated in lritro (Cheng e l  al., 199 1 ; Picciotto el al. , 1992; Dulhanty & Riordan, 
1994). For example, Cheng and coworkers reported the phosphorylation of seven serine 
residues in vitro, and four of those seven were phosphorylated in viva (Cheng el a/., 
1991). All of the serinc residues which are phosphorylated in vivo are contained within 
the R region (Cheng e l  ui., 199 1 ; Picciotto el al., 1992). 
The relative contribution of each phosphoserine to CFTR activation is a 
contro\?ersial subject. Point mutation studies in which individual serine residues were 
converted to non-phosphoacceptor alanines have reported conflicting results. The 
substitution of any single serine has little effect on CFTR activity in response to PKA 
(Cheng ef 01.. 199 I), and while, originally, triple and quadruple mutants were thought to 
show a greatly reduced response (Cheng et al., 199 1 ), later studies showed that these 
mutants still retain the ability to respond to PKA (Chang e f  a l ,  1993). In fact, CFTR 
still remains responsive to PKA even after mutagenesis of ail ten potential 
phosphoacceptor sites from serine to alanine (Chang el al.. 1993). 
Because these ten consensus sites are categorised as "classical" or "strong" sites 
for PKA phosphorylation, the proposal was made that CFTR may contain additional 
cryptic or weaker consensus sequences that can also be phosphorylated by PKA. and 
that these sites might be responsible for the CFTR response in the absence of the ten 
classic sites (Chang el d., 1993). The 1 OSA mutant retains approximately 25% of the 
responsiveness of the wild-type CFTR, even though phosphorylation of this mutant by 
PKA could not originally be detected in vifro (Chang el al., 1993). The investigators 
concluded that the PKA-responsiveness of the 1 OSA mutant must be mediated by a 
previously undetected phosphoacceptor serine. In fact, the use of systems expressing 
large amounts of CFTR allowed these investigators to confirm that serine 753 is 
phosphorylated in the 1 OSA mutant, and that conversion of this serine to an alanine 
residue eliminates most of the remaining PKA-responsiveness ofthe I OSA mutant 
(Seibert el al., 1995). The relevance of Ser-753 phosphorylation 10 the activity of wild- 
type CFTR in physiological situations, however, has not been determined. 
An alternative possibility is that phosphorylation may have different effects on 
different serine residues. A recent report suggests that phosphorylation has a 
stirnulatory effect on some serine residues in the R domain and an inhibitory effect on 
others, and that the final activity level of CFTR in response to PKA might therefore be 
an additive one (Riordan, 1994; Wilkinson el al., 1997). 
Intriguingly, construction of a mutant in which the R domain is deleted 
(CFTRAR) results in a constitutively active channel (Rich el al., 1991), unlike wild-type 
CFTR, which requires a CAMP-mediated stimulus to attain maximal activity. Based on 
these findings, the proposal was made that the R domain normally inhibits channel 
activity, and that phosphorylation of sites within the R domain might either contribute 
to a conformational change which allows ion movement through the CFTR 
transmembrane pore (Rich er aL, 199 I), or that phosphorylation might increase the 
electrostatic repulsive forces between the R domain and some other part of the protein, 
presumably the mouth of the ion channel (Rich el al. , 1991 ; Fuller & Benos, 1992). 
In fact, PKA-mediated phosphorylation of shark and human R domain 
polypeptides has been shown to cause a decrease in the amount of a-helix in the protein, 
with a corresponding increase in the random coil content as measured by circular 
dichroism spectroscopy (Dulhanty & Riordan, 1994). The investigators suggested that 
these findings support the notion of a conformational change causing a shift of the R 
domain, following phosphorylation, to expose the mouth of the CFTR ion channel and 
allow ion passage (Dulhanty & Riordan, 1994). Hence, an analogy has been made to 
the ball-and-chain modcl of the Shaker potassium channel, in that the R domain may act 
as a tethered "ball" which can reversibly plug the CFTR ion pore (Fuller & Benos, 
1992; Rich el al., 1993). 
2.3.1.5.1.2 Regulation by Protein Kinase C (PKC) 
In addition to the consensus sites for PKA, the CFTR R domain also contains 
seven consensus sequences for phosphorylation by protein kinase C (PKC); additional 
PKC consensus sites arc found outside the regiliatory rcgion (Riordan el ul.. 1989). 
The sites within the R domain can be phosphorylated by PKC in vitro (Picciotto ef  ul., 
1992; Berger el al., 1993) and in vivo (Picciotto et al., 1992). However, while the 
consensus sites outside the R region can be phosphorylated in vitro, they do not appear 
to be phosphorylated in vivo (Picciotto et al., 1992). 
Protein kinase C is activated when certain agonists increase the cell membrane 
turnover of phosphatidylinositol phosphate, an event which results in the generation of 
inositol trisphosphate (IP,) and diacylglycerol (DAG) (Nishizuka, 1995). DAG is 
directly responsible for PKC activation, while IP, stimulates the release of calcium from 
intracelluiar stores (Nishizuka, 1995). Protein kinase C can also be activated by phorbol 
esters, a class of tumor-promoting agents that includes phorbol 12-myristate 13-acetate 
(PMA) and phorbol 12, I Mibutyrate (PDB) pewton, 19951. 
The role of PKC in the regulation of CFTR is less clear than the role of PKA. In 
3T3 cells (Berger et al.. 1993) and CHO cells (Tabcharani et al., 199 1 ) transfected with 
CFTR, the addition of I'KC to excised membrane patches stimulated CFTR channel 
activity. In both cases, however, the magnitude of the current activated by PKC was 
much smaller than that activated by PKA (Tabcharani el al., 199 1 ; Berger el al.. 1 993). 
Furthermore, while one group reported that PKA-stimulated currents were higher in the 
presence than in the absence of PKC (Tabcharani el ul., 1 99 1 ), the other group found no 
such effect (Berger el a/., 1993). 
A more recent report suggests that in the CHO expression system, constituitivc 
phosphorylation of CFTR by PKC may be required for acute PKA activation of the 
channel (Jia ef  aL, 1997). CFTR channel activity normally decreases over time after 
exposure of excised patches to PKA, a phenomenon referred to as channel rundown; 
this rundown could be reversed in these studies by thc addition of PKC to the bath 
solution. In addition, pretreatment of the cells with the PKC inhibitor chelerythrinc 
prevented the activation of CFTR by PKA. The investigators suggested that CFTR 
channel rundown is due in part to the progressive dephosphorylation of PKC sites, and 
furthermore that the initial stimulus of CFTR by PKA requires a basal level of CFTR 
phosphorylation by PKC (Jia el al., 1997). These results are consistent with the 
findings of several other investigators, but whether this phenomenon can bc reproduced 
in other systems remains to be studied. 
In some epithelial cell types endogenously expressing CFTR. activation of PKC 
alone has a small but significant effect on chloride secretion, as well as exerting a 
synergistic effect on CAMP-stimulated secretion. Short-term activation of PKC by 
phorbol esters causes an increased chloride secretion in HT-29 cells (Vaandrager at al., 
1992; Bajnath el a/. ,  1993), though exposure to these tumor promoters for more than 
two hours tends to inhibit CFTR activity (Vaandrager et al., 1992; Breuer et al., 1993). 
The long-term inhibitory effects of PKC have been variousiy ascribed to PKC-mediated 
downregulation of basolateral potassium transport (Vaandrager st ul., 1 992) and to 
increased CFTR proteolysis (Breuer el al., 1993). 
In T84 intestinal epithelial cells, most investigators report that activation of PKC 
by phorbol esters has no effect on chloride secretion (Warhurst el al., 199 1 ; Kachintom 
ei al. , 1 992; Reenstra, 1993), though there are reports that exposure to PMA can 
stimulate an apical chloride conductive pathway (Lindeman & Chase, 1992). The 
predominant effect of PKC activation in this cell line appears to be the inhibition of 
CAMP-dependent chloride secretion (Trapnell ei al., 1 99 1 ; Warhurst et al., 199 1 ; Shen 
el aL, 1993), though again, there are conflicting reports concerning this phenomenon 
(Reenstra, 1993). Various proposals have been made to explain this inhibitory effect, 
including PKC-mediated inhibition of basolateral potassium channels (Reenstra, 1993; 
Shen et a/., 1993), and, based on the PMA-induced decrease in CFTR message in these 
cells, downregulation of CFTR protein in the apical membrane (Trapnell et al., 199 1 ). 
To summarize, while the effects of protein kinase A on CFTR activity arc 
clearly always stirnulatory regardless of the cell system under investigation, the 
consequences of protein kinase C activation are more obscure. A number of isoforms of 
PKC have been identified (Newton, 1995; Nishizuka. 1999, with different biophysical 
properties and patterns of tissue expression. Future investigations will require more 
carefully defined experimental parameters in order to hlly clarify the effects of this 
kinase on CFTR fimction. 
2.3.1.5.1.3 Regulation by cGMP-dependent Protein Kinase (PKG) 
A variety of enteropathogenic microorganisms can cause secretory diarrhea a 
disease which can result in a potentially life-threatening loss of fluid and electrolytes. 
Certain Escherichia c d i  strains produce a heat-stable enterotoxin (STa), and this 
peptide is responsible in many cases for inducing the intestinal secretory response by 
stimulating the production of cGMP in rnucosal epithelia (Vaandrager & De Jonge, 
1994). 
STa structuraIly resembles the endogenous intestinal epithelial peptide guanylin, 
and both molecules act through the same epithelial receptor to activate a membrane- 
associated form of guanylate cyclase (GC) (Forte & Hamra, 1996). At least two 
isoforms of guanylate cyclase exist. but the only form which can be detected in 
intestinal epithelia is the GC-C isoform (Jarchau er al.. 1994; Vaandrager & De Jonge, 
1994 ). Activation of GC-C, like the activation of adenylate cyclase, results in an 
increased intracellular production of a cyclic nucleotide second messenger: in this case. 
cGMP. cGMP acts in a manner analogous to cAIMP. activating cGMP-dependent 
protein kinases (PKG. also known as cGK), as well as regulating specific 
phosphodiesterases (Vaandrager & De Jonge. 1994) . There is also evidence that cGMP 
can gate certain channels through direct interactions with these proteins (Vaandrager & 
De Jonge. 1994). 
The elevated cGMP levels evoked by STa binding correlate with large increases 
in chloride secretion into the intestinal lumen; salt and water absorptive activities are 
thought to be simultaneously inhibited (Vaandrager & De Jonge, 1994). Functional 
CFTR is required for this chloride secretion, since in CF humans and CF knockout 
mice. the intestinal epithelium is unresponsive to cGMP analogues as well as to CAMP 
(O'Loughlin e t  al., 1 99 1 ; Cuthbert et al., 1994; Goldstein el  al., 1994; Vaandrager & De 
Jonge, 1994). 
The mechanism by which this increase in cGMP activates CFTR is still under 
investigation. The secretory response to cGMP in T81 cells and in CaCo-2 intestinal 
epithelial cells has been ascribed to a cGMP-mediated activation of PKA. rather than to 
an activation of a cGMP-dependent kinase (Forte et ul., 1992; Tien er al., 1993; Chao el 
a!. , 1994; Cuthbert er a[., 1994), although one group of investigators reported that the 
secretory response in T84 cells was due solely to the activation of PKG (Lin et al., 
1 992). 
CFTR can be phosphorylated in vitro by PKG purified from bovine lung 
(Picciotto el a/., 1992; Berger et al. , 1993). In h m a n  airway epithelia, however, CFTR 
does not respond in vivo to cGMP agonists, nor can excised membrane patches 
containing CFTR be activated by the direct addition of cGMP and PKG (Berger el al.. 
1993). 
The different results obtained from ainvay and intestinal epithelia may be 
explained by a tissue-specific distribution of PKG isozymes. The enzyme purified from 
bovine lung is the type la isoform (Berger el ul.. 1993), which is restricted in the 
intestine to smooth muscle cells of the lamina propria (Marken et til . .  1995). The 
isoforrn expressed in the epithelial layer of the small intestine and the proximal colon is 
the type I1 isoform (Jarchau er a/,, 1994; Markert er al. . 1995). Importantly, PKG I1 
mRNA cannot be detected in airway epithelia, nor can its presence be demonstrated in 
the intestinal epithelial cell lines T84, CaCo-2. or HT-29.c119A (Jarchau el al., 1994; 
~Markert el ul., 1995). Outside the intestine, PKG I1 message has only been detected in 
brain and kidney (Jarchau el ul., 1994). 
The phosphoacceptor sites on CFTR which are recognised by PKG I overlap 
with those recognised by PIW; the sites phosphorylated by PKG I in vitro are four of 
the sites phosphorylated by PKA (Picciotto el al., 1992). Phosphopeptide mapping 
demonstrates that the pattern of in vitro phosphorylation oFCFTR by PKG 11 is similar 
to that of PKG I. but with one significant exception. One peptide phosphorylated by 
PKA and PKG I1 is not phosphorylated by PKG I (French el aL, 1995). though it is not 
clear which specific residue within the peptide is phosphorylated. Differential 
phosphorylation of the CFTR molecule by PKG 1 and PKG 11 may therefore account for 
the difference in the abilities of the two kinases to activate CFTR. 
PKG 11, but not PKG I, can activate CFTR in membrane patches excised from 
stably transfected 3T3 fibroblasts and the rat intestinal cell line IEC-CF7 (French ei al., 
1995). Likewise, whereas coexpression of CFTR and PKG I1 in the rat intestinal cell 
line confers sensitivity to stimulation by cGMP agonists to these cells, coexpression of 
CFTR and PKG ip does not (Vaandrager et al., 1997). These findings are consistent 
with a model in which the stimulation of chloride secretion in the intestine in response 
to cGMP agonists occurs only in the presence of functional GC-C. PKG 11, and CFTR. 
The secretory response to cGMP agonists in cells lacking PKG I1 has been proposed to 
occur as a result of a cross-activation of PKA by very high levels of cGMP (Vaandrager 
& De Jonge, 1 994; Markert el al., 1995). 
2.3.1 S.2 Regulation by Nucleotides 
2.3.1.5.2.1 Regulation by Intracelluiar Nucleotides 
The presence of ATP is an absolute requirement for CFTR activity. 
Phosphorylation of the R domain by protein kinase A, first of all, is necessary but not 
sufficient to open the channel (Anderson el of., 1 99 1 ; Bell & Quinton, 1 993). Most 
investigators report that the channel will remain open after this PKA-mediated 
phosphorylation only as long as ATP or its hydrolyzable analogues remain present in 
the cell or bath solution (Anderson el al., 199 1 ; Nagel el a!. , 1992). 
The additional requirement for ATP over and above its role as a source of 
phosphorylation is related to its ability to interact with the two nucleotide binding 
domains of the CFTR molecule, labelled NBD 1 and NBD2. Some debate initially arose 
as to whether hydrolysis necessarily accompanies ATP binding to these domains, due to 
the fact that some reports indicated that the nonhydrolyzable analogue 5'-adenosine 
(P, y -imino) triphosphate (AMP-PNP) can stimulate CFTR activity in sweat glands 
(Quinton & Reddy, 1992) and in T84 cells (Bell & Quinton. 1993). These investigators 
suggested that nonhydrolytic ATP binding to CFTR might provide a mechanism 
through which CFTR activation is linked to cellular energy levels in order to prevent 
depletion of energy reserves through excessive chloride secretion (Quinton & Reddy, 
1992; Bell & Quinton, 1993; Riordan, 1994). 
This activation by AMP-PNP appears to depend. however, on the 
phosphorylation status of CFTR. AMP-PNP only stimulates CFTR activity under 
conditions in which the protein has already been phosphorylated by PKA (Bell & 
Quinton, 1993; Hwang et d., 1994; Carson el a l ,  1995). Reports of CFTR activation 
by AMP-PNP can therefore be reconciled with reports that this nucleotide does not 
activate CFTR, since in these earlier studies the channel was not phosphorylated 
(Anderson et a/. , 199 1 ). 
Mutation analysis and experiments with various nucleotide analogues support 
the hypothesis that the interaction of ATP with both nucleotide binding domains is part 
of the gating cycle of CFTR. Most of the reports concerning nucleotide interaction with 
CFTR are consistent with a cycle made up of four separate stages or states, all of which 
occur after the R domain has been phosphorylated by PKA (Gadsby & Naim. 1994; 
Hwang el al-, 1994; Carson el a/., 1995). The first state occurs before the binding of 
ATP to either NBD, and in the second, ATP has bound to both domains. The channel 
remains closed in both of these states. Following ATP hydrolysis at the first NBD 
(NBDI), the CFTR channel opens. In the final state, hydrolysis of the second ATP at 
NBD2 promotes closing of the channel (Gadsby & Naim, 1994; Hwang el dl., 1994; 
Carson el al., 1995). Hydrolytic activity of CFTR was recently demonstrated, and 
shown to be dependent upon the presence of Mg2+ and phosphorylation of the CFTR 
protein, which confirms the proposed CFTR gating hypothesis (Li el uf., 1996b). While 
this model may not fi l ly explain all of the observed aspects of CFTR gating, it serves as 
the best model of CFTR behaviour based on current knowledge. 
2.3.1.5.2.2 Regulation by Extracellular Nucleotides 
Extracellular nucleotides, and in particular ATP, are known to induce chloride 
secretion in a variety of epithelial and non-epithelial cell types (Dubyak & El- 
Moatassim, 1993). Epithelial cells which have been shown to respond to extracellular 
ATP include airway surface epithelium and tracheal submucosal glands, as well as 
pancreatic. biliary, and intestinal cell lines (Mason er al., 199 1 ; Dho el al., 1992; McGill 
et a!. , 1 994; Yamaya el a[., 1996; Chan et d., 1996). 
Investigations of the effects of extracellular nucleotides are complicated not only 
by the existence of multiple receptor subtypes for these ligands, but also by the rapid 
metabolism of ATP in the extracellular medium by a variety of ectonucleotidases 
(Dubyak & El-Moatassim, 1993). Activity of these enzymes results in the generation of 
ADP, AMP. and adenosine, substances which have also been shown to have a 
stimuiatory effect on chloride secretion in epithelial cells (Stutts er d., 1992). 
Transport of ATP from the intracellular to the extracellular environment may 
involve the exocytotic release of stored ATP (Dubyak & El-Moatassim, 1993) or the 
movement of ATP through specific plasma membrane transporters. As previously 
mentioned. some investigators have demonstrated permeability to ATP in membrane 
proteins such as P-glycoprotein and CFTR, though other reports are more consistent 
with an ATP transport pathway associated with. but distinct from. CFTR (Abraham et 
ui.. 1993; Devidas & Guggino. 1997). 
Purinergic receptors of at least five subtypes can be distinguished based on the 
relative affinities with which various nucleotides bind each receptor. The distribution of 
receptor subtypes varies according to cell type and tissue of origin (Dubyak & El- 
Moatassim. 1993), and purinergic receptors can be found on both apical and basolateral 
membranes in many epithelial cells (Knowles cr al.. 199 1 ; Mason et al., 199 1 ; Clarke & 
Boucher, 1992; Hwang er al. , 1996). 
P1, receptors appear to predominate in the apical membrane of airway surface 
epithelium and submucosai glands (Mason et al., 199 1 ; Yamaya et al, 1996). These 
apical P,, receptors stimulate chloride secretion via separate calcium-dependent and 
calcium-independent pathways (Stutts et al., 1 994; S tutts e l  al. , 1 995; Hwang el al., 
1996). Elevation of intracellular calcium activates an apical calcium-regulated chloride 
channel, while increased cAMP production is thought to activate CFTR and the ORCC 
(Stutts et al., 1994: Stutts et al., 1995a; Hwang et al.. 1996). Basolateral application of 
ATP in these cells activates a different population of purinergic receptors, and secretion 
in this case may be independent both of intracellular free calcium and cAMP levels, but 
appears to result from CFTR activity nonetheless (Hwang et al., 1996). 
CF airway epithelia respond differently to the application of extracellular ATP 
than do normal airway cells. Mucosal ATP or UTP stimulates chloride secretion in both 
normal and cystic fibrosis airway epithelial cells (Knowles el al., 199 1 ; Mason et a/.. 
199 1 ; Clarke & Boucher, 1992; Stutts et al., 1992), suggesting that apical purinergic 
receptors of the P2" subtype cause the activation of a chloride secretory pathway distinct 
from CFTR. Since P2, receptor activation is associated with an increase in intracellular 
free calcium levels, and because the calcium-regulated chloride secretory pathway is 
known to be preserved in CF (Widdicombe, 1986; Boucher et al., 1989; Anderson & 
Welsh. 199 1). it seems likely that ATP activates the calcium-regulated chloride channel 
in CF airway. Purinergic agonists are therefore included in the category of compounds 
which may have a possible therapeutic effect in CF (Clarke & Boucher. 1992; Collins. 
1992). 
Exposure of intestinal epithelial cells in monolayers to extracellular ATP also 
results in a chloride secretory response. The purinergic receptor profile of these cells 
remains a matter of debate, however. Both PZu purinergic and A2 adenosine receptors 
have been observed on the apical as well as the basolateral membranes of T84 cells. 
though there is some debate as to the relative contribution of each subtype to the net 
secretory response to extracellular ATP (Barrett er al.. 1989; Dho et al. , 1992; Stutts et 
al., 1995a). A? adenosine receptors stimulate cAMP production, and because CAMP- 
activated chloride channels are thought to predominate in intestinal chloride secretion, it 
has been suggested that A2 receptors rather than P2" receptors may account for the 
majority of the intestinal secretory response to mucosal ATP (Stutts et al., 199ja). 
Luminal purinergic P2 receptors have also been observed in other intestinal 
epithelial cell lines, including CaCo-2 cells and polarized HT29 subclones (Guo et al., 
1995; Merlin et al., 1996; Inoue et al., 1 997). In CaCo-2 cells, both apical and 
basolateral membranes contain P2u receptors; in addition, the apical membrane contains 
receptors specific for uridine, and ADP-specific receptors have been observed in the 
basolateral membrane (Inoue et ol., 1997). All of these receptors are linked to increases 
in intracelluiar calcium. which appears to result in chloride secretion due to CFTR 
activation subsequent to basolateral potassium efflux (Inoue et ul., 1997). 
2.3.1.6 Function of CFTR in Intracellular Organelles 
Not all investigators agree that the defect in plasma membrane CFTR activity 
alone can account for the entire spectrum of cellular abnormalities associated with 
cystic fibrosis. For example, CF mucus glycoproteins have elevated levels of 
fucosylation and sulfation and decreased sialy lation compared to non-CF 
glycoconjugates (Wesley et al., 1983 ; Cheng et al., 1989; Dosanjh et al.. 1994; Zhang et 
ub, 1995). Defective sialylation has been proposed to increase the susceptibility of CF 
airway epithelia to infection by Pseudornonas aeruginosa. as these cells express high 
levels of a receptor for this organism. identified as asialoganglioside 1 (aGM,) on their 
surfaces (Imundo et al.. 1995). Psezrdurnonas does not bind to the normally sialplated 
form of the molecule (GM,), nor do nonpathogenic bacteria such as Escherichia coli 
bind to aGM,, although Staphylococczrs aureus, another common CF pathogen, does 
bind aGM, (Krivan et ul., 1988; Irnundo el al. ,  1995). Hence, the production of airway 
mucus that is simply dehydrated due to defective chloride secretion may not be 
sufficient to explain the prominence of infections by Pseztdornonas and Staphylococczrs 
aurerrs in the CF clinical profile. 
Glycosylation of proteins and lipids occurs within the Golgi, and the addition of 
hcose, sulfate, and sialic acid in particular are thought to occur within the trans-Golgi 
network (Al-Awqati et al., 1992). These reactions appear to be competitive for 
substrate, and are pH-dependent (Al-Awqati el al.. 1992; Barasch & Al-Awqati, 1993). 
As such, the effectiveness of these enzymes depends strongly on the internal Golgi pH. 
The sial y Itransferases have acid pH optima, for example, while the hcosy Itransferases 
and sulfotransferases prefer to operate closer to neutral or slightly alkaline pH (Al- 
Awqati ef al., 1992). The internal pH of intracellular organelles is determined by the 
activity of an electrogenic vacuolar H+ ATPase, and the acidification of these 
compartments has been shown to depend on chloride channels which operate in parallel 
to the proton pump in order to maintain the transmembrane potential (Glickman et al-, 
1983; Mellman et al., 1 986). 
An elegant proposal made some time ago linked this requirement for chloride 
channel activity with the abnormal glycosyiation pattern seen in CF epithelia One 
group of investigators reported that the pH of prelysosomes, endosomes. and the trans- 
Golgi network was significantly higher in CF nasal epithelia than in normal cells 
(Barasch el al.. 199 1). They funhermore suggested that CFTR is responsible for the 
conductive chloride pathway in these organelles, and that the absence of CFTR activity 
generates this alkaline pH. High lumenal pH was predicted to favour activity of 
sulfotransferases over that of sialyltransferases, resulting in the production of 
hypersulfated. undersialylated glycoconjugates (Barasch el al., 199 1 ; Al-Awqati et al. . 
1992: Barasch & Al-Awqati. 1993). These findings are consistent with most reports 
concerning the composition of CF mucus glycoproteins (Wesley er al.. 1983; Cheng el 
al-. 1989; Dosanj h er a/.. 1994; Zhang et a/.. 1995). 
Functional CFTR has been demonstrated in the membranes of clathrin-coated 
vesicles (Bradbury el a/., 1 993), endoplasmic reticulum (Pasyk & Foskett, 1995), and 
endosomes (Lukacs er al., 1992; Biwerski & Verkrnan. 1994; Dunn el al., 1994). There 
is considerabIe debate, however, as to whether CFTR actually contributes to the 
acidification process in these compartments. Endosomal pH has been assessed in a 
number of CF and normal cells, for example. including 3T3 fibroblasts and CHO cells 
stably transfected with CFTR. T84 intestinal epithelia. and CFPAC- I pancreatic CF 
cells. as well as a rescued transfectant of this cell line (Lukacs et al.. 1992: Biwerski & 
Verkrnan. 1994; Dunn cr a/., 1994). In none o f  these studies was the pH of endosomes 
from CFTR-expressing cells shown to significantly differ from the pH of endosomes 
purified from cells not expressing CFTR, or which expressed defective CFTR. 
Investigators concluded that while CFTR may be present and functional in these 
membranes, the control of endosomal pH occurs through CFTR-independent pathways. 
Similar results were obtained in a study investigating the acidification of the 
trans-Golgi network. A technique was developed to measure the intra-Golgi pH in 
living cells, involving the selective fusion of liposomes containing fluorescent markers 
with the trans-Golgi space (Seksek el a!., 1996). The pH of the trans-Golgi was 
measured in 3T3 fibroblasts transfected with wild-type or with AF508 CFTR, and in 
untransfected fibroblasts. as well as in cells endogenously expressing CFTR such as the 
pulmonary Calu-3 cell line. Again, expression of CFTR did not significantly alter the 
pH of the trans-Golgi in any of the cells examined (Seksek et al., 1996). Since those 
cells not endogenously expressing CFTR presumably contain an alternative vacuolar 
chloride conductance, these results are not entirely surprising. 
They do. nonetheless. directly contradict the earlier reports of defective 
acidification in these intracellular organelles (Barasch el 01.. 199 1 ). While 
methodological differences and the use of non-genetically matched cell types may 
account for some of these inconsistencies, CF glycosy lation abnormalities may not 
currently be said with any degree of confidence to result from intracellular acidification 
defects. 
The proposed permeability of CFTR to nucleotides might. however. explain the 
abnormal glycosylation patterns seen in CF. Functional CFTR has been demonstrated 
in the ER membrane of CFTR-expressing CHO cells (Pasyk & Foskett. 1995). and 
CFTR in this membrane has also been associated with a CAMP-regulated ATP 
permeability (Pasyk & Foskett, 1997), leading to the suggestion that CFTR might 
furthermore be associated with transport pathways for other nucieotides in the 
membranes of internal organelles. Specifically of interest is the transport of 3'- 
phosphoadenosine 5'-phosphosulfate (PAPS). which is synthesized in the cytoplasm and 
then transported into the Golgi lumen. where it serves as the sulfate donor for sulfation 
reactions (Hirschburg & Snyder, 1987). CFTR in membrane patches excised from 
transfected CHO cells was reported to be permeable to PAPS as well as to ATP (Pasyk 
& Foskett, 1997). The authors speculated that CFTR might be involved in the 
regulation of PAPS concentration within the Golgi by serving as an alternative "leak" 
pathway, parallel to the PAPS transporter (Pasyk & Foskett, 1997). Absence of CFTR 
would consequently result in a higher intralurnenal PAPS concentration, thereby 
favouring sulfation reactions at the expense of sialylation reactions. 
A number of caveats apply to this hypothesis. The ATP permeability of  CFTR 
is not an accepted phenomenon, and the PAPS permeability was only demonstrated in 
the presence of high nucleotide concentrations on both sides of the excised plasma 
membrane patches (Pasyk & Foskett, 1997). Furthermore. while the earlier report by 
these authors had concluded that AFS08 CFTR is a functional chloride channel in the 
ER membrane. it is not known how the AF508 mutation might affect nucleotide 
permeability, if such a property exists. As well, this model does not offer an 
explanation for the absence of hypersulfation in cells that do not endogenously express 
CFTR. Consequently, while these preliminary findings may suggest an interesting 
avenue of investigation, further research will be required to clarify the association 
between C FTR and intracellular glycosy lation. 
The final intracellular role of CFTR under consideration concerns the insertion 
and retrieval of material from the plasma membrane via exocytosis and endocytosis. 
This hypothesis stems from reports that intracellular cAMP Ievels regulate membrane 
recycling (Bradbury et ul., 1992b; Sorscher et al., l992), and that vesicular chloride 
channels appear to be required for exocytosis of secretory granules (Gasser et al., 1988). 
The initial report directly linking CFTR activity with plasma membrane 
recycling demonstrated that cAMP agonists such as forskolin or CPT-CAMP inhibited 
endocytosis and stimulated exocytosis in CFPAC-1 cells transfected with hnctional 
CFTR, but not in mock-transfected or untransfected cells (Bradbury et al., 1992a). This 
led to the suggestion that cAMP not only stimulates chloride channel activity through 
activation of PKA, but also promotes the retention of chloride channel units at the cell 
surface, thereby increasing whole-cell chloride conductance (Bradbury ef al., 1992a; 
Bradbury et al., 1992b). 
Similar results have been reported in a number of other cell types, including T84 
intestinal epithelia (Prince el al., 1994; Santos & Reenstra, 1994) and CFTR-transfected 
HeLa cells and 3T3 fibroblasts (Biwersi et al., 1996; Howard et al., 1996). As well, 
other investigators confirmed these results in transfected CFPAC- 1 cells, and were 
further able to demonstrate that the inhibitory effects of forskolin on endocytosis are a 
property of wild type CFTR, but not the G55l D mutant (Prince et a!., 1994). 
The effects of cAMP on CFTR-associated membrane trafficking may be cell 
type-specific, however. cAMP does not appear to afkct the rates of exocytosis or 
endocytosis in transfected CHO cells (Dho et al., 1993), although CFTR is known to be 
present and functional in endosomes from such cells (Lukacs et al.. i 992). Likewise, 
forskoIin stimulation of human tracheal 9HTEo- cells did not correlate with an 
inhibition of endocytosis (Santos & Reenstra, 1994). Furthermore, the inhibitory effects 
of forskolin on T84 cells could not be duplicated with CPT-CAMP by these 
investigators. This led to the proposal that both the regulation of CFTR activity and the 
control of plasma membrane recycling may be CAMP-dependent. but that they are 
distinct processes (Dho et ul., 1993; Santos & Reenstra, 1994). 
In summary, while CFTR may be functional in the membranes of a number of 
intracellular organelles. a consensus has yet to be reached concerning the physiological 
importance of CFTR in these compartments. and what. if any. role defective 
intracellular CFTR might play in the development of CF-associated pathology. 
2.3.2 Other Apical Chloride Channels 
2.3.2.1 The Outwardly Rectifying Chloride Channel (ORCC) 
As previously mentioned, the defective chloride conductance in cystic fibrosis 
was initially attributed to an outwardly rectifying channel first described in human 
tracheal epithelial cells (Welsh, 1 986). This channel was CAMP-regulated in normal 
tissues, but did not respond to cAMP agonists in CF tissues (Welsh & Liedtke, 1986; 
Schournacher et al., 1987; Li et al., 1988). However, cloning of the CF gene allowed 
investigators to demonstrate that expression of this gene did not necessarily correlate 
with the presence of the ORCC in epithelial cells. Although the presence of the ORCC 
could be confirmed through depolarization-induced activation in T84, CaCo-2, PANC- 
I .  and 9HTEo-IS cell lines, significant amounts of CFTR message could only be 
detected by reverse transcriptase PCR in T84 and CaCo-2 cells (Ward er al.. 199 1). 
CFTR mRNA levels were extremely low in the pancreatic and tracheal cells compared 
to the intestinal cell lines. 
Furthermore, the appearance of a small-conductance, linear, chloride-selective 
channel in cells transfected with the CF gene (Anderson et al., 199 1 a; Kartner et a!. , 
199 1 ) led investigators to question the relationship between the ORCC and the CF gene 
product. Expression of wild-type CFTR in CF bronchial epithelial cells restored the 
PKA sensitivity of the ORCC currents (Egan et ai., 1992), and while the CF knockout 
mouse contains potentially functional ORCC, these channels are unresponsive to P U  
(Gabriel et al.. 1993). Thus, the presence of wild-type CFTR appears to be required for 
normal activation of ORCC in epithelial cells. This requirement has also been shown 
when the two proteins are co-incorporated into planar lipid bilayers and purified PKA 
and ATP are supplied in the bath solutions (Jovov er d.. 1 99%). 
Once separate idsntities had been established for CFTR and ORCC, it became 
clear that the two channels had distinct biophysical properties. The ORCC is anion- 
selective, with a halide permeability sequence of I- > Cl' > Br' (Halm & Frizzell, 1 992). 
The current-voltage relationship of the ORCC is outwardly rectifying, meaning that the 
channel conducts more current at higher voltages in symmetrical chloride solutions 
(Welsh, 1986; Halm & Frizzell, 1992). The single-channel conductance of the ORCC is 
voltage-dependent: at depolarizing voltages, the channel conductance is 60-80 pS. while 
at hyperpolarizing voltages, the single-channel conductance ranges between 20 and 40 
pS when measured in symmetrical chloride solutions (Frizzell & Halm. 1990; Halm & 
Frizzell, 1992). Also, as already mentioned, the ORCC can be activated both in normal 
and in cystic fibrosis cells by a sustained exposure to depolarizing voltages over +5O 
mV (Hwang et ol., 1989), which provides a convenient means of confirming the 
presence of the channel in excised membrane patches. 
The pharmacological profile of the ORCC includes a sensitivity to anthracene-9- 
carboxyiate and its derivatives such as DPC and 5-nitro-2-(3- 
pheny1propylamino)benzoic acid (NPPB) (Welsh, 1986; Frizzell & Halm, 1990). 
Unlike CFTR, the ORCC-mediated currents can be blocked by DIDS, and this 
distinction provides a useful method of distinguishing the two currents in whole-cell 
recordings (Schwiebert el al., 1 994). 
A number of mechanisms appear to regulate the activation of the ORCC. In 
normal and in CF-complemented cells, but not in cystic fibrosis epithelial cells, the 
ORCC can be activated by exposure to CAMP agonists or to PKA and ATP (Welsh, 
1986; Welsh & Liedtke, 1986; Schoumaker et al., 1987; Li el al., 1 988; Egan el 
a1.J 992). 
ORCC are also regulated by PKC, although the response of the channel to PKC- 
mediated phosphorylation appears more complex than its response to PKA. Hwang and 
coworkers (1989) reported an activation of ORCC by PKC in normal airway epithelial 
cells, while ORCC from CF airway could not be activated by this kinase . Another 
group reported that this stirnulatory effect of PKC was calcium-dependent; while PKC 
activated the ORCC at low (1  0 nM or less) Ca2+ levels, PKC actually inhibited ORCC 
activity at high (1 pM) Ca2+ levels (Li el al., 1989). The biphasic nature of this response 
might be due either to the action of distinct PKC isolbrms with different calcium 
sensitivities, or to a calcium responsive element inherent in the ORCC itself. 
For many years investigators using electrophysiological techniques could only 
observe the ORCC in excised membrane patches; not until modifications were made to 
existing protocols were ORCC currents obtained from whole-cell recordings. These 
modifications included recording at a more physiological temperature, rather than 
standard room temperature conditions, as well as increasing the MgATP concentration 
from 1 m M  to 5 mM, which approximates intracellular concentrations of the nucleotide 
(Schwiebert el al., 1994). The requirement for elevated ATP concentrations led 
researchers to investigate the possibility of a regulatory role for ATP in ORCC 
activation. In fact. the presence of extracellular ATP as well as the presence of 
functional CFTR was found to be an absolute requirement for the activation of ORCC- 
mediated currents in these studies, in that trapping of extracellular ATP by hexokinase 
treatment abolished the CAMP sensitivity of the ORCC in normal airway epithelial cells 
(Schwiebert et a!., 1995b). These researchers also presented data that implicated the 
CFTR molecule itself in the transport of ATP across the plasma membrane from the 
interior of the cell (Schwiebert et al., 1995b) though the role of CFTR as a possible 
ATP transporter remains controversial (Devidas & Guggino, 1997). 
The model proposed to explain the regulatory relationship between CFTR and 
ORCC involves the transport of ATP into the extracellular space, either by CFTR or a 
CFTR-associated protein. This ATP then activates a purinergic receptor, most likely of 
the P,, subtype, based upon the ability of various nucleotides to substitute for ATP. In 
turn, the purinergic receptor mediates the activation of the ORCC. either directly or 
through the actions of an associated G protein (Schwiebert et nl.. 1995a). Pertussis 
toxin-sensitive G proteins can be copurified with an ORCC from bovine tracheal 
epithelia (Ismailov et d. 1996). and Gel,-; have been implicated in the regulation of 
ORCC from human airway epithelia (Schwiebert et ul- . 1995a), though purinergic 
receptor stimulation of this G protein has not yet been shown to activate the ORCC. 
While some reports have shown that extracellular ATP alone can activate the 
ORCC (Schwiebert et ul., 1994; Schwiebert et al., 1995b), other groups have not been 
able to reproduce these findings (Jovov et a/. , 1995b). and have suggested that ATP 
transport may not be the only function mediated by CFTR in the regulation of the 
ORCC. Mutations in the CF gene result in a wide variation in the severity of the 
disease phenotype, and this variability cannot be predicted based solely on the location 
of the mutation within the CF gene (Welsh et uf., 1995). Because CFTR controls the 
ORCC as well as acting as a chloride channel itself. CF mutations which block both 
conductive pathways may result in a more severe clinical syndrome than mutations in 
which only one of the pathways is affected. 
This hypothesis is supported by the finding that two CF mutations which are 
associated with varying clinical severity also differ in their ability to activate the ORCC. 
G551D CFTR is a mutant which causes severe pulmonary disease (Welsh et a!., 1995 j. 
When an ORCC purified from bovine tracheal epithelium was co-incorporated into a 
planar lipid bilayer with G55 1D CFTR, the addition of extracellular ATP could not 
activate the ORCC despite the presence of PKA (Jovov ei al., 1995b) in the bath 
solutions. Expressed in CF-lacking human airway cells, G S  l D retains the ability to 
form a small linear chloride channel, albeit with a lower conductance than wild-type 
CFTR, but cannot activate ORCC in these cells (Fulmer et al., 1995). The A445E 
mutant, on the othzr hand, retains not only its inherent chloride channel activity. though 
with a lower conductance than wild-type, but also its capacity to activate ORCC 
(Fulmer er ul., 1995). A145E is associated with mudl milder pulmonary symptoms 
than G55 1 D (Fulmer el ul., 1995: Welsh el al.. 1995). leading to the speculation that 
there may be a correlation between the ability of CFTR to act as a regulator of other 
channels and the severity of the associated disease phenotype (Fulmer el al., 1995). 
2.3.2.2 Calcium-Activated Chloride Conductances 
Epithelial chloride secretion can also be induced by agents which act by 
increasing intracellular levels of free calcium. This category of secretagogues includes 
the muscarinic cholinergic agonist carbachol. the calcium ionophores A23 187 and 
ionomycin. and hormones such as neurotensin, histamine, and substance P. Calcium 
may interact directly with effector proteins, or it may bind calmodulin. altering cell 
physiology through the activation of calmodulin-sensitive protein kinases (CaMK). 
Calcium-regulated channels appear to have a more selective tissue distribution 
than CAMP-regulated chloride channels such as CFTR and the ORCC. These cAIMP- 
dependent channels have been characterised in a variety of epithelial tissues including 
airway, intestine, pancreas, salivary and sweat glands. In each tissue, not only are the 
the biophysical properties of the channels fairly consistent, but increased chloride 
secretion in response to CAMP agonists can be attributed directly to chloride channel 
activation. 
The nature of the calcium-dependent chloride conductive pathway, on the other 
hand, is slightly more complex. In some cells or tissues, calcium agonists appear to 
activate a specific calcium-regulated chloride channel (Willumsen & Boucher, 1989; 
Cliff & Frizzell, 1990; Anderson & Welsh, 199 1 ; Morris and Frizzell, 1993). In others, 
the chloride secretory event is secondary to the activation of basolateral potassium 
channels. Increased exit of potassium ions hyperpolarizes the cell, increasing thereby 
the driving force for apical chloride secretion, and it has been suggested that in these 
circumstances chloride exit occurs through already open channels such as CFTR 
(Anderson & Welsh, 199 1 ; Anderson ef al., 1992; Barrett, 1 993). In investigating 
calcium-regulated chloride secretion, then, investigators must be careful to distinguish 
between two potentially distinct exit pathways. 
Cells which exhibit a calcium-regulated chloride channel include primary 
cultures of airway epithelia (Willumsen & Boucher. 1989: Anderson & Welsh. 199 1 ; 
Wagner el  ui., 1 99 1 ), sweat gland secretory coil (Reddy & Bell. 1 996: Reddy et ai., 
1997) and salivary gland epithelia (Cook et ai., 1994; Arreola et a/., 1994). As 
mentioned previously. this caicium-dependent chloride current is preserved in CF 
airway (Frizzell et a/. , 1986; Widdicombe. 1986; Boucher el al.. 1989; Anderson & 
Welsh, 199 1 ; Wagner er a/. . 199 1 ) and in sweat gland epithelia (Sato & Sato. 1984; 
Reddy n d.. 1996). In fact. in CF knockout mice such as the cj~r'"'"" strain. airway 
epithelial calcium-regulated chloride channel activity is upregulated. possibly as a 
protective mechanism against the loss of the CAMP-dependent pathway (Clarke et ai., 
1994; Grubb e t  al., 1994). 
The role of calcium-regulated chloride channels in intestinal epithelia is more 
controversial. Several groups have reported calcium-activated single-channel chloride 
currents in intestinal cell lines such as T83 (Cliff & Frizzell. 1990; Anderson & Welsh, 
199 1 ; Worrell & Frizzell. 199 1 ) and HT-29 (Morris & Frizzell. 1993) epithelia, but only 
in whole-cell recordings. obtained when undifferentiated cells are grown on 
impermeable supports. Under such conditions. the ceils do not form polarized 
monolayers. When cultured on sf iaces  that allow them to differentiate and become 
polarized. this calcium-activated current disappears if the basolateral membrane is 
pemeabilized by exposure to nystatin, removing the calcium-dependent activation of 
potassium channels in that membrane (Anderson & Welsh, 199 1 ). These investigators 
concluded that the calcium-regulated chloride channels seen in undifferentiated T84 
cells are not expressed when the cells differentiate (Anderson & Welsh, 199 1 ; Anderson 
et af., 1992). 
Other groups, however, have shown that calcium-regulated chloride currents are 
present in the intestinal epithelial HT-29 cells, both in the unpolarized parental line and 
a polarized clone of this line. HT-29Cf. 19A (Vaandrager ef a!. . 199 1 ; Morris ef 01.. 
1993). The gating and kinetics of the chloride channel are similar in polarized and in 
unpolarized cells, though the density of channels present in the membrane appears to be 
considerably lower in polarized cells (Morris et al.. 1993; Morris & Frizzell. 1994). 
Consequently. at least some cell lines may retain this channel afier attaining the fully 
differentiated state. 
In intact normal intestinal epithelia, calcium agonists cause an increase in 
chloride secretion (Benchneider et d, 1988: O'Loughlin el a!.. 199 1 ). Unlike CF 
airway epithelia, however, the calcium-dependent pathway is thought to be inactive in 
the intestinal epithelium of CF patients, since the chloride secretory response to calcium 
agonists is absent in the majority of CF small intestines studied (Berschneider et ui.. 
1988; Taylor el d., 1988; O'Loughlin et a[.. 199 1 ) .  
Most strains of transgenic cfir (4) mice also show severe intestinal 
histopathology (Zeiher el al., 1995; Grubb & Gabriel. 1997). resulting in early death of 
affected animals unless their diet is supplemented with a polyethylene glycol solution 
(Grubb, 1995). Electrophysiological studies examining the epithelial reponse to CAMP 
and calcium agonists in these mice have repofled an absence of chloride secretion in 
response to both classes of agonists. consistent with a model in which CFTR is the sole 
mediator of intestinal chloride secretion (Clarke et al. , 1994; Cuthbert er a/. , 1994). 
An exception to this may be the cJ~'~'"'" mouse. Most of these mice exhibit the 
expected CF intestinal phenotype resulting from an absence of epithelial CFTR, and die 
either soon after birth (class I mice) or shortly after weaning (class II mice) (Romahel  
et of., 1996). A subpopulation of these mice, however. denoted class 111. survive well 
beyond the age of weaning. Although there are some pathological changes in the 
intestine of class I11 mice, they are not as severe as those seen in class I and class [I 
mice. Furthermore, while CFTR-mediated chloride conductance is defective in the 
intestine of all three classes, the class I11 mice are alone in possessing an intestinal 
chloride-selective current which can be activated by calcium ionophores or by UTP 
(Rozmahel et a(. , 1996; Wilschanski et ui., 1996). The presence of this conductive 
pathway has been shown to be related to the genetic background of the mice (Romahel  
et al., 1996), though the mechanism through which this pathway becomes upreguiated is 
unknown. 
This phenotypic variability in CF mice may have implications for the intestinal 
effects of CF in humans. While early studies report that the response of CF intestinal 
epithelium to calcium agonists is typically absent (Berschneider er ai., 1988; Taylor et 
al.. 1988; O'Loughlin el ai., 1 99 1 ; Veeze et al, 199 1). some groups have reported that 
in a minority of CF patients, jejunal or rectal epithelial biopsy samples show a small but 
significant secretory response to calcium agonists, though none to CAMP agonists 
(Taylor cr ul.. 1988; Veeze el cli- , 1 99 1 ). Few of the human CF intestinal studies have 
involved large numbers of experimental subjects, however, so the possible significance 
of these findings. or their relationship to the physiology of class I11 cflf'""'" mice. is 
currently unclear. 
The properties of the calcium-regulated chloride current have been characterised 
to some extent in various epithelia. Unlike the current attributable to CFTR. the 
calcium-regulated current exhibits time- and voltage-dependence; this current activates 
in a time-dependent fashion at depolarizing voltages, and inactivates at hyperpolarizing 
voltages (Anderson er rr l . ,  1992: Friuell & Morris. 1994). The halide permeability 
sequence of this current. I- > Br* > Cl'. also differs from that of CFTR, as does its 
sensitivity to chloride channel blockers (Cliff & Frizzell. 1 990; Anderson & Welsh, 
199 1). The calcium-regulated chloride current is inhibited by DPC and by disulfonic 
stilbene derivatives such as DIDS. Furthermore, the effects of calcium agonists and 
CAMP agonists on chloride secretion are additive (Cliff & Frizzell, 1990; Anderson & 
Welsh, 199 1 ; Frizzell & Moms, 1994), suggesting that the two classes of agonists 
stimulate different apical membrane chloride channels (Anderson et ul., 1992; Frizzell 
& Moms, 1994). 
The single-channel basis of the calcium-regulated chloride conductance has been 
studied in some epithelia. The channel characterised in undifferentiated HT-29 cells has 
a single-channel conductance of 13 to 16 pS. with an outwardly rectified current-voltage 
relationship (Moms & Frizzell, 1993a). The properties of this intestinal epithelial 
channel are consistent with those of a 15 pS calcium-regulated chloride channel purified 
from bovine tracheal epithelium (Ran & Benos, 199 1 ; Ran & Benos, 1992), though the 
precise relationship between the two has yet to be investigated. These properties are 
also similar to those of a calcium-activated chloride channel studied in rat parotid 
salivary gland (Arreola et aL. 1996). though again, any closer relationship has not been 
established. 
Regulation of this channel activity appears to depend upon intracel lular levels of 
free calcium. Agents such as histamine or carbachol increase chloride secretion by 
stimulating the release olcalcium from intracellular stores: this is most ofren 
accomplished through the receptor-mediated activation of a phospholipase C isoform 
which stimulates the generation of inositol 1.4.5-trisphosphate [Ins( 1 ,4.5)P3], the 
messenger directly responsible for the release of stored calcium into the cytosol. 
Calcium chelators such as EGTA or BAPTA prevent the activation of chloride secretion 
in response to calcium agonists in airway and intestinal epithelia (Morris & Friuell, 
1993; Harris & Hanrahan, 1994). 
At least some of the activating effects of calcium on this channel are mediated 
by the activation of the calmodulin-sensitive protein kinase I1 (CaMKII). both in 
intestinal epithelial cell lines (Worrell & Frizzell, 199 1 : Morris & Frizzell, 1993 b) and 
in airway epithelia (Wagner et a!., 1991). Peptide inhibitors of this kinase prevent the 
activation of the calcium-regulated chloride current (Wagner et al.. 199 1; Morris & 
Frizzell, 1993b) without affecting either basolateral potassium channel activity or 
intracellular calcium mobilization (Moms & Frizzell, 1993 b). 
The chloride secretory response produced by calcium agonists is transient, 
unlike secretion in response to CAMP agonists, which is sustained as long as the 
stimulus remains present (Barrett, 1997). The absolute magnitude of the secretory 
response also correlates poorly with the levels of intracellular free calcium (Barrett. 
1997). Because of these two findings, it has been suggested that in addition to initially 
activating stirnulatory pathways, the actions of some calcium agonists may also include 
the subsequent generation of inhibitory signalling mechanisms (Kachintom er al., 1993; 
Vajanaphanich et a[. , 1 994). 
The activation of phospholipase C stimulates the production of a number of 
other phosphoinositide metabolites as well as that of Ins( l.4,5)P, (Menniti ef  al., 1993). 
Some calcium agonists. such as the muscarinic agonist carbachol, have been shown to 
increase the intracellular generation of one such mrtaboli te. D-myo-inositol 3,4.5,6- 
tetrakisphosphate [Ins(3 .4.5.6)P4 ] (Kachintom el al., 1 993). Furthermore, increases in 
1ns(3,4.5,6)P4 levels parallel the inhibition of carbachol-induced chloride secretion in 
T84 and in CFPAC- 1 cells (Kachintom el al., 1993 ; Vajanaphanich et al.. 1994; Ho el 
at., 1997). The inhibitory effect on chloride secretion is specific to Ins(3.4,5.6)P4 and 
not to any other phosphoinositide (Kachintom et al.. 1993; Xie el u2.. 1996). 
The mechanism through which Ins(3 .4,j,6)P4 inhibits chloride secretion does not 
appear to involve the inhibition of basolateral potassium channels (Smitham et a/., 
1996; Barrett, 1997). Ins(3,4,5,6)P4 has been shown, however, to directly inhibit the 
activity of bovine tracheal calcium-activated chloride channels reconstituted into planar 
lipid bilayers (Ismailov et al , 1996). Whether this channel serves as a physiological 
target of Ins(3,4,5,6)P4 in epithelial cells has yet to be demonstrated. 
Some calcium agonists appear to stimulate calcium-dependent chloride secretion 
through different pathways. Although both agents increase intracellular free calcium 
levels, the effects of histamine on chloride secretion are additive with those of carbachol 
(Kachintom et al., 199j), and unlike carbachol, histamine does not stimulate the 
production of Ins(3,4,5,6)P4 (Kachintom et ul., 1993). Other agents, such as epidermal 
growth factor (EGF), do not themselves act as chloride secretagogues, but may inhibit 
previously activated calcium-dependent chloride secretion (Uribe et al., 1996; Barrett, 
1997). Also, as mentioned above, many of the purinergic receptor agonists act by 
increasing intracellular Free calcium levels, and may activate calcium-regulated chloride 
channels in those cells possessing such channels (Knowles et al., 1 99 1 ; Mason et al., 
199 1 ; Clarke & Boucher, 19%). 
In summary, calcium-dependent chloride secretion provides an alternative to the 
CAMP-mediated pathway. In some epithelia such as sweat gland and airway, distinct 
calcium-regulated chloride channels have been shown to exist in the apical membrane, 
and this pathway is preserved in cystic fibrosis. In other tissues, especially intestinal 
epithelia, the calcium-dependent pathway appears to be defective in CF. The existence 
of separate apical calcium-regulated channels in native intestinal epithelia remains 
under investigation, though the existence of a CF mouse strain (cfPfH") in which this 
pathway is intact raises a number of interesting questions. 
From the above discussion, it seems clear that there are multiple pathways 
controlling epithelial chloride secretion. To reiterate the aims of this project in their 
proper context, then, the purpose of this study was to identify, through a molecular 
biological approach, the gene and gene product responsible for one particular chloride 
conductance pathway previously characterised in the small intestine. It was fiuther 
intended to investigate the expression of this gene in various porcine tissues. First, this 
would allow a correlation between the expression of the gene and the presence of the 
antigen recognised by an anti-chloride conductance antibody. And second, knowledge 
of the tissue expression of this gene would also permit a comparison of its tissue 
distribution with that of the other major chloride channels. 
3.0 Cloning Strategies for the Isolation of PG33 cDNA 
3.1 Introduction 
Fluid secretion by the intestinal crypts is controlled primarily by transepithelial 
electrolyte transport. especially the secretion of chloride ions into the gut lumen via 
apical chloride channels. The clinical importance of chloride secretion is illustrated by 
the drastic pathological changes seen in various secretory diarrheas, including cholera, 
and in cystic fibrosis. Redundancy in chloride channel species may therefore act as a 
protective mechanism, providing epithelial cells with the ability to mobilize different 
protein populations in response to different hormonal or neural stimuli. 
To date. a number of chloride channel species have been identified in the small 
intestine. This includes CFTR, the ORCC, and C1C-2, though the existence of calcium- 
regulated chloride channels in intact intestinal epithelium remains subject to debate. 
Whether these channels represent the full complement of chloride conductive pathways 
in the small intestine is also currently unknown. 
Chloride conductance in the small intestine has been the focus of investigation 
in this laboratory for several years. The pig proved to be a useful experimental model 
for early in silu loop studies of fluid flux in response to various secretagogues (Forsyth 
& Gabriel, 1990; Uwiera et al., 1992). Pigs have also been used as a source of material 
for the preparation of brush-border membrane vesicles from small intestinal epithelia 
(Forsyth & Gabriel, 1988; Forsyth & Gabriel, I989a). These vesicles are usefid as a 
means to study the activity of apical membrane proteins under controlled 
electrochemical conditions. 
Studies using brush-border vesicles depend on the ability to selectively establish 
an electrical gradient across the vesicle membrane by manipulating the potassium and 
chloride concentrations inside and outside of the vesicle during preparation (Forsyth & 
Gabriel. 1988; Forsyth & Gabriel, l989a). In the presence of such gradients, addition of 
the potassium ionophore valinomycin immediately before an assay causes rapid entry of 
potassium into the vesicle, imposing an electrical gradient across the membrane. This 
in turn provides conditions favourable to the movement of chloride along its 
electrochemical gradient across the vesicle membrane. By comparing 36C1 uptake 
under these conditions to uptake in the absence of a potassium gradient, chloride 
movement though non-conductive pathways such as the Cl*/HCO,* exchanger can be 
excluded. As a result, electrogenic movement of chloride ions through strictly 
conductive pathways such as membrane channels can be calculated. 
. Under these experimental parameters, the characteristics of a chloride 
conductive pathway in porcine jejunal brush-border vesicles have been defined. The 
activity of this pathway appears to be dependent upon the buffer composition in which 
the vesicles are prepared; no conductance is observed when vesicles are prepared in 
imidazole-acetate buffers, but when the buffer contains N-2-hydroxylethylpiperazine- 
N'-2-ethanesulfonate (HEPES) and tetramethylammonium (TMA), an increase in 
chloride conductance can be demonstrated in the presence of a potassium gradient 
(Forsyth & Gabriel, 1988. Forsyth & Gabriel. I989a). The kinetics of this conductance 
are saturable (Forsyth & Gabriel, 1988). and this pathway is only marginally sensitive to 
conventional chloride channel blockers such as anthracene-9-carboxylate or 4- 
acetamido-4'-isothiocyanolstilbene-2.2'-suphonic acid (SITS) (Forsyth & Gabriel. 
1988). 
The chloride conductance in HEPES-TMA-buffered vesicles can, however. be 
specifically inhibited by a-phenylcinnamate (Forsyth & Gabriel, 1989b), and this fact 
was used in a ligand protection assay to identify candidate proteins from porcine ileal 
brush-border vesicles. The inclusion of CI- and a-phenylcimamate (a-PC) is thought to 
protect the chloride conductance protein when the remainder of the brush-border protein 
complement is labelled with phenyl isothiocyanate (PITC). Because the binding of a- 
PC to the conductance protein is uncompetitive, if fluorescein isothiocyanate (FITC) is 
subsequently added to the preparation, the fluorescein group may then attach to this 
conductance protein and act as a reporter group for scanning fluorescence densitometry. 
This procedure identified fluorescein labelling on proteins from HEPES-TMA buffered 
vesicles in two molecular mass ranges, approximately 130 kDa and 23 kDa (Forsyth & 
Gabriel, 1991), though exact protein species could not be identified. 
Parallel projects were designed to identify the protein species responsible for 
conductive chloride transport through the production of specific anti-chloride 
conductance antibodies (Gabriel et nl., 1992; Racette et ul., 1996). Because of the 
complex nature of the protein populations present in brush-border vesicles, and because 
of the technical difficulties associated with purification of membrane-associated 
proteins, a single protein species was not available for preparation of antigen for 
immunization. Instead, the entire complement of brush-border membrane protein was 
separated by SDS-PAGE, then subdivided into molecular size fractions and 
electroeluted. Each size fraction. five in total, served as the basis for an antigen group 
used to immunize Balbk mice. The polycIona1 antibodies raised in these mice were 
then tested for the ability to inhibit j6Cl uptake in ileal brush-border membrane vesicles. 
Only antibodies from mice immunized with fraction I (molecular mass over 1 10 kDa) 
exhibited significant inhibitory ability in this assay (Gabriel et al., 1992). This is 
consistent with the results of the FITC labelling studies. which implicated a protein of 
approximately 130 kDa in the chloride conductive process in these vesicles (Forsyth & 
Gabriel. 199 1 ). 
Possession of monoclonal antibodies offers certain advantages in the study of 
antibody-antigen interactions. The antigen fraction that had produced the anti-chloride 
conductance polyclonal antibodies consisted of a heterogenous group of proteins. and 
despite the elimination of protein species under 1 10 kDa from consideration, a 
significant number of candidates remained. Mice which had produced antibodies 
reacting positively in Western blots and which had inhibited conductive chloride uptake 
were therefore used as a source of spleen cells for the generation of monoclonal 
antibody-producing hybridoma cells (Kohler & Milstein. 1975). 
Two hybridorna cell lines were eventually selected as antibody sources, based 
on the functional ability to inhibit 36Cl uptake by porcine ileal apical membrane vesicles 
(Racette er ul., 1996). The hybridoma line IC2-4B2 produced an IgM-class 
immunoglobulin which was extremely effective at inhibiting j6C1 uptake by vesicles. 
but which had a relatively low affinity for antigen as shown by dilution studies. The 
286-21 hybridoma, on the other hand, was an IgG-producing cell line. This antibody 
had a higher affinity for antigen than the IgM monoclonal, but bound with a lower 
avidity in the fhctional assay (Racette et a/., 1996). 
Repeated attempts to resolve the identity of the antigen through standard dot 
blot, Western, and Far- Western assays using these mAb were unsuccessful. The IgG 
monoclonal antibody has been shown, however, to irnmunoprecipitate a 90 kDa antigen 
from "S-labeled cultures of porcine jejunal enterocytrs (IPEC-R cells) (Racette el al., 
1996). This species could only be immunoprecipitated when the cells were grown in 
the presence of tunicamycin, a compound which prevents the N-linked glycosylation of 
newly synthesized proteins (Racette rt al., 1996). The current working hypothesis is 
that the complex nature of the physical interactions in the brush-border-associated 
glycocalyx prevents antibody binding under any other conditions. 
Still. further information was required about the nature of the protein responsible 
for chloride conductance in brush-border vesicles, though dot blot and 
immunoprecipitation studies had demonstrated that this antigen was not CFTR (Racene 
el al., 1996). A porcine intestinal expression cDNA library had been obtained so that 
the rnAb could be used to identify the gene encoding this antigen, in parallel with the 
protein characterization studies. 
Expression libraries are constructed so that the foreign cDNA sequences are 
inserted into a phagemid or plasmid vector at a site under the control of an inducible 
promoter. Typically, this promoter is the Escherichicr coli lacZ promoter. which 
controls the expression of mRNA coding for P-galactosidase. Induction of promoter 
function results in the production of mRNA coding for fusion proteins in which the 
initial amino acids of P-galactosidase are linked to the polypeptide sequences 
initial amino acids of P-galactosidase are linked to the polypeptide sequences 
corresponding to the foreign cDNA. If the structural integrity of epitopes in this 
polypeptide is maintained, this fusion protein may react with specific antisera in a 
Westem-type blot. Thc goal of this study was therefore to identify such a fusion 
protein, in the hopes of then obtaining the full-length transcript of the cDNA encoding 
the antigen recognised by the anti-chloride conductance mAb. 
3.2 Materials and Methods 
Custom porcine intestinal cDNA library: Invitrogen (kind gift of Dr. Brad 
Bosworth, University of Iowa). Human infant intestinal cDNA library: Invitrogen. 
Hybond-C nitrocellulose and Hybond-N+ nylon filters, Amersham. Alkaline 
phosphatase-conjugated anti-mouse IgG and anti-mouse IgM, Sigma. Digoxygenin- 
dUTP and alkaline phosphatase-conjugated anti-digoxygenin antibody, Boehringer- 
Mannheim. A1 1 other chemicals reagent or molecular biology grade. All primers 
custom synthesized by the University of Calgary Core DNA Services. 
3.2.1 Expression Screening of the Porcine Intestinal cDNA Library 
Approximately 5xlO2cfu of the custom intestinal cDNA library were spread on 
sterile Hybond-C nitrocellulose filters overlaid onto 82-mm LB+arnpicillin (1 OOpg/rnL) 
plates and grown overnight ai 37" C. Sets of two duplicate filters were prepared from 
each master filter and grown on LB+arnp plates in the presence of isopropylthio-P-D- 
galactopyranoside (IPTG) for 4 hours at 37°C. The colonies were then lysed by 
exposure to chloroform vapour for 15 min and the filters washed overnight in lysis 
buffer (1 00 m M  Tris-HC1,pH 7.8, 150 m M  NaCI, 5 mM MgCI,, 1.5% BSA, 1 pg/mL 
DNase 1,40 pg/mL lysozyme). 
The resulting cellular debris was removed by two successive room temperature 
washes in 20 mM Tris-HCI, pH 7.5,500 m M  NaCl, 0.1 % Tween 20 (TTBS). Filters 
were then blocked for 2-3 hours in TTBS containing 1 % gelatin before addition of the 
primary antibody. This consisted of the 1C2 and 2H6 monoclonal antisera diluted 1 :40 
and 1 :20 respectively in blocker. Incubation was carried out for 60 minutes before the 
Binding of the mAb was detected after a 60-minute incubation with alkaline 
phosphatase-conjugated anti-mouse IgM and anti-mouse igG. diluted 1 : 10 000 and 
1:5000 respectively in blocker. Unbound secondary antibody was removed by three 
final 10 minute washes in blocker. Bound secondary antibody was visualised by 
developing the filters in 100 mM Tris-HCI. pH 9.5, 100 mM NaCl, 50 m M  MgClz 
containing 225 pg/mL nitro-blue tetrazolium (NBT) and 1 75 pg/mL 5-bromo-4-chloro- 
3-indolyl-phosphate (BCIP). Positive colonies were identified by the appearance of a 
purple precipitate in the same location on both duplicate filters, and the colour reaction 
was stopped by a water wash. 
Lmmunoreactive colonies were picked from the master filter and inoculated into 
100 mL cultures of ZYT broth containing 100 pg/mL ampicillin, then grown overnight 
at 3 7 O  C. Bacterial cells were pelleted for 20 minutes at 4000 x g and resuspended in 25 
mM Tris-HCI, pH 8,jO mM glucose, and 10 mM EDTA. Lysozyme was added to a 
final concentration of 2.5 mg/mL. Cells were lysed and chromosomal DNA and 
membrane-protein complexes precipitated by first adding freshly prepared 0.2 M NaOH 
containing 1% SDS, then precipitating on ice in 3 M potassium acetatel 5 M acetic acid. 
The solution was centrifuged for 15 min at 2500 x g and the supernatant recovered by 
filtration. Nucleic acids were precipitated by the addition of 0.6 volumes of isopropanol 
and pelleted in a 1 0 minute spin at 2500 x g. The pellet was rinsed with 70% ethanol 
and resuspended, when dry, in 10 mM Tris-HCI. pH 7.5, 1 rnM EDTA (TE). 
High molecular weight RNA species were eliminated by the addition of LiCl to 
a final concentration of 2.5 M followed by a 10 minute spin at I0 000 x g. The 
remaining DNA was recovered by precipitation in 1 volume isopropanol and another 
identical centrifugation. The resulting pellet was rinsed in 70% ethanol. dried, and 
resuspended in TE plus 20 pg/mL RNase A, followed by a 30 minute incubation at 
room temperature to degrade any remaining RNA. 
Plasmid DNA was precipitated by the addition of NaCl and polyethylene glycol 
(PEG)-8000 to final concentrations of 0.8 M and 6.5% respectively. The resulting pellet 
was resuspended in TE: PEG-8000 and protein contaminants were removed by 
successive extractions in phenol, phenol:chloroform. and chloroform. The purified 
plasmid DNA was precipitated by adding 0.25 volumes 10 M ammonium acetate and 2 
volumes 95% ethanol and centrifbging, after a 10 minute incubation at room 
temperature, for 10 minutes at 13 000 x g. The pellet was washed in 70% ethanol and 
resuspended in sterile water for sequencing. 
Sequencing of the cDNA inserts was by the Sanger dideoxy chain-termination 
method (Sanger et al., 1977) using Sequenase v2.0 (USBiochemicals). One pmol of 
sequencing primer (either the flanking T7 promoter sequence as an antisense primer, or 
the Sp6 promoter sequence as a sense primer) was annealed to 10 p g  of plasmid 
template in a reaction solution containing 40 m M  Tris-HC1 (pH 7.5),20 mM MgCI,, 50 
m M  NaCl for 5 minutes at room temperature. In the labelling reaction, 10 mM DTT, 10 
pCi 'jS-dATP, 1.5 p M  each dGTP, dCTP, and dTTP. and 2.6 units of T7 DNA 
polymerase (Sequenase v2.0) are added to the annealing reaction and incubated for 3 
minutes on ice. Following this. the reaction is terminated by the addition of 33.3 pfvl 
each of dGTP, dATP, dTTP, and dCTP; as well, either ddGTP, ddATP, ddCTP, or 
ddTTP are added to a final concentration of 33.3 pM. The termination reaction is 
carried out for 3-5 minutes at 37"C, then stopped by the addition of 0.65 volumes of 20 
rnM EDTA. 0.05% bromophenol blue, 0.05% xylene cyan01 in 95% formamide. Five 
pL each sequencing reaction was loaded onto a 5% Long Ranger polyacrylamide gel 
(J.T. Baker) containing 50% w/v urea. The reactions were electrophoresed in 0 . 6 ~  TBE 
at i 700 V for 3- 12 hours. then dried for one hour and exposed to X-ray film (Kodak) for 
36 hours before developing. 
3.2.2 Oligonucleotide Screening 
3.2.2.1 Preparation of Digoxygenin-labeled Probes 
Labeling of internal PG33 sequences with digoxygenin-dUTP was carried out by 
polymerase chain reaction (PCR) in a solution containing 20 mM Tris-HCl, pH 8.8, 10 
mM KCI, 1 0 mM (NH4),S04, 2 m M  MgSO,, 0.1 % Triton X- 100 containing 200 plM 
each dGTP. dATP, dCTP, 165 plM dTTP, 35 pm dig-dUTP. 2.5 units Taq polymerase, 
and 25 pmol each sense and antisense primer. Amplification was complete after 30 
rounds in which each cycle consisted of 94°C for 45 sec, 52OC for 45 sec. and 72°C for 
1 min. For cDNA screening of the porcine intestinal library, the probe I sense primer 
was 9 1 1 s [5' GGTCGATACAGCGTA] and the antisense primer was 24 1 a [5' 
TTACGGTCCTTACCA 3'1. For Southern blotting of clones, probe I1 was constructed 
using 896a [5' CTCCCAGAGCCCACACTTTTACG 3'1 as an antisense primer and 
1004s [5' ACAAGTTACCTTGGAATT 3'1 as a sense primer. Pro be 111 was constructed 
using PLas [5' GCATATGTCTGCAAACCACCTG 3'1 as an antisense primer, and the 
Sp6 promoter sequence [j' GCTATTTAGGTGACACTATAG 3'1 as a sense primer. 
To eliminate cross-reactivity with vector sequences, probe I11 was digested with 
BstX I after digoxygenin labelling in a reaction solution containing 5 mM Tris-HCI, pH 
7.9. 10 mM NaCl, 1 mM MgCl?, and 0.1 M DTT overnight at 55°C. The digested DNA 
fragment were then separated by electrophoresis through a 0.8% low melting point 
agarose gel containing 0.4 pg/mL ethidiurn bromide. The gel was run in 1x TAE 
buffer. and the desired DNA band was cut out of the gel and eluted using a Geneclean 
kit (BIO 10 1). 
3.2.2.2 cDNA Screening of the Porcine Intestinal Library 
Master filters were prepared as described above. Duplicate filters were made 
using Hybond-N+ nylon filters and grown for 4 hours at 37°C. The duplicates were 
denatured by a 5 minute exposure to 1.5 M NaCV 0.5 M NaOH, neutralised for 5 
minutes in 1 -5 M NaCII 0.5 M Tris-HCI, pH 8. and DNA was crosslinked to the filters 
by a 30-second exposure to UV light. 
Filters were prehybridised at 65 "C in 5x S SC. 0.1 % laurylsarcosine, 0.02% 
SDS plus 2% blocker (Boehringer-Mannheirn), and hybridised overnight at 65°C in the 
same solution containing 15 ng/mL digoxygenin-labeled probe. 
Unbound probe was removed by two 15-minute washes at room temperature, 
tirst in 3x SSC/ 0.1% SDS. then in 0. l x  SSC/O. 1% SDS. The filters were briefly 
equilibrated in buffer 1 (0.1 M maleic acid, 150 mM NaCI, pH 7 3 ,  then blocked for 30 
minutes in buffer I containing 0.5% blocker. Alkaline phosphatase-conjugated anti- 
digoxygenin antibody (Boehringer-Mannheim) was diluted 15000 in blocker and 
incubated with the filters for another 30 minutes, then removed by three successive 10- 
minute washes in buffer 1. The colour reaction to visudise positive clones was carried 
out as described above. Plasmid purification and sequencing of cloned inserts was 
carried out as previously described. 
3.2.3 Southern Blotting 
Ten pL of the PCR product were electrophoresed on a 0.8% agarose gel 
containing 0.4 pg/mL ethidium bromide in lx TBE buffer. The gel was denatured for 
one hour in 1.5 M NaCI, 0.5 M NaOH, then neutralised for one hour in 1.5 M NaCI, 0.5 
M Tris-HCI (pH 8). Capillary transfer of nucleic acid to a Hybond N or Hybond Ni- 
nylon membrane previously equilibrated in 20x SSC took place overnight in 20x SSC. 
The membrane was then rinsed briefly in 6x SSC, air dried. and the DNA was fixed to 
the membrane by a 30-second exposure to UV light. Membranes were prehybridised, 
hybridised. and developed as described above. 
3.2.4 RNA Purification and Northern Blotting 
Poly A+ RNA was purified directly from porcine parotid salivary gland using a 
Quickprep Micro mRNA purification kit (Pharmacia). Postmortem tissue samples were 
taken from 15-20 kg weanling Yorkshire-Landrace mixed breed pigs (obtained from 
Prairie Swine Centre). 0.5 g tissue was homogenised for 30 seconds in 0.8 mL 
extraction buffer (5.5 M guanidium thiocyanate, 25 mM sodium citrate (pH 7.0), 0.5% 
sarkosyl ). Samples were diluted in 2 volumes of elution buffer (10 mM Tris-HC1, pH 
7.5, 1 mM EDTA), then cell debris was removed by a 1-minute centrihgation at 10 000 
.u g. Supernatant was resuspended in oiigo(dT)-celIulose and mixed for 3 minutes on an 
orbital shaker. Samples were repelleted at 10 000 x g for 10 seconds, and the 
supernatant aspirated. Samples were washed five times with 1 rnL high-salt buffer (1 0 
mM Tris-HCI, pH 7.5. 1 mM EDTA, 0.5 M NaCI), and twice with I mL low-salt buffer 
(Tris-HCI, pH 7.5, I mM EDTA, 0.1 M NaCI), before polyA+ RNA was eluted in low- 
salt buffer. 
Twenty pg polyA+ parotid RNA was loaded onto a I %  agarose gel containing 
6.6 % formaldehyde afrer denaturation of the sample for 1 5 minutes at 65 "C in i x 
MOPS running buffer (20 rnM morpholinopropanesuIfonic acid, 5 m M  sodium acetate, 
I mM EDTA. pH 7.0). 50% formarnide, 2.2 M formaldehyde. Samples were 
eIectrophoresed in lx MOPS running buffer, then transferred by capillary action to 
Hybond N+ nylon membranes overnight in 20x SSC. RNA was fixed to the membrane 
by baking for 2 hours at 80 "C. Prehybridization took place at 65 "C in 6x SSC. 5x 
Denhardt's solution (0.1 % polyvinylpyrrolidone, 0.1% Ficoll400.0.1% bovine serum 
albumin). 1 00 pdrnL sheared denatured salmon sperm. 0.5% SDS. Hybridization 
occurred in the same solution at 65°C. with the addition of 15 ng/mL digoxygenin- 
labelled probe. Blots were washed and developed as described above. 
3.2.5 PCR Screening of Porcine Intestinal Library 
The gene-specific antisense primer 896a [5' 
CTCCCAGAGCCCACACTTTTACG 3'1 was selected from near the 5' end of PG33c 
and used to directly amplify PG33 sequences from the pig intestinal library. The 
flanking Sp6 promoter sequence [j' GATTTAGGTGACACTATAG 3'1 was used as a 
sense primer. 
One ,uL of the porcine intestinal library containing 1 x lo5 cWpL was amplified 
in a reaction solution containing 20 mM Tris-HCI (pH 8.8), 10 mM KCI. 10 mM 
(NH&SO,, 2 mM MgSO,, 0.1% Triton X-100,200 p M  dNTPs. 5% DMSO. 20 pmol 
each primer, 2.5 units Tuq polymerase, and 2.5 units Tuq Extender (Stratagene) for 40 
cycles at 94°C for 45 sec, 52'C for 45 sec, and 72'C for 1 minute 30 seconds. 
Five 100-pL reactions were pooled and the mineral oil was removed by 
extraction with one volume of chloroform. The PCR products were precipitated with 
0.1 volumes 3 M sodium acetate, pH 5.2, and 2.2 volumes 95% ethanol. The products 
were run on a 1% low melting point-agarose gel in TAE buffer, and the largest products 
[size range between 800 and 1500 base pairs] were eluted from the gel using the 
Geneclean kit. 
One ng of the eluted products was subjected to another 25 cycles of PCR 
amplification under the conditions described above. Five 1 00-pL reactions were 
chloroform-extracted, pooled, and ethanol precipitated. A 5' phosphate was added to 
the products after they were heated at 70°C for 5 minutes; the reaction contained 50 
rnM Tris-HC1 pH 7.6, 10 mM MgCL, 1 m M  ATP, I rnM DTT, 5% PEG-8000, and 10 
units T4 polynucleotide kinase (New England Biolabs). The reaction was carried out at 
37°C for 30 minutes, then the enzyme was removed by phenol-chloroform extraction 
and ethanol precipitation with 2.2 volumes 95% ethanol. 
3.2.5.1 Preparation of Vector DNA 
The plasrnid vector pcDNAII was digested with 20 units of EcoRV (NEB)in the 
presence of 10 mM Tris-HC1, pH 7.9.50 mM NaCI, 10 mM MgCl?. 1 mM DTT, and 
100 pg/rnL BSA ovemight at 37 OC. The enzyme was removed by phenol:chloroform 
extraction, and the cut vector was precipitated with 0. I volume 3 M sodium acetate and 
2.2 votumes 95% ethanol. 
5' phosphates were removed by treatment with calf intestinal alkaline 
phosphatase (CIAP) (Gibco BRL) by incubating vector DNA at 50°C for 1 hour in the 
presence of 50 m M  Tris-HCI, pH 8.5,O.l mM EDTA. and 1 unitipmol DNA ends of the 
CIAP enzyme. At the end of the reaction. CiAP was removed by phenol:chloroforrn 
extraction. The DNA was ethanol precipitated and its concentration estimated by 
visualisation on an ethidium bromide-containing (0.33 pg/mL) 0.8% agarose gel. 
3.2.5.2 Ligation and Transformation 
1600 ng phosphorylated. blunt-ended PCR product was ligated into 50 ng 
EcoRV-cut pcDNAII in a reaction containing 50 mM Tris-HC1 pH 7.6. 10 mM MgCl?, 
I mM ATP. 1 m M  DTT, 5% PEG-8000, and 1 unit T4 DNA ligase (Gibco BRL). The 
reaction was allowed to continue overnight at 16°C and the ligation was diluted 1 :j in 
reaction was allowed to continue overnight at 16°C and the ligation was diluted 1 :5 in 
TE before transformation. 
Ten pL of the diluted ligation were tranformed into competent DHSa cells by 
incubating the DNA with the cells for 30 minutes on ice. The cells were then heat- 
shocked for 90 seconds at 42OC, left on ice for a f i rher  90 seconds, and incubated with 
2YT media in a shaking incubator at 37OC. After a sufficient time interval to allow 
expression of the ampicillin resistance phenotype, the cells were plated on 2YT+amp+ 
X-gal, and grown overnight at 37°C. In the presence of X-gal, bacteria transformed 
with recombinant plasmid DNA can be distinguished fiom nonrecombinants, as 
recombinant colonies are white while nomecombinant colonies are blue. 
Successllly transformed colonies were PCR screened using the 896a antisense 
and Sp6 sense primers as described above. Plasmid DNA from positive clones was 
purified and sequenced as previously described. 
3.2.6 PCR Screening of Human Intestinal Library 
1x1 O7 cfh of a human infant intestinal library (Invitrogen) were PCR amplified 
for 40 cycles as described above using the 896a and Sp6 primers. A second, 25-cycle 
round was then performed on 1 p L  of the products fiom the first round, this time using 
the antisense primer PLas [5' GCATATGTCTGCAAACCACCTG 3'1 fiom near the 5' 
end of PG33d, and a different Sp6 sequence [cSp6: 5' AGGTGACACTATAGAATAC 
3'1 as a sense primer. 
Five 100-pL reactions were pooled and 5'-phosphorylated as described above. 
350 ng of the human PCR product were ligated into 25 ng of EcoRV-cut pcDNAlI 
which had previously been treated with CIAP, then the ligated material was transformed 
as described previously into supercompetent DHSaFtI, cells (Gibco BRL). Positive 
clones were selected for sequencing based on PCR screening of transformants with 
PLas and cSp6. 
3.3 Results 
The initial screening of the porcine intestinal expression library with the 
monoclonal antibodies 1 C2 and 2H6 resulted in the selection of a cDNA clone which 
will subsequently be referred to as PG33. This clone reacted strongly with the 
antibodies in a Western blot assay, and restriction digest of the clone with Hind 111 and 
Xba I revealed that the size of the foreign insert was 943 base pairs (Figure 3.1. lane 2). 
The insert was sequenced and found to contain a continuous open reading frame in 
frame 2. 
A 700-base pair probe constructed f?om internal sequences of PG33 was labelled 
with digoxygenin, and this probe was used to rescreen the porcine intestinal library. 
The first clone obtained was 103 1 base pairs, approximately 100 base pairs larger than 
PG33 (Figure 3.1, lane 3). This clone is referred to as PG33b. Using the same 
techniques, a third clone was isolated. This clone contained the complete sequence of 
PG3 3 and PG3 3b plus approximately an additional 1 60 bases, making PG3 3c 1 1 5 8 base 
pairs in size (Figure 3.1, lane 4). The open reading frame remained continuous 
throughout these two clones. 
Attempts to obtain an estimate of transcript size by Northern analysis of small 
intestinal poly A+ RNA were unsuccessful. Poly A+ RNA was therefore purified from 
porcine parotid salivary gland to assess the size of the full-length PG33 transcript. 
Based on the Northern blot analysis, the size of the PG33 message is approximately 2.7 
kb (Figure 3.2, lane 1 ). 
Because of the apparent limitation on the size of the clones which can be 
identified by conventional cDNA screening, the next two clones were obtained using a 
PCR-based cloning strategy. This technique is designed to screen large numbers of 
recombinant plasmids rapidly and specifically for sequences of interest. The PCR 
products generated can then be subcloned directly into another vector for analysis. In 
this case, the inserts were subcloned into a vector derived from the pGEM lineage, 
pDK 1 0 1, which had been cut before ligation with EcoRV. 
The antisense primer 896a was selected from the sequence near the 5' end of 
Figure 3.1. Hind 111-XbaI digests of PG33 clones in pcDNA 11. Lane 1 : pBR322-BstN 
1 standards (1  857, 1058,929,383 bp). Lane 2: Hind 111-Xba I digest of PG33. Lane 3 : 
Hind 111-Xba I digest of PG33b. Lane 4: Hind 111-Xba I digest of PG33c. 
Figure 3.2. Northern blot demonstrating hybridization of PG33 probe I to porcine 
parotid salivary gland mRNA. Samples were electrophoresed on a denaturing gel, then 
transferred to Hybond N+ nylon membranes and hybridized with digoxygenin-labeled 
probe I. A: RNA standards (9.49,7.46,4.40,2.37, 1.35, and 0.24 kb). B: Northern 
blot. Lane 1 : 20 pg porcine parotid mRNA. Lane 2: Barn HI-cut PG33. Lane 3: 
unlabeled PCR product corresponding to the probe I sequences (positive control). 
PG33c and used in conjunction with the Sp6 promoter primer from the pcDNAI1 vector 
to directly amplify the remaining PG33 sequences from the porcine intestinal library 
(see Figure 3.5 for schematic illustrating the overlap between PG33 clones). Since the 
library contains a heterogeneous population of cDNA inserts, this reaction resulted in 
the amplification of multiple PCR products of increasing size. The largest products (a 
population between 800 and 1500 base pairs in size) were selected for enrichment to 
increase the probability of obtaining the remainder of the PG33 transcript. This 
population was gel-eluted and then PCR-amplified a second time under the same 
reaction conditions, though with fewer total cycles, so that large amounts of product 
would be available for ligation. 
This strategy resulted in the successful isolation of a fourth clone, 91 8 bp in size, 
which is referred to as PG33d. PG33d contains the sequence at the 5' end of PG33, and 
an additional 600 bp further 5' in the PG33 transcript (Figure 3.3A, lane 3). In a 
Southern blot of PG33c and PG33d, the PG33d clone can be seen to hybridize as 
strongly as the PG33c clone to a digoxygenin-labeled probe constructed from the 5' end 
of PG33c, whereas the plasmid vector pcDNA I1 did not react at all with the probe 
(Figure 3.3B). This PCR-based strategy is therefore a valid technique for selecting 
cDNA clones. 
Because the sequence obtained through cloning of PG33d did not complete the 
full-length transcript of PG33, attempts were made to repeat this PCR-based strategy 
using the porcine intestinal library in order to obtain the sequences further 5' to PG33d. 
These attempts were unsuccessful; either the library does not contain full-length 
transcripts of this gene, or there are limitations on the ability of the PCR methodology 
to amplify this sequence from this particular template. 
Instead, the antisense primer PLas, which had been designed from the 5' end of 
PG33d, was used to screen by PCR amplification a cDNA library constructed from 
human infant intestinal RNA. PCR amplification with PLas and the flanking Sp6 
promoter primer as a sense primer generated a population of products of increasing size 
similar to those obtained during the amplification of PG33d. The largest of these PCR 
Figure 3.3. PCR-based cloning of PG33d from a porcine intestinal cDNA library. A: 
PCR amplification of clones PG33c and PG33d using the internal PG33 antisense primer 
896a and the pcDNA I1 Sp6 promotor sense primer. Lane 1 : pBR322-BstN I standards 
(1 857,1058,929,383 bp). Lane 2: PG33c amplified with 896a and Sp6. Lane 3: 
PG33d amplified with 896a and Sp6. Lane 4: pcDNA I1 vector amplified with 896a and 
Sp6 (negative control). B: Southern blot demonstrating cross-hybridization between 
PG33c and PG33d. DNA from gel in panel A was transferred to a nylon membrane and 
hybridized to digoxygenin-labeled probe 11. Lane 4: pcDNA I1 vector amplified with 
896a and $6. Lane 3: PG33d amplified with 896a and Sp6. Lane 2: PG33c amplified 
with 896a and Sp6. 
1 
products was subcloned into EcoRV-cut pDKlOI, and is referred to as PG33e. P G X e  
is 683 base pairs in size (Figure 3.4A, lane 3), and strongly cross-reacts in a Southern 
blot with a probe constructed from internal sequences from the porcine clone PG33d 
(Figure 3.4B). 
The 5' end of the PG33d clone has a 188-base overlap with the 3' end of the 
PG33e clone, which allows a comparison to be made between the nucleotide and 
predicted amino acid sequences of the porcine and human PG33 genes. Nucleotide 
homology between the two genes in this region is 80% (Figure 3.6A). The predicted 
amino acid sequence has an 89% identity, which increases to 95% if conservative amino 
acid substitutions are included in the calculation (Figure 3.6B). 
The full PG33 sequence obtained to date includes a 2322-base pair cDNA of 
which a 2040-base open reading frame encodes a 679-amino acid protein product 
(Figure 3.7). Hydrophobicity analysis of the predicted amino acid sequence indicates 
four potential transmembrane domains. Examination of the predicted amino acid 
sequence reveals the presence of 3 potential phosphorylation sites for protein kinase A 
and cGMP-dependent protein kinase, 15 potential phosphorylation sites for protein 
kinase C, 7 potential phosphorylation sites for CaMK 11, and 8 potential sites for 
phosphorylation by casein b a s e  11. The predicted protein product also contains 6 
consensus sites for N-linked glycosylation. 
The cDNA sequence of PG33, when originally compared to known sequences, 
matched no DNA sequences contained in the GenBank database. Two recently 
identified genes, however, have been found to contain significant nucleotide and amino 
acid homology to the PG33 cDNA and predicted protein product. The first gene was 
identified in bovine tracheal epithelium and encodes the calcium-regulated chloride 
channel Ca-CC (Cunningham el a!., 1995). The PG33 cDNA cloned so far has a 60% 
nucleotide homology to the bovine chloride channel (Figure 3.8). Based on the deduced 
amino acid sequence, there is a 43% amino acid identity, increasing to 57% if 
conservative substitutions are also included (Figure 3.9). 
The second gene with significant homology to the PG33 cDNA is lung- 
Figure 3.4. PCR-based cloning of PG33e from a human intestinal cDNA library. A: 
PCR amplification of clones PG33d and PG33e using the internal PG33 antisense primer 
PLas and the pcDNA 11 Sp6 promoter sense primer. Lane 1 : pBR322-BstN I standards 
(1 857, 1058,929,383 bp). Lane 2: PG33d amplified with PLas and Sp6. Lane 3: 
PG33e amplified with PLas and Sp6. Lane 4: pcDNA I1 vector amplified with PLas and 
Sp6 (negative control). B: Southern blot demonstrating cross-hybridization between 
PG33d and PG33e sequences. DNA from gel in panel A was transferred to a nylon 
membrane, then hybridized to digoxygenin-labeled probe 111. Lane 4: pcDNA I1 vector 
amplified with PLas and Sp6. Lane 3: PG33e amplified with PLas and Sp6. Lane 2: 
PG33d amplified with PLas and Sp6. 
Figure 3 -5.  Schematic illustrating the overlapping arrangement of the PG3 3 clones. 
Arrows indicate the locations of the internal antisense primers 896a and PLas used to 
obtain the clones PG33d and PG33e. 
p i g  T G T G A T C A A G A G G A A A T A C C C G A C G G A C G G A T C T G A T T C G G G G A  
human TGTGATTAGGAAGGAATATCCAACTGATGGATCTGmTTGTGCTGCTGACGGATGGGGA 
****** * ** * **** ** ** ** ******** ******  * *****  ** ***** 
p i g  GGACAACACGATAAGCGCGTGCTTCACGGAGGTGAAGCAGAGCGGAGCCATCATCCACAC 
human AGACMCACTATAAGTGGGTGCTTTAACGAGGTCAAACAAAGTGGTGCCATCATCCACAC 
******** ***+* * ****** * ***** *+ * *  **  * *  ************** 
pig  GGTCGCCCTTGGGCCCTCGGCAGCGAAGGAGCTGGAGCTGGAGGAGCTGTCGCAGATGACAGGTGG 
human AGTCGCTTTGGGGCCCTCTGCAGCTCAAGMCTAGAGGAGCTGTCCWTGACAGGTGG 
***** * ******** ***** * * *  ** ***********  * ***********  
pig TTTGCAGA 
human TTTGCAGA 
******** 
p i g  VIKRKYPTDGSEIVLLTDGEDNTISACFTEWKQSGAIILEELSQMTGGLQ 
human V I R K E Y P T D G S E I V L L T D G E D N T I S G C F N E V K Q S G A I I H T T G G L Q  
* * * -  ********************X**f******************* ******  ******  
Figure 3.6. Comparison of porcine PG33d sequences in the region overlapping with the 
human PG33e sequences. A: Porcine and human DNA sequence alignment. Asterisks 
under the sequence indicate nucleotide identity. B: Alignment of porcine and human 
predicted amino acid sequence. Asterisks under the sequence represent amino acid 
identity; dots indicate conservative amino acid substitutions. 
Figure 3.7. Nucleotide sequence and predicted amino acid sequence of the translated 
PG33 cDNA. The full length of the current PG33 cDNA is 2322 base pairs, with a 
continuous open reading frame in the first 2041 bases encoding a 679-amino acid 
protein product. The four potential transmembrane domains are underlined. The 
protein sequence contains 6 consensus sequences for N-linked glycosyiation (* ), 3 
potential phosphorylation sites for CAMP- and cGMP-dependent proteins kinases (* ), 
7 potential sites for Ca2'/calrnodulin kinase I1 (V ), 8 potential sites for casein kinase 11 
(. ), and 15 potential sites for protein kinase C (a ). 
ACGGAGAAGGCTTCTATUTGTTTGCACNACATGTTGATTCTATAGTTGAATTCTGTACA 
T E K A S I M F A ? H V D S I V E F C T  
a 
GAACAAAACCNCAACCAAGAAGCTCCAAAAACGAAAATCAAAAATCGAATCTCCGAANAA 
E Q N ? N Q E A P K T K I K N R I S E ?  
ACATGGGAAGTGATCCGTGATTCTGAGGACTTTAAGAAAACCfSCTCCTATGACAACACAG 
T W E V I R D S E D F K K T T P M T T Q  
* 
CCACCAAATCCCNNNNNNACCTTCTCATTGCTGaGATTGGACmGmTTGTGTGTTTA 
P P N P ? ? T F S L L Q I G Q R I V C L  
GTCCTTGACAAATCTGGAAGCATGGCGACTGGCGACTGGTAACCGCCACAATNGACTGAATCAAGCC 
V L D K S G S M A T G N R H N ? L N Q A  
GACAGTGCTGCCCATGTACAAAGTGAACTCATACAGATAAACAGTGGCAGTGACAGGGAC 
D S A A H V Q S E L I Q I N S G S D R D  
a 
ACACTCGCCAAAAGATTACCTGCAGCAGCTTCAGGAGWACGTC~TCTG~GCGGGCTT 
T L A K R L P A A A S G G T S I C S G L  
CGATCGGCATTTNNNACTGTGATWGAGGAAATACCCGACGGACGGATCTGAGATTGTG 
R S A F ? T V I K R K Y P T D G S E I V  
TTACTGACTGACGGGGAGGACAACACGATAAGCGCGTGCTTCACGGAGGTGAAGCAGAGC 
L L T D G E D N T I S A C F T E V K O S  
GGAGCCATCATCCACACGGTCGCCCTTGGGCCCTCGGCAGCGMGGAGCTGGAGGAGCTG 
G A I I H T V A L G P S A A K E L E E L  
TCGCAGATGACAGGTGGTTTGCAGACATATGCTTCAGACCAGGCCGAGAACAACGGCCTC 
S Q M T G G L Q T Y A S D Q A E N N G L  
ATTGACGCTTTCGGGGCCCTTTCGTCCGGGMCAGAGCTGCCTCCCAGCGCTCCATCCTT 
I D A F G A L S S G N R A A S Q R S I L  
a 
v 
TCGGGGCCCCTTTCGTCCGGGAACAGAGCTGCCTCCCAGCGCTCCATCCAGCTGGAGACA 
S G P L S S G N R A A S Q R S I Q L E T  
7 
GGGCTTAACCCTCCAAG-CAACGAATGGATGAATGGCACAGTGGTGGTGGACAGCACT 
G L N P P R N N E W M N G T V V V D S T  
+ I 
G T T G G G G A A A G G A C A C T T T G T T T C T C A T T C A C C T T G G A A C T T  
V G E R T L C F S F T L E R K F L S P I  
CCTTTTTTTGGGGTTCCCAGCGGAAGAAGCCAGGACAGTTTCTTGGTTGGWCACMC 
P F F G V P S G R S Q D S F L V G K H N  
0 
AAGATGGCTTACTTCCAAGTCCCAGGCACGGCCAAGGTTGGCATGTGGAAGTACAGCCTG 
K M A Y F Q V P G T A K V G M W K Y S L  
NNNNNNNNNCAAGCAAGTTCACAAACCTCACTTTNGACCGTCAGCTCCCGTCGGTCCAGC 
? ? ? Q A S S Q T S L ? T V S S R R S S  
0 .  * 
v 
GCTACCCTGCCTCCGGTTACCGTGACCTCTAAAATGAACAAAGACACGGGCAAATTCCCC 
A T L P P V T V T S K M N K D T G K F P  
a 
AGCCCCATGGTAGTTTACACGAAGATTCACCAAGGAACCCTGCCCATTCTCAGGGCCAAG 
S P M V V Y T K I H O G T L P I L R A K  
GTCACAGCCCTGATAGAATCAGAGAATGGGGAAAACAGTTACCTTGGAATTACTGGACAAC 
V T A L I E S E N G K T V T L E L L D N  
GGAGCAGGCGCTGATGCTACCAAGAATGACGGTATCTACTCGAGGTATTTTACAGCTTAC 
G A G A D A T K N D G I Y S R Y F T A Y  
v 
GATGCAAATGGTCGATACAGCGTAAAAGTGTGTGGGCTCTGGGAGGAGTGMCACGC-CGC 
D A N G R Y S V K V W A L G G V N T P R  
AGAAGGGCACCCCCCCTCGGAGTGGAGCCATGTACATACGTGGCTGGATTGAGAATGGGG 
R R A P P L G V E P C T Y V A G L R M G  
AGATCAAATGGAACCCGCCGAGACCCGACATTAACAAGGACGACCTTCAGGGCAAGCAAG 
R S N G T R R D P T L T R T T F R A S K  
v 0 
TGTGTTTCAGCCGAACAGCCTCGGGGGGTTCATTCGTGGCCTCCGACGTTCCGMGTCTC 
C V S A E Q P R G V H S W P P T F R S L  
CATACCCGATCTTTTCCACCCTGTAAGATCACCGACCTGAAGGCCGGGATCCAAGGGGAC 
H T R S F P P C K I T D L K A G I Q G D  
AACCTCATCAACCTGACGTGGACGGCTcCTGGGGATGATTACGACCACGGAAGAGCTGAC 
N L I N L T W T A P G D D Y D H G R A D  
+ 
AGGTACATCATCAGAATAAGCACAAaTATTCTTGATCTCAGAGACAaGTTCMTGATTCT 
R Y I I R I S T N I L D L R D K F N D S  
v 
GTTCAAGTGAACACCACGGATCTCATCCCAAAGGAGGAGGCWCTCAGAGGAGGTCTTTGTG 
V Q V N T T D L I P K E A N S E E V F V  
+ 
TTTAAACCAGAAGGCATCCCTTTTACmTGGCACGGATCTCTTmTTGCTGTACAGGCT 
F K P E G I P F T N G T D L F I A V Q A  
GTCGATAAGACCAACCTGAAGTCAGAAATCTCCAACATTGCAmGTATCTTTGTTCCTT 
V D K T N L K S E I S N I A Q V S L F L  
CCCCGGAGGCTCCTCCGGAGACCTTCCGGAGACACCTGCTCCtTCTCTGCCTTGTCCTGa 
P R R L L R R P S G D T C S F S A L S >  
* 
v 
aattcaggtcaacagcaccattcctggcattcacattttaaaaattatgtggaagtggct 
gggagaattacagctatcgatagcctagggctgagttttcctgagataaacaaatcatcc 
atcctgcttttgattatgaaaatttataaaaatgcattttagactttctgcacgaggcaat 
ttaatgaaatacaatgctaaacaactagatatgtacgtataaaagctattcatgtcaata 
Figure 3.8. Aligned nucleotide sequences of PG33, Ca-CC, and Lu-ECAM-I. 
Asterisks indicate nucleotides that are conserved between all three genes. 
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AAATGGTGCCTCGTCTGACTGTCATTCTGTTCCTAACTTTGCACCTCCTGCCTGGAATGA 
AAATGGTGCTCTGTCTGAATGTTATTCTGTTCCTAACTTTGCATCTCTTGCCTGGAATGA 
CTAGTGTGCCAGMGATGAAAAACTCATTCAAAACATAAAGGAAATGGTAACTGAAGCTT 
CCAGTGTGCCAGAAGATGAAAAACTCATTGAAAACATAAAGGAAATGGTAACTGMGCTT 
CTACTTACCTGTTTCATGCCACCAAACGAAGAGTTTATTT~GGMTGT~GCATTTTM 
C T A C T T A C C T G T T T C A T G C C A C C A A A C G A A G A G T T T A T C  
T T C C A A T G A C G T G G A A G T C A A A A T C T G A G T A C T T A A T G C C T G A C C  
TTCCAATGACCTGGAAATCAAAATCTGAGTACTTCATACCAAAACAAGAATCATATGACC 
AGGCAGAAGTCATAGTTGCTAATCCTTPPCCTAAAACATGGAGATGATCCCTATA~CTTC 
AGGCAGATGTCATAGTTGCTAATCCCTATCTAAAATATGGAGATGATCCCTATA-CTTC 
AATATGGAAGATGTGGAGAAAAAGGACAATATATATACATTTTACTCCAAACTTCTTGCTGA 
AATATGGAAGGTGTGGAGAAAAAGGAAAATATATATACATTTTACTCCAAACTTCTTGTTGA 
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lu-ecam- 1 
pg3 3 
ca-cc 
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T T G C A C N A C A T G T T G A T T C T A T A G T T G A A T T C T G T A C A G A G  
TTATGCAAAGTCTCCATTCTGTGACTGAATTTTGTACAGAAAAAACACACAATGTGGAAG 
TTATGCCAAGTCTCCATTCTGTGACTGAATTTTGTACAGAAAAAAC4CACAATACAGAAG 
C t  t t t + * r t *  * * t e e +  *+*+***** t*t t * C t  r*** 
C C T T C T C A T T G C T G C A G A T T G G A C A A A G A A T T G T G T G T T T  
CATTTTCATTGCTCAAGTCCAAACAGCGAGTAGTTTGTTTGGTACTTGATAAATCTCGAA 
CATTTTCATTGCTCAAGTCCAAACAGCGGGTAGTCTGTTTGGTACTTGATAAATCTGGAA 
* *t +****+**  t* ,** * * *  t*+** t* + + * * *  ***+**+*** 
GCATGGCGACTGGTAACCGCCACAATNGACTGMTCAAGCCAGGAGCNTTTTCCTGATGC 
GCATGTCTTCAGAAGATCGTCTCTTTCGAATGAATCAAGCAGCAGAATTATTCTTGATTC 
GCATGTCTG CAGAAGACCGTCTCTTTCAAATGAATCAAGCAGCAGAACTATACTTGATTC 
* + * * *  f t * *  **+*++**** t * **** 
GGACAGTTGAGCTGGGTCCTGGGGGTTGGGATGGT~~TTTGA~GTGCTGCC~TGTAC 
AAATTATTGAAAAGGGATCCTTGGTTGGGATGGTTACATTTGACAGTGTTGCTGAAATCC 
A A G T T A T T G A A A A G G G A T C T T T A G T T G G G A T G G T T A C T C C  
* * * *  t ********+*+ +**+****t*+** + * *  * * 
AAAGTGAACTCATACAGATAAACAGTGGCAGTGACAGGGACACACTCGCCAAAAGATTAC 
G A A A T A A T C T M C A A A A A T A A C T G A T G A T A A T G T T T A T G A T C T G C  
AAAATCATCTAACAAGAATAACTGATGATAATGTTTACCAAAAGATCACCGCAAAACTGC 
tt + *  *+I+ + +  + + *  * * * *  * *  + t 
*+  **  * * * *  ** t* * *  * *  * *  * *  * *  * * * * *  tf* 
T G A T C A A G A G G A A A T A C C C G A C G G A C G G A T C T G A G A C G  
TTATTCAGAGTCAACAGAGCACTTCTGGTTCTGAAATCATACTACTAACCGATGGGGAAG 
TTATCCACAGTGACCAGAGTACTTCTGGTTCTGAAATCATACTATTAACTGATGGGGAAG 
* *  * *  * * + * +  * * * * *  **  * t* * * *  * *  ***** * 
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TCGCCCTTGGGCCCTCGGCAGCGAAGGAGCTGGAGCTGGAGGAGCTGTCGCAGATGACAGGTGGTT 
T T G C C C T G C G A C C T T C T G C T G C C A A A G A A C T G G A G A C A C T G G A G G - -  
TTGCTCTGGGACCCTCTGCTGCCAAAGAACTGGAGACATTGTmTATGAmGGAGG-- 
f * *  * *  + *  * *  * *  * *  * *  t *  t *  + * + * * *  * * * +  * * * t * t * * *  * *  
TGCAGACATATGCTTCAGACCAG-GCCGAGAACAACGGCCT-TTGACGCTTTCGGGGCC 
- - - -  -ACATCGGTTTTATGCCAATAAAGACATAAATGGCCTTACTMTGCGTTCAG---- 
- - - -  -ATATCGTTTTTTTGCCAATAAAGACATAACTGGCCTTACTMTGCTTTaG--T- 
+ * *  * *  * * +  * *  + t t * * *  * * *  + * *  f 
GGGAACAGAGCTGCCTCCCAGCGCTCCATCCAGCTGGAGA-~GGGCTTMCCCTCWG 
A G A A G T G G C A G T A T C A C T C A G C A G A C T A T T C A G T T G G A A A  
A G A A G T G G A A G C A T C A C T C A G C A G G C T A T T C A G T T G G A A A  
* *  * * * *  * t t  * * *  * * * *  * *  * *  t 
AAACAACGAATGGATGAATGGCACAGTGGTGGTGGACAGCACTGTTGGGGAAAGGACACT 
GAA-AAGAAATGGGTAAATGGTACGGTGCCTGTGGATAGTAWTTGG--WTGAaCT 
G G A - A G G A A A ? i G A G T A A A C G G C A C A G T G C C T G T A G A C C T  
i * *  + * *t t *  t *  * + +  * *  t *  * *  + *  + * + *  * * *  * * * * * *  
TTGTTTCTCATTCACCTTGGAACGGAAGTTCCTTTCCCCATTCCTTTTTTTGGGGTTCC 
T T C T T T G T T G T - C A C A T G G A C A A T A A A A A A G C - - - - - - C A G G A T C C  
T T C T T T G T T G T - C A C A T G G A C A A T A C A A A A A C - - - - - - C A G A T C C  
* *  **+ * + * * *  + + t * *  * *  * * * * *  
CAGCGGAAGAAGCCAGGACAGTTTCTTGGTTGGAAAACACAA-CAAGATG------- -GC 
AAAAGGAAAGAAATATAAAACCTCAGATTTCAAAGAAGATAAGCTAAATATTCATTCTGC 
AAAAGGAAAGAAATATAAAACCTCGGATTTCAAAGAAGATMGTTAAATATTCGATCTGC 
* * * t *  * * t * *  * *  * * *  * *  
NCAAGCAAGTTCACAAACCTCACTTTNGACCGTCAGCTCCCGTCGGTCCAGCGCTACCCT 
T C A T G C C A G T C C T C A A A T A C T A A C A G T G A C A G T G A C C A C T C T A C  
TCATGC~GCTCTCAAATGCTAACAGTGACAGTGACCACTCGAGWGAAGTCCTACTAT 
* *  * *  * *  .*** * *++ *t * * *  * *  * * * *  
G C C T C C G G T T A C C G T G A C C T C T A A A A T G A A C A A A G A C A C G T  
A C C C C C A G T A A C T G C A A C A G C T C A C A T G A G T C A A A A T A ~ G T  
A C C C C C A G T A A T T G C A A C A G C T C A C A T G A G T C A A C A T A - T  
* *  f *  * *  * * *  * *  * t * *  * *  f *  . t + *  * * * *+  * 
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CCTGATAGAATCAGAGAATGGGAAAACAGTTACCTTGGMTACTGGAWCGGAG-GG 
CATTATAGAAACTGAAGATGGCCATCAAGTAAWCTGGAGCTCTGGGAWTGGTGCAGG 
CATTATAGAAACCGAAGATGGACATCAAGTAACATTGGAGCTCTGGGACAATGGTGCAGG 
t t t***** * *  t t t *  t t *  * *  t*** + t * r * *  t t  ***a* 
TGGTCGATACAGCGTAAAAGTGTGTGGGCTCTGGGAGGAGTGm~cG-cmcG~G~GGG 
TGGTAGATACAGTTTAAAAGTACATGCCGAGGWG~~~CGGCTAGGCTMGTTT 
TGGTAGATACAGTTTAAAAGTACATGCACAGGCAAGAAACAACACGGCTAGGCTAAATTT 
* * * *  * ******  ******* **  * *  **  * * * * * *  * * *  * 
CACCCCCCCTCGGAGTGGAGCCATGTACATACGTGGCTGGATTGAGAATGGGGGAGATCAA 
AAGACAACCACAGAACAAAGCCCTGTATATACCAGGCTATATTGAAAATGGTAAAATTAT 
AAGACAACCACAGAACAAAGTTCTATATGTTCCAGGCTACGTTGAAAACGGTAAAATTAT 
* *  * *  * *  * *  * * * * *  * * * *  *t * *  * t t  
ATGGAACCCGCCGAGACCCGACATTAACAAGGACGACffTaGGGWGWGTGTGTTT 
ACTGAACCCACCCAGACCTGAAGTCAAAGATGACCTGGWGCTGAAATAGMGACTT 
ACTGAACCCACCCAGACCTGAAGTCAAAGATGACCTGGCAAAAGCTAAAATAGAAGACTT 
* * * * * *  +*  ***** **  * *  * * *  * * * *  * 
CAGCCGAACAGCCTCGGGGGGTTCATTCGTGGCCTCCGACGTTCCGAAGTCTCtATACCC 
TAGCAGACTAACCTCTGGAGGGTCATTTTACTGTATCAGGAGCTCC---TCCTGGTAATC 
TAGCAGACTAACCTCTGGAGGGTCATTTACTGTATCAGGAGCTCCTCC-TCCTGGTAATC 
t** *+ * **t* * *  **  * * * * *  + *  t * * *  * * t* * 
GGTACATCATCAGAATAAGCACAAATATTCTTGATCTCAGAGACAAGTTCAATGATTCTG 
GCTACATTATAAGAATAAGTAAGAGTTTCCTGGATCTCCAAAAAGATTTTGACAATGCTA 
GCTACATTATMGAATAAGTAAGAGTTTCATGGATCGTCAAGAAGATTTTGACAATGCGA 
* * * * * *  * *  * * * * * * * *  * * * * * *  Z + * *  *t * 
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TTCAAGTGAACACCACGGATCTCATCCCAAAGGAGGCCAACTCAGAGGAGGTCTTTGTGT 
CTTTAGTGMTACTTCCAGTCTAAAACCTAAGGAGGCCGGCTCAGATGAAAATTTTGAAT 
CTTTAGTGAATACTTCTAATCTAATACCTAAGGAGGCCGGATCAAAAGWTTTTGAAT 
* * * * * * *  * *  * * i f  * * *  * * * * * r * * *  * * *  * * *  * * * *  * 
TTAAACCAGAAGGCATCCCTTTTACAAATGGCACGGATCTCTTCATTGCTGTACAGGCTG 
TTAAACCAGAACCTTTTAGAATAGAATAGAAAATGGCACCAACTTCTATATTGCAGTCCAAGCCA 
TTAAGCCAGAACATTTTAGAGTAGAAAATGGCACCAAATTCTATATTTCAGTCCAAGCCA 
* * * *  * * * * * *  t *********  * ***  * * +  * *  * *  * *  
CTTCCCCGGAGGCTCCTCCGGAGACCTTCCGGAGACACCTGCTCCTTCTCTGCCTTGTCC 
C T A T G C C A G A A G A - - - - C - A G T G T C C C T G C T C T G G G T A C C T T T  
CTCTACCAGAAGA-----CAGTGTGTCCATGATCTGGGTACCAAGATTTCTGAAATCACTCT 
* *  * *  * *  f * * +  t * * *  
G C T G G G A G A A T T A C A G C T A T C G A T A G C C T A G G G C T G A G T T  
GAACTGAGATTCAATGTTATACATAGTT---GGWCATTTATTTAG--GATTTAATTT 
GCACTGATAACCAATGTTATACATAGTT---GGTAGTT---GGTACACATTTATTTAG--GATTTAATTC 
t+  * * t r +  ++++  t +  t t t  t+ * t t  
* t t t t *  * *  
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  
GAGTCAGTAATGCTAACTATCTCATCCTCTACTGCCCTCTTCTCTGTTTACCTTWTCT 
- - - - - - - - - - - - -  -AGACTTTCTGCACGAGGCAATTTTA-------------ATGAAATAC 
- - - - - - - - - - - - - -  -GAACATATGAATGTTGTAAATTT----------- CCTAAATAC 
TTCCCCAGCATTAGGATCTTTTCCAATGAGTCAGCTCTTAGCATCGGGTGGCCAAAATAT 
* * * * *  
pg3 3 
ca - cc 
lu-ecam- 1 
P93 3 
ca-cc 
lu-ecam- 1 
Figure 3.9. Alignment of predicted amino acid sequences for PG33, Ca-CC, and Lu- 
ECAM-I. Asterisks indicate amino acids that are identical in all three protein products; 
dots indicate conservative amino acid substitutions. Potential transmembrane domains 
are underlined. 
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AEVIVANPYLKI~GDDPYTLQYGRCGEKGQY IHFTPNFLLTLPI YGSRGRAFVHEWAHL 
ADVIVANPYLKYGDDPYTLQYGRCGEKGKYIHFTPNFLLTNNFHIYGSRGRVFVHEWAHL 
- - - - - - - - - - -  -TEKASIMFAH-VDSIVEFCTEQ-NNQEAPKTKI K N R I S -  E T W E V I R D S  
EAKCTFIPEKSQTARESIMFMQSLHSVTEFCTEKTHNVEAPNLQNKMCNGKSTWDVIMNS 
EAKCTFLPKKSQTAKESIMMPSLHSVTEFCTEKTHNTEAPNLQNKMCNGKSTWDVIMNS 
* . * * * *  - * .  ****em . *  *t* . t * I . * *  I  
E D F K K T T P M T T Q - - P P N P T F S L L Q I G Q R I V C L V L D K S G S M S - F L M R T  
TDFQNTSPMTEMNPPTQPTFSLLKSKQRWCLVLDKSGSMSSEDRLFRMNQ~LFLIQI 
VDFQNTSPMTEMNPPTHPTFSLLKSKQRWCLVLDKSGSMSAEDRLFQMNQAAELYLIOV 
* * -  * . + * *  * * **** .  * * ~ * * * * * * * * * * * ~ ~  . * * *  * * . .  
R-KYPTDGSEIVLLTDGEDNTISACFTEVKQSGAIIHTVALGPSAAKELEELSQMTGGLQ 
QSQQSTSGSEIILLTDGEDNEIHSCIEEVKQSGVIIHTIALGPSMKELETLSDMTGGHR 
HSDQSTSGSEIILLTDGEDNEINSCFEDVKRSGATIHTInKELETLSNMTGGYR 
t  * * * * ~ t * * * t t * t  * *  - * * - * *  * * * * ~ * t * * * t * t t * t  * f  * * * *  - 
EWMNGTVVVDSTVGERTLCFSFTLERKFLSPIPFFGVPSGR---SQDSFLVGKHNKMAYF 
KWVNGTVPVDSTIGNDTF---FVVTWTIKKPEILLQDPKGKKYKTSDFKEDKLNIHSARL 
KRVNGTVPVDSTVGNDTF- - - FVVTWTIOKPEIVLQDPKGKKYKTSDFKEDKLNIRSARL 
*++*  * * * *  . *  
. 
* .  * 
. . 
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YSVKVWALGGVNTPRR--RAPP---LGVEPCTWAGLRMGRSNGTRRDPTLTRTTFRASK 
YSLKVHAEAXNNTARLSLRQPQNKALY I PGYIENGKI I WPPRPEVKDDLAKAEIEDFSR 
YSLKVHAQARlWX"X'RWLRQPQNKVLWPGYVENGKIILNPPRPEVKDDLAKAK1E~FSR 
tt  - * t  t tt + * * * .  . - .  . 
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SYIIRISKSFMDRQEDFDNATLVNTSNLIPKEAGSKENFEFKPEHFRVENGTKFYISVQA 
t++*C* * +  
+ . * * + -  * * * * , *  t  * * *+  * * *  - * - * * a  
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+ 
. . * *  * t a t * *  * - +  . . .  
products was subcloned into EcoRV-cut pDKlO I,  and is referred to as PG33e. PG33e 
is 683 base pairs in size (Figure 3.4A, lane 3), and strongly cross-reacts in a Southern 
blot with a probe constructed from internal sequences from the porcine clone PG33d 
(Figure 3.4B). 
The 5' end of the PG33d clone has a 188-base over1 ap with the 3' end of the 
PG33e clone, which allows a comparison to be made between the nucleotide and 
predicted amino acid sequences of the porcine and human PG33 genes. Nucleotide 
homology between the two genes in this region is 80% (Figure 3.6A). The predicted 
amino acid sequence has an 89% identity, which increases to 95% if conservative amino 
acid substitutions are included in the calculation (Figure 3.6B). 
The full PG33 sequence obtained to date includes a 2322-base pair cDNA of 
which a 2040-base open reading frame encodes a 679-amino acid protein product 
(Figure 3.7). Hydrophobicity analysis of the predicted amino acid sequence indicates 
four potential transmembrane domains. Examination of the predicted amino acid 
sequence reveals the presence o f  3 potential phosphorylation sites for protein kinase A 
and cGMP-dependent protein kinase, 15 potential phosphorylation sites for protein 
kinase C. 7 potential phosphorylation sites for CaMK 11. and 8 potential sites for 
phosphorylation by casein kinase 11. The predicted protein product also contains 6 
consensus sites for N-linked glycosylation. 
The cDNA sequence of PGX. when originally compared to k n o w  sequences, 
matched no DNA sequences contained in the GenBank database. Two recently 
identified genes, however, have been found to contain significant nucleotide and amino 
acid homology to the PG33 cDNA and predicted protein product. The first gene was 
identified in bovine tracheal epi thei ium and encodes the calcium-regulated chloride 
channel Ca-CC (Cunningham ei ai., 1995). The PG33 cDNA cloned so far has a 60% 
nucleotidc homology to the bovine chloride channel (Figure 3.8). Based on the deduced 
amino acid sequence, there is a 43% amino acid identity. increasing to 57% if 
conservative substitutions are also included (Figure 9). 
The second gene with significant homology to the PG33 cDNA is lung- 
endothelial cell adhesion molecule- 1 (Lu-ECAM-I), isolated from bovine aortic 
endothelial cells and thought to be involved in the organ-specific metastasis of tumor 
cells (Elble el a/.,  1997). Nucleotide homology between the two cDNAs is 6 l % (Figure 
3.81, while amino acid identity is 43%; the DNA sequence homology observed between 
Ca-CC and Lu-ECAM-I is 92%. while amino acid homology between the two is 88% 
(Elble et at., 1997). 
3.4 Discussion 
The technical difficulties associated with the purification of integral membrane 
proteins such as ion channels are considerable, as evidenced by the limited success of 
previous attempts by this laboratory to isolate the protein species responsible for the 
chloride conductive pathway under investigation. Molecular biological techniques offer 
an alternative approach to the study of protein function, in which the isolation of the 
gene for the protein of interest provides a potential source from which a purified protein 
product can be translated in vitro. 
Use of an anti-chloride conductance monoclonal antibody to screen a porcine 
expression library resulted in the identification of the apparently novel, though not full- 
length, cDNA clone PG33. Based on Northern analysis of poly A+ RNA purified from 
porcine parotid salivary gland, the estimated size of the PG33 transcript is 2.7 kb. 
Repeated attempts to obtain a transcript size from Northern blots of porcine small 
intestinal RNA were unsuccessful. This does not necessarily indicate that PG33 mRNA 
is not expressed in the small intestine, since this message can be successfully amplified 
from ileal RNA by reverse transcriptase PCR (see Chapter 4: Tissue Expression). 
Two factors appear to contribute to the negative results of the small intestinal 
Northems. The first is the low copy number of the PG33 message: based on the amount 
of template required to amplify PG33 by RT-PCR, the copy number is 0.01 % or less. 
Furthermore, extremely large amounts of polyA+ RNA (20 pg) were required to 
visualise the PG33 transcript in the Northern blot of parotid RNA. Second, exposure to 
extracellular RNases known to be present in the intestinal lumen may contribute to the 
deterioration of the sample during RNA purificiation from small intestinal tissue, 
exacerbating the experimental difficulties. 
Cloning of PG33 cDNA through a variety of approaches has resulted in a current 
total length of 2322 base pairs of confirmed sequence. The open reading frame is 
continuous throughout the five PG33 clones, of which four were isolated from the 
porcine cDNA library and one from a human intestinal library. Nucleotide and amino 
acid homology between the pig and human sequences is extremely high. The 
conservation of amino acid sequence between the two species suggests that the 
translated protein product of a porcine-human chimera would not have a significantly 
different three-dimensional structure than a protein translated from an entirely porcine 
cDNA. 
Comparison of the PG33 cDNA sequence with sequences from DNA and 
protein databases reveals significant homology with only two reported sequences. The 
protein product of one of these genes, Ca-CC, has been shown to function as a calcium- 
regulated chloride channel in bovine tracheal epithelium (Cunningham er al., 1995). 
This is consistent with the hypothesized role of the related P G X  gene product in 
intestinal epithelium. 
The other gene. however, encodes an endothelial cell adhesion molecule (Lu- 
ECAM- 1 ) that appears to promote tumor metastasis LO lung tissue (Elble & Pauli. 1996; 
Elble el of.. 1997). There are other instances in which ion channel activity and cell 
adhesion function have been reported in a single protein; for example, the 
Cuenorhabdiris elegons unc- 105 gene product is a homolog of the degenerinENaC 
superfamily of sodium channels, and this gene product is thought to function in 
mechanosensation through an interaction with type IV colIagen (Liu et dl., 1996). The 
Lu-ECAM- I protein has not yet been shown to function as a chloride channel. though 
considering its extremely high (88%) amino acid homology with the Ca-CC gene 
product, it would perhaps be surprising if Lu-ECAM-1 did not exhibit channel activity. 
An examination of the deduced amino acid sequence of the PG33 protein 
product reveals the presence of four regions of relatively high hydrophobicity which 
might potentially act as transmembrane domains. These regions, though predominantly 
hydrophobic, also contain basic residues, which is consistent with a possible role as a 
membrane channel through which negatively charged chloride ions may pass. 
Comparison of the amino acid sequences of PG33, Ca-CC, and Lu-ECAM-I 
demonstrates that three of the four hydrophobic regions are well conserved between the 
three proteins (Figure 9). 
The protein sequence of the PG33 gene product also contains six consensus sites 
for N-linked glycosylation. This is consistent with the apparent glycosylation status of 
the antigen against which the anti-chloride conductive antibody was raised. Since the 
antigen could only be immunoprecipitated from a complex population of brush-border 
membrane proteins when tunicarnycin pretreatment prevented protein glycosyIation 
(Racette el a!., 1 W6), it seems likely that the antigen was itself a target for N-linked 
gl ycosy Iation. 
Further analysis of the amino acid sequence identified a number of potential 
phosphoacceptor sites for phosphorylation by multiple serine/threonine protein kinases. 
The majority of the potential phosphorylation sites are for protein kinase C and 
Ca"/calmodulin kinase 11, though there are also several for casein kinase 11. Only a few 
potential sites for phosphorylation by PKA or PKG occur in the PG33 protein sequence. 
Which, if any, of these sites act as phosphoacceptors in viiro or in vivo has yet to be 
determined. All of the sites identified appear to be relatively "strong", or classical, 
consensus sequences for phosphorylation by each protein kinase. 
While the precise locations of the consensus sequences in PG33 differ from 
those in Ca-CC, the overall pattern is similar: multiple sites for PKC, CaMK 11, and 
casein kinase 11, but few for PKA or PKG (Cunningham et al., 1395). Ca-CC also 
contains consensus sites for phosphorylation by tyrosinc kinase which are not found in 
PG33 (Cunningham et ul., 1995). Under physiological conditions, the primary control 
over Ca-CC activity appears to be through the activity of CaMK I1 (Fuller ef al., 1994). 
If the PG33 cDNA encodes a similar chloride channel, potential regulatory mechanisms 
will require investigation. 
One area in which PG33 differs from Ca-CC and Lu-ECAM-I is the relative 
sizes of the cDNAs. The full-length bovine cDNA is reported to be 3001 bases, 
however, with a 2712-base continuous open reading frame encoding a 903-amino acid 
protein product (Cunningham et ai., 1995). Northern analysis of bovine tracheal mRNA 
shows a single band at 3.1 kb. This is somewhat larger than the estimated size of the 
PG33 transcript, which is 2.7 kb including untranslated regions. The cDNA sequence of 
Lu-ECAM- 1 was obtained from a number of overlapping clones. The first, a 3.3 kb 
sequence encoding a 905-amino acid protein product, was isolated by PCR from reverse 
transcribed bovine aortic endothelid celI (BAEC) RNA. The other three clones, of the 
same size and smaller (3.3, 2.8, and 1.3 kb) were isolated from a BAEC cDNA library. 
Northern analysis of BAEC RNA showed the presence of multiple bands, consistent 
with these sizes. and the major Lu-ECAM-I protein species observed in this tissue are 
thought to be the result of proteolytic processing of a single initial translational product 
(Elble et d., 1997). 
The Ca-CC and Lu-ECAM-I cDNAs align with only very minor gaps between 
the coding portions of the two sequences, consistent with the high degree of homology 
shared by these two genes. The PG33 cDNA sequence also aligns well with Ca-CC and 
Lu-ECAIM-I for the majority of the sequence. There is one region. however, in which 
the nucleotide and amino acid sequence of PG33 diverges from that of Ca-CC and Lu- 
ECAM-1. The 17-amino acid sequence between Ser-249 and Ser-265 of the PG33 
protein product does not have a counterpart in the sequence of either the Ca-CC or the 
Lu-ECAM-1 protein. Furthermore, the first 12 residues of the region beginning at S249 
(SSGNRAASQRSI) are repeated following the serine residue at position 265. The 
remaining 5 residues are not repeated. This repeated sequence may be the result of an 
exon duplication that did not occur in either Ca-CC or Lu-ECAM- I .  
In summary, the isolation of the PG33 cDNA has identified the third member of 
a novel gene family. One of the other members of this family, Ca-CC, has been shown 
to act as a calcium-regulated chloride channel. The other, Lu-ECAM- 1, is known to 
function in cell adhesion, but as its discovery is very recent, no reports have yet been 
published concerning a possible role as a chloride channel. The use of an anti-chloride 
conductance antibody to select PG33 as well as its sequence homology to Ca-CC and 
Lu-ECAM- I are consistent with a role for this gene product in ion transport. 
Testing of this hypothesis will require the isolation of the remainder of the PG33 
sequence and the construction of a full-length chimera. The protein product of this 
chimeric cDNA can then be expressed, reconstituted into a planar lipid bilayer system, 
and definitively tested tbr chloride channel function. 
4.0 Expression of PG33 in Porcine Tissues 
4.1 Introduction 
The presence of channel proteins in cell membranes permits the passage of ions 
across the otherwise relatively impermeable lipid membrane; the movement of these 
ions is involved in a number of critical processes in both epithelial and nonepithelial 
cell types. Linked to the osmotic movement of water. electrolyte transport controls net 
fluid absorption and secretion across epithelial barriers. Ion transport also plays 
important roles in the regulation of cell volume and internal pH, as well as in 
maintaining the cell membrane potential. 
Multiple channel types are involved in the transport of each of the major 
electrolytes. Some of these channels are found in only a single cell type, while others 
are broadly distributed. Presumably, the tissue distribution of a channel type is related 
to its physiological function: widely expressed chanr~els may be involved in essential 
processes common to many different cell types, while tissue-specific channels may play 
roles in the hc t ions  of specialised cells. 
Widely expressed chloride channels include some members of the CIC family, 
the cystic fibrosis transmembrane conductance regulator (CFTR). and the outwardly 
rectifying chloride channel (ORCC), while other members of the CIC family have a 
restricted tissue expression. 
The CIC family contains a number of structurally related genes, many of which 
have been shown to act as voltage-gated chloride channels. The first member of the 
family, CIC-0. was originally cloned from the electric organ of Torpedo marrnorata, 
and is involved in the generation of electric current by this organ (Jentsch et al., 1990). 
In rapid succession thereafter. several homologous genes were cloned and their 
skeletal muscle tissue and is defective in the disorder myotonia (Stcinmeyer et al., 
1991), though CIC-1 mRNA can be detected in lower levels in other tissues. The CIC- 
K subfamily, including CIC-K1 and CIC-KZ, is expressed in the highest levels in the 
kidney (Uchida ef aL. 1999, and may be involved in the regulation of urine 
concentration (Uchida el al., 1993; Pusch & Jentsch, 1994). Another recently cloned 
family member, C1C-5, is aiso kidney-specific (Lloyd el al., 1 996; Sakamoto el al., 
1996). 
Several members of the CIC family have a broader tissue expression than CIC- 1 
and the CIC-K subfamily. C1C-2 has a nearly ubiquitous pattern of tissue distribution; 
its mRNA is detectable not only in epithelial tissues such as pancreas, liver, intestine, 
stomach, and the cell lines CFPAC-1 and T84, but also in nonepithelial tissues 
including heart, brain, 3T3 fibroblasts, and the Chinese hamster ovary (CHO) cell line 
(Thiemann el al., 1992). Expressed in Xenopus oocytes, CIC-2 acts as a chloride 
channel that can be activated by strong hyperpolarizing voltages (Thiemann et al., 1992) 
and by exposure to hypotonic solutions (Grunder et al., 1992). Because the voltages 
required to activate CIC-2 are nonphysiological, however, it has been suggested that the 
more likely physiological activator of ClC-2 function is altered cell volume (Grundcr et 
al., 1992; Pusch & Jentsch, 1994). 
CIC-6 and CIC-7 are widely expressed in both rat and human tissues, including 
brain, testis, ovary, skeletal muscle, small and large intestine, pancreas. and lung 
(Brandt & Jentsch, 1995). These gene products are currently classified as putative 
chloride channels, since neither has yet been shown to cause chloride channel activity in 
Xenopus expression systems (Brandt & Jentsch, 1995; Buyse et al., 1 997). 
Other chloride channels with a wide tissue distribution include CFTR as well as 
the outwardly rectifying chloride channel (ORCC). It seems clear, based on the severe 
and widespread clinical pathology that results from defective CFTR expression, that this 
chloride channel plays a major role in the control of fluid and electrolyte secretion in 
many exocrine tissues. While tissue expression of CFTR correlates in general with the 
characteristic histopathology of the disease, not all tissues that express CFTR exhibit 
characteristic histopathology of the disease, not all tissues that express CFTR exhibit 
morphological changes as a result of chloride impermeability through this channel. 
CFTR is strongly expressed throughout the small intestine. with a decreasing 
gradient of expression both from crypt to villus and from duodenum to ileum (Tresize & 
Buchwald, 199 1 ; Strong el al., 1994). CFTR message can also be detected in pancreatic 
intercalated ducts and interlobular ducts (Tresize & Buchwald, 199 1 ; Strong et al., 
1994) and in the epithelial lining of the gallbladder and colon (Strong et al., 1994). 
Moderate levels of CFTR expression can be detected in airway epithelia with 
higher levels in the underlying submucosal glands (Engelhardt et al., 1992). Other 
tissues in which CFTR is expressed include the intercalated and interlobular ducts of the 
major salivary glands, the secretory coils of apocrinr sweat glands, thyroid follicular 
cells, epididymai cells in the testis, and the uterine endometrium (Tresize & Buchwald, 
199 1 ; Crawford el a/., 1 99 1 ; Tresize et al., 1992; Tresize et al., 1993 ; Dewyst et al., 
1997). In addition to its presence in these native tissues, CFTR is also endogenous to 
many immortalized cell lines such as the intestinal cell lines T84. CaCo-2. and HT-29, 
as well as a number of cultured airway and pancreatic cell lines (Riordan et a!., 199. 
1989; Ward et ul., 199 1 : Crawford er a[.. 199 1 ). 
Although it is predominantly expressed in epithelial tissues, CFTR can also be 
found in a variety of nonepithelid tissues including the heart (Levesque et al., 1992), 
lymphocytes (McDonald et al., 1992), and the kidney (Crawford et al., 1 99 1 ). While 
overt pathology has not been described in these tissues in cystic fibrosis, CAIMP- 
regulated currents are defective in CF lymphocytes (McDonald el a/., 1992), and CFTR- 
mediated currents have been suggested to play a role in cells affected by autosomal 
polycystic kidney disease (Hanaoka et al., 1996). 
Because the gene encoding the ORCC has not yet been cloned, cDNA probes are 
not available for in situ hybridization studies. Consequently, the presence of the 
channel in a given tissue or cell must be confirmed by functional tests such as its 
activation in excised membrane patches by strong depolarization. Nonetheless. the 
outwardly rectifying chloride channel appears to have a tissue distribution similar, 
though not identical, to that of CFTR. The ORCC can be found in epithelia fiom the 
small and large intestine (Halm & Frizzell, 1992), the pancreatic ducts (Ward e i  al., 
1 W ) ,  airways (Welsh, 1986), and sweat gland (Krouse et aL, 1989), as well as in 
nonepithelial tissues such as lymphocytes and the heart (Garber, 1992; Duan et al., 
1997). 
A number of chloride channel species have been described as having a restricted 
tissue expression. In addition to members of the ClC family such as CIC-I, C1C-KI and 
CIC-K2, a calcium-activated chloride channel (Ca-CC) purified fiom bovine trachea 
(Ran & Benos, 199 1; Ran & Benos. 1992) was not detected in any of the other bovine 
tissues examined (Cunningham et a/. , 1995). As well, neuronal chloride channels gated 
by amino acids such as GABA and glutamate are involved in transmission of nerve 
impulses and are restricted to the central nervous system (Cull-Candy & Ogden, 1985). 
PG33 was originally identified in small intestinal epithelium, which traditionally 
exhibits both secretory and absorptive abilities. Though the only known homologue of 
PG33 is the calcium-regulated chloride channel Ca-CC. whether the PG33 gene product 
can also function as a chloride channel has not yet been established. It was thought 
important. however, to investigate the tissue distribution of PG33 in order to compare 
its expression to that of known chloride channels such as CFTR, the ORCC, and the 
bovine calcium-regulated channel. Expression of PG33 in many tissues might indicate 
a housekeeping function for this gene product. Alternatively, if the expression of PG33 
is restricted to certain tissues, the identification of such tissues might provide 
information suggesting a more specialised role for the PG33 protein. 
In addition, the PG33 cDNA was selected through the use of an anti-chloride 
conductance monoclonal anti body raised against small intestinal brush- border 
membrane antigens. In immunohistochernical studies. this antibody identified the crypt 
region as the primary location of this antigen in porcine small intestine. Presence of the 
PG33 message should, in theory, correlate with expression of antigen recognised by the 
monoclonal antibody. 
The simplest and most sensitive technique which would allow both of these 
questions to be investigated is reverse transcriptase PCR (RT PCR). As well, in situ 
hybridization studies were undertaken, both to confirm the results of the RT PCR 
experiments and to identify the specific cell types within porcine tissues in which the 
PG33 message is expressed. 
1.2 Methods 
42.1 Reverse Transcriptase PCR 
Total RNA was purified according to the acid guanidium thiocyanate-phenol- 
chloroform method of Chomczynski and Sacchi (1 98 7). Postmortem tissue samples 
were removed from weanling pigs of mixed Yorkshire-Landrace breed (through kind 
permission of Dr. Linda Hiebert), and homogenized in 4 M guanidium isothiocyanate, 
25 mM sodium citrate pH 7, and 0.5% laurylsarcosine (solution D). The samples were 
then repeatedly extracted in 0.1 volumes 2 M sodium acetate (pH 4), 1 volume of 
phenol, and 0.2 volumes of a 24: 1 chlorofom-isoamyl alcohol mix until no interface 
was visible between the aqueous and organic phases. RNA was precipitated by the 
addition of I volume of isopropanol at -20°C for an hour followed by a 15 minute 
centrifugation at 9000 x g. The pellet was resuspendcd in solution D and extracted once 
again, then reprecipitated as described above. The resulting pellet was washed with 
95% ethanol, air dried, then resuspended in DEPC-treated water. 
The template for each reverse transcription reaction was 5 p g  total RNA, 
denatured by heating at 90°C for 5 minutes immediately before the initiation of the 
reaction. Generation oFcDNA from the RNA was accomplished in a reaction solution 
containing 50 m M  Tris-HC1 pH 8.15, 6 rniM MgCL, 40 mM KCI, 1 mM DTT, 1 mM 
each dGTP, dATP, dCTP, dTTP, 33.7 units RNAGuard (Pharmacia), 100 units 
Moloney murine leukemia virus (MMLV) reverse transcriptase (Gibco BRL), and 1 
pmol of the 24 l a  antisense primer [5'AATGCCAGGAATGGT]. The reaction was 
allowed to continue for 30 minutes at 42"C, then the enzyme was denatured in a 5- 
minute heat treatment at 94°C. 
One pL of the reverse transcription was used as a template for amplification of 
internal PG33 sequences. The PCR reaction conditions were identical to those 
previously described, except that the primers used to amplify the internal PG33 segment 
were the 24 1 a antisense primer and the 9 1 1 s sense primer 15' 
GGTCGATACAGCGTA], and the total number of cycles was 30. 
3.2.2 In situ Hybridization 
4.2.2.1 Preparation of Tissue Sections 
Postmortem tissue samples were removed from experimental pigs as described 
above. Sections measuring approximately 10 rnrn x 10 rnm x 3 mrn were fixed for 3 
hours in an ice-cold solution containing 85% ethanol. 5% glacial acetic acid, and 4% 
formaldehyde. Tissue sections were then stored in 70% ethanol at -20°C until 
processed. 
Processing involved sequential one-hour exposures to formalin. 70% ethanol, 
80% ethanol, and 95% ethanol, followed by 3 hours in absolute ethanol, 3 hours in 
xylene, and 4 hours in paraffin. Samples were then embedded in paraffin cassettes and 
stored at room temperature until thin-sectioned. Sequential thin sections were sliced by 
microtome onto 3-aminopropyItriethoxylsilane (TESPA)-treated glass slides and dried 
overnight at 42 "C. 
3.2.2.3 Probe Synthesis 
Synthesis of the j5S-labelled probes was carried out for 90 minutes at 37°C in 
reactions containing 40 mM Tris-HCI pH 7.5,6 mM MgCl,, 10 rnM NaCI, 2 m M  
spermidine, 100 mM DTT, 0.5 mM each ATP, CTP. GTP, 12.5 p M  UTP, 25 pmol j5S- 
UTP, 0.5 units b a s i n  (Promega), 50 units RNA polymerase (Promega), and 2 p g  
linearised template. The sense probe was constructed from Apa I-cut PG33d template, 
and the Sp6 RNA polymerase (Promega) was used to accomplish cRNA synthesis. 
Antisense cRNA was produced using T7 RNA polymerase (Gibco BRL) on Kpn I-cut 
PG33c. 
Template DNA was then removed by the addition of 1 unit RNasin, 10 units 
RNase-free DNase I (Promega), 20 pg yeast tRNA, and a further incubation at 37°C for 
15 minutes. The unincorporated nucleotides, enzymes, and salts were removed with the 
maid RNA purification kit (BIO 10 l), and the labeled cRNA was eluted into a 50% 
formamide solution. 
4.2.23 Pre-hybridization Treatment of Tissue Sections 
Tissue sections were dewaxed and rehydrated by a 10-minute bath in xylene 
followed by a second, 5-minute bath in xylene. Sections were then exposed to loo%, 
90%, 70%, and 30% ethanol for 30 seconds each. Hydrolysis of protein crosslinks was 
initiated in a 20 minute bath in 0.2 M HCI; the acid was then removed in a 5 minute 
rinse in TE. Further protein hydrolysis was accomplished by a 15 minute incubation at 
37°C in proteinase K (20 pg/rnL) in TE. Proteinase K was neutralised by a 2-minute 
exposure to 0.2% glycine in PBS, followed by a 3-minute equilibration in PBS. Tissue 
RNases were neutralised by a 20-minute post-fixing on ice in 4% paraformaldehyde in 
PBS, and the paraformaldehyde was then removed in a 5-minute PBS wash. Non- 
specific binding sites were blocked by a 10-minute exposure to 0.1 M triethanolamine in 
0.5% acetic anhydride. The sections were then left to equilibrate in 2x SSC. 
4.2.2.4 Hybridization and Post-Hybridization Washes 
Tissue sections were hybridized overnight at 50°C in a solution containing 10 
mM Tris-HCl pH 7.6.300 m M  NaCI, 5 mM EDTA, 10 m M  DTT, 10% dextran 
sulphate, 50% formamide, 100 pg/mL yeast tRNA, 500 pM uridine 5' [a-thio] 
triphosphate (thio-UTP), and 0.25 ng/mL "S-labeled cRNA probe. 
Coverslips were removed from the slides in 2x SSC, and the sections washed 
twice for 30 minutes at 50°C in 50% formamide, 2x SSC, 10 m M  2-mercaptoethanol. 
Sections were equilibrated at 37°C for 15 minutes in 4x SSC in TE, then the 
nonspecifically bound '~S-CRNA was digested by a 30-minute exposure to 30 pg/mL 
RNase A in 4x SSC in TE at 37°C. RNase was removed by a 30-minute wash at 37OC 
in 4x SSC in TE, and the digested j5S-UTP was then removed by washing in 50% 
formamide, 2x SSC, 10 rnM 2-rnercaptoethanol for an hour at 50" C. The sections were 
equilibrated briefly at room temperature in 2x SSC, then dehydrated by 30-second 
exposures to 30%. 50%, 70%, and 93% ethanol, all in 0.3 M ammonium acetate. 
Dehydration was completed by a 30-second exposure to absolute ethanol and the 
sections were then allowed to air dry. 
4.2.2.5 Autoradiography and Staining 
Slides were dipped in photographic emulsion (Kodak), air-dried. then exposed at 
-20°C for 3 to 14 days. Slides were developed at room temperature for 2.5 minutes in 
Kodak D 19 developer, washed briefly in water, and fixed for 5 minutes in Kodak rapid 
fixer. 
After an overnight soak in water, slides were dehydrated for 2 to 3 minutes in 
60% ethanol. They were then stained for 30 seconds4 minutes in 0.2% toluidine blue 
in 60% ethanol and washed briefly in water. The final stages involved two 2.5-minute 
washes in acetone and two 2.5-minute washes in xylene to dehydrate the stained 
emulsion. Coverslips were fixed in place with Permount (Fisher). 
4.3 Results 
PG33 message was detected in pig ileal total RNA samples using the reverse 
transcriptase PCR technique (Figure 4.1. lane 2). This validates the use of the anti- 
intestinal chloride conductance monoclonal antibody to screen an intestinal expression 
library, since the antibody was raised against protein from the apical membrane of 
intestinal brush-border epithelial cells. The antibody subsequently reacted with a fusion 
protein product encoded by a cDNA from the expression library, and this cDNA had 
been reverse transcribed from poly A+ RNA purified from porcine small intestinal 
epithelia. 
While PG33 message was detected in small intestinal mucosa, it was not 
detected in total RNA from large intestinal mucosal samples (Figure 4.1, lane 3). 
Figure 4.1. Intestinal and airway expression of PG33. Five pg total RNA was reverse 
transcribed with MMLV-reverse transcriptase and the 21 4a antisense primer, then PCR- 
amplified for 30 cycles using the PG33 internal primcn 241a and 91 is, thcn visualised in 
a 0.8% agarose gel containing 0.25 pg/mL ethidium bromide. A: Schematic of PG33 
indicating the internal sequence amplified by 24 1 a and 9 1 1 s. B: RT PCR amplification 
of PG33. Lane 1 : pBR322-BstN I standards (1 857, 1058,929,383, and 121 bp). Lane 
2: small intestine. Lanc 3: colon. Lane 4: trachea. Lane 5: bronchi. Lane 6: lung. Lanc 
7: PG33 positive control. Lane 8: no template control. 
Hence, the expression of PG33 may be restricted to specific regions within the 
gastrointestinal tract. Likewise, PG33 message was detected in samples from tracheal 
epithelia (Figure 4.1, lane 4), but not in samples taken from large bronchial epithelia 
(Figure 4.1, lane 5) or from lung parenchyma (Figure4. I ,  lane 6) .  
The expression of PG33 in other exocrine tissues was also investigated. Total 
RNA was purified from tissue samples taken from the major salivary glands of the pig, 
which are the parotid, mandibular, and sublingual glands. The minor salivary glands. 
including the buccal, labial, and pharyngeal glands were not examined. PG33 message 
was detected in samples from all three major salivary glands (Figure 4.2, lanes 3-5). 
While RT PCR is not a strictly quantitative procedure, a rough estimate of relative 
message abundance may be made since the amount of total RNA reverse transcribed 
was the same in all tissue samples. Consequently, of the major salivary glands. thc 
expression of PG33 appcars to be highest in the parotid, followed by the sublingual, and 
lowest in the mandibular gland. 
Reverse transcriptase PCR was also performed on pancreatic total RNA 
samples. Surprisingly, considering the classically exocrine nature of the pancreas, no 
PG33 message was detected in these samples (Figure 4.2, lane 2). The expression of 
PG33 in a number of other tissues was also investigated. Total RNA was purified from 
heart, skeletal muscle, stomach, liver, and kidney, and PG33 message was not detected 
in any of these samples (Figure 4.3, lanes 2-6). 
In summary, of all the tissues examined using the reverse transcriptase PCR 
technique. PG33 message was only detected in the small intestine, the trachea, and the 
parotid, mandibular, and sublingual salivary glands of the pig. 
Although RT PCR has the advantage of being an extremely sensitive method of 
detection, this technique does not allow the identification of  the specific cell types 
within a tissue that express the genes of interest. In situ hybridization, on the other 
hand, permits the investigation of gene expression from a histological perspective. The 
expression of PG33 was therefore studied by in situ hybridization in a number of 
porcine tissues which had been previously identified by RT PCR as either expressing or 
Figure 4.2. Pancreatic and salivary gland expression of PG33. Five pg total RNA was 
reverse transcribed with the 241a antisense primer and PCR-amplified for 30 cycles using 
the PG33 internal primers 24 1 a and 9 1 1 s, then visualised in a 0.8% agarose gel 
containing 0.33 p g h L  ethidium bromide. A: Schematic of PG33 indicating the 684-bp 
internal sequence amplified by 241 a and 9 1 1 s. B: RT PCR amplification of PG33. Lane 
1 : pBR322-BstN I standards (1 857, 1058,929,383, and 121 bp). Lane 2: pancreas. 
Lane 3 : parotid gland. Lane 4: submandibular gland. Lane 5: sublingual gland. Lane 6: 
PG33 positive control. Lane 7: no template control. 
Figure 4.3. Expression of PG33 in heart, skeletal muscle, stomach, liver, and kidney. 
Five pg total RNA was reverse transcribed with the 241 a antisense primer and PCR- 
amplified for 30 cycles using the PG33 internal primers 241a and 91 1s. Products were 
visualised in a 0.8% agarose gel containing 0.33pg/mL ethidium bromide. A: Schematic 
indicating the PG33 internal sequence amplified by 241 a and 91 1s. B: RT PCR 
amplification of PG33. Lane 1: pBR322-BstN I standards (1 857.IOS8.929. 383. and 
121 bp). Lane 2: heart. Lane 3: skeletal muscle. Lane 4: stomach. Lane 5: Iiver. Lane 
6: kidney. Lane 7: PGX positive control. Lane 8: no template control. 
not expressing this gene. This included ileum and trachea. both of which were positive 
for PG33 expression in the RT PCR studies, and heart, pancreas, colon, and lung, 
tissues in which PG33 message had not been detected in the RT PCR studies. 
The in situ hybridization experiments confirmed the expression of PG33 in the 
small intestine and the ~rachea. In the trachea, PG33 message was detected in the 
surface epithelium (Figure 4.4, panels B and C). The underlying submucosal glands 
also exhibited an extremely strong signal, but no signal was apparent elsewhere within 
the submucosal layer (Figure 4.4, panels A and B). Expression of PG33 message 
appeared to be highest in the glands themselves, rather than the epithelium lining the 
collecting ducts opening onto the tracheal surface. Within the submucosal glands, serous 
cells could not be distinguished from mucus-producing cells at the level of resolution 
available. The tracheal lamina propria, cartilage, and adventitia were all negative 
(Figure 4.4, panel A). No signal was observed in the sense control sections (Figure 1.4, 
panel D). 
In the ileum, the epithelial cells in both the crypts and villi exhibited a diffuse 
but moderately strong signal, indicative of PG33 expression throughout this region 
(Figure 4.5, panel B; Figure 4.6, panel B). No gradient of distribution was apparent 
along the crypt-villus axis. Isolated epithelial celIs scattered throughout the villus were, 
however, highly positive (Figure 4.5, panel B). The lamina propria, muscularis 
mucosae, and underlying submucosal regions were all free of specific signal (Figure 4.5, 
panel A; Figure 4.6, panel A). Control sections exhibited no specific signal (Figure 4.5, 
panels C and D; Figure 4.6, panels C and D). 
Colonic epithelium did not exhibit specific signal in experimental tissue sections 
(Figure 1.7, panels A and B), nor was signal observed in the intestinal glands that could 
be distinguished from non-specific signal as seen in control sections (Figure 4.7, panels 
C and D). Specific signal was not observed in the muscularis mucosae, in the 
submucosa, or in the underlying smooth muscle layers (Figure 4.7, panels A and B). 
In the lung, no signal was detected in the alveolar epithelium (Figure 4.8, panels 
A and B). Bronchial epithelium and smooth muscle observed within the lung sections 
Figure 4.4. Bright field photomicrographs demonstrating in situ hybridization of a 35S- 
labeled PG33 cRNA probe in porcine tracheal tissue sections. A: cross-section of 
trachea (x 1 0) hybridized with antisense cRNA probe. B: tracheal epithelium and 
submucosa (x20) hybridized with antisense cRNA probe. C: increased magnification of 
tracheal epithelium hybridized with antisense cRNA probe. D: tracheal epithelium and 
submucosa (x20) hybridized with control (sense) cRNA probe. 

Figure 4.5. Bright field photomicrographs demonstrating in situ hybridization of  a "S- 
labeled PG33 cRNA probe in villus region of porcine ileal tissue sections. A: cross- 
section of villus (x20) hybridized with antisense cRNA probe . B: increased 
magnification of villus section hybridized with antisense cRNA probe. C: cross-section 
of villus hybridized with control (sense) cRNA probe. D: increased magnification of 
villus section hybridized with sense cRNA pro be. 

Figure 4.6: Bright field photomicrographs demonstrating in situ hybridization of a '%- 
labeled PG33 cRNA probe in crypt region of porcine ileal tissue sections. A: cross- 
section of crypt region (~20) hybridized with antisense cRNA probe. B: increased 
magnification of crypt region hybridized with antisense probe. C: cross-section of crypt 
region (x20) hybridized with control (sense) cRNA probe. D: increased magnification 
of crypt region hybridized with control probe. 

Figure 4.7. Bright field photomicrographs demonstrating in situ hybridization of a "S- 
labeled PG33 cRNA probe in porcine large intestinal tissue sections. A: cross-section 
of colonic epithelium and submucosa (x20) hybridized with antisense cRNA probc. B: 
increased magnification of colonic epithelium hybridized with antisense probe. C: 
colonic epithelium and submucosa (x20) hybridized with control (sense) cRNA probe. 
D : increased magnification of colonic epithelium hybridized with control probe. 

Figure 4.8: Bright field photomicrographs demonstrating in situ hybridization of a "S- 
labeled PG33 cRNA probe in porcine lung tissue sections. A: cross-section of lung, 
including alveoli and respiratory bronchioles (x 10) hybridized with antisense cRNA 
probe. B: alveolar epithelium (x40) hybridized with antisense cRNA probe. C: alveolar 
epithelium (x20) hybridized with control (sense) cRNA probe. 

were also negative (Figure 4.8, panel A), as were control lung sections (Figure 4.8, 
panel C). No PG33 signal was detected in cardiac muscle fibers of porcine heart that 
could be distinguished from nonspecific signal in control sections (not shown). 
Likewise, while granule density at first glance appears to indicate signal in the pancreas. 
including exocrine acinar cells and intralobular and interlobular epithelial cells, 
background was consistently high in these sections and the signal is not specifically 
associated with cells (Figure 4.9, panels A and B). This signal was therefore considered 
to be non-specific. 
4.4 Discussion 
Two complementary techniques have been used to investigate the tissue 
expression of PG33 message in the pig. A number of tissues were first examined 
through PCR amplification of PG33 internal sequences from reverse transcribed total 
cellular RNA. PG33 message was detected in small intestinal samples, the tissue from 
which PG33 cDNA had originally been isolated using an anti-chloride conductance 
monoclonal antibody. This confirms that PG33 mRNA is expressed in the same tissue 
that contains the antigen recognised by the monoclonal antibody . Furthermore, in situ 
hybridization identified the epithelium of the ileum as the specific cell type in which 
PG33 message is present. This is consistent with the original source of antigen against 
which the monoclonal antibody had been raised, which was purified ileal epithelial 
brush-border membrane protein. 
Previous immunohistochemical studies had also identified crypt epithelia as the 
intestinal cells expressing the protein antigen recognised by the monoclonal antibody 
(Racette er a/.,  1 W6), though the level of resolution of those experiments was not 
sufficient to assign an apical or basolateral location to the antigen. The antibody used in 
these studies strongly inhibited conductive chloride uptake into apical membrane 
vesicles. Because transepithelial chloride movement drives fluid secretion into the gut 
lumen, and this occurs predominantly in the crypt regions (Welsh el al., 1982), antibody 
recognition of a crypt antigen is consistent with a role for that antigen in the secretory 
Figure 4.9: Bright field photomicrographs demonstrating in situ hybridization of a "S- 
labeled PG33 cRNA probe in porcine pancreatic tissue sections. A: cross-section of 
pancreas (x20) hybridized with antisense cRNA probe. B: increased magnification of 
pancreatic ductal epithelium hybridized with antisense cRNA probe. C: pancreatic ductal 
epithelium (x20) hybridized with control (sense) cRNA probe. D: increased 
magnification of pancreatic ductal epithelium hybridized with control probe. 

process. 
While the monoclonal bound most strongly in the intestinal crypts, PG33 
message was detected in both the crypt and villus regions of the small intestine. 
Expression of mRNA in a cell does not, however, always correlate with the presence of 
the corresponding protein in that cell. In addition, the immunohistochemical studies 
had demonstrated some binding of the monoclonal to the villus epithelium (Racette et 
(11.. 1996). but because the control tissue sections had also exhibited some villus signal, 
especially in the associated glycocalyx, definitive conclusions about the expression of 
the antigen in these cells were not made. Hence, expression of the PG33 gene product 
in the villus epithelium remains a possibility. 
In addition to the diffuse signal seen throughout the crypt and villus surface 
epithelium. isolated cells within the villi exhibited a very strong signal, which 
presumably indicates a high level of PG33 transcript within these cells. These cells 
could not be identified as morphologically distinct from the other epithelial cells. The 
presence of scattered, strongly positive cells is not without precedent; human airway 
and small intestinal CFTR exhibits a similar pattern of expression in which moderate 
signal is seen throughout the surface epithelium, along with a small population of 
isolated cells with extremely high signal (Tresize & Buchwald. 199 1 : Engelhardt et a!. , 
1992; Strong et a!., 1994). Previous reports had not been able to assign identities to 
these cells with any degree of confidence. though investigators speculated that these 
cells may be specialised for some CFTR-associated function such as chloride secretion 
(Strong er al., 1994). It is not known whether the cells expressing high levels of PG33 
message are the same cells as those described in these reports. 
In situ hybridization studies of selected other porcine tissues confirm the results 
of the RT PCR investigations in that specific PG33 message was detected in trachea but 
not colon, lung, pancreas. or heart. The expression of PG33 message may therefore be 
tissue-restricted. unlike that of CFTR, the ORCC. and CIC-2. all of which have a 
widespread tissue distribution. Other chloride channels with a tissue-specific 
expression pattern include the CIC-K subfamily, ClC- 1, and the bovine calciurn- 
activated channel. While the ClC-K subfamily and CIC-1 are expressed predominantly 
in kidney and skeletal muscle (Steinrneyer et al., 199 1 ; Sakamoto rt a/. , 1 996), 
respectively, the calcium-activated channel has been documented only in bovine trachea 
to date (Cunningham et al. , 1995). These channels, and by extension PG33, may be 
involved in tissue-specific processes. as opposed to more widely expressed channels; it 
has been suggested, for example, that C1C-2 may be important in the control of cell 
volume (Pusch & Jentsch, 1994). 
In situ hybridization of a 35S-Iabeled PG33 cRNA probe to tracheal tissue 
sections revealed that PG33 is expressed in this tissue in a cell-specific manner. Signal 
was detected in surface epithelial cells. which are thought to contribute to the thin fluid 
layer lining the surface of the airways (Welsh. 1987). The submucosal glands also 
exhibited extremely strong signal, indicative of high levels of PG33 transcripts in these 
cells, though it could not be determined whether the cells expressing PG33 were serous, 
mucous, or whether both cell types express P G 3 .  
The tracheal expression of PG33 echoes that of CFTR which is also found 
predominantly in the submucosal glands and, to a lesser extent. in the surface 
epithelium (Engelhardt ct a/.. 1992). CFTR is strongly expressed in the serous tubules 
of the submucosal glands, and in isolated cells along the collecting duct (Engelhardt el 
a!. , 1992; Finkbeiner er a!. , 1994). The serous tubules lie distal to the mucous tubules, 
and are thought to secrete a fluid which flushes the secreted mucus out of the tubules 
and into the collecting duct of the gland (Welsh, 1987). In CF, these glands become 
progressively blocked with accumulated mucus (Welsh et al.. 1995). presumably due to 
a defect in serous fluid secretion (Engelhardt rr ul,. 1992: Yamaya et cd. .  1991). The 
concentration of PG33 message in the submucosal glands may indicate a similar 
physiological role for this gene product. 
The only other tissues examined which were shown via RT PCR to express 
PG33 were the salivary glands. Parotid, mandibular. and sublingual glands all 
expressed varying levels of PG33 message. RT PCR does not allow a precise 
quantitation of mRNA present within a sample. Assuming, however, similar RNA 
integrity and enzyme activity in all samples, PG33 expression appears to be lowest in 
the mandibular gland, moderate in the sublingual, and highest in the parotid gland. 
The composition of salivary secretions from these glands varies according to 
species. In most species. including the pig, the parotid gland consists almost entirely of 
serous acini (Cook er al.. 1994). In the sublingual gland of the pig, on the other hand, 
the acinar endpieces are predominantly mucous (Dellmann. 1993). Cell composition 
varies according to species in the mandibular gland, and sexual dimorphism is moreover 
seen in some species, including pigs (Cook el al., 1994). Serous cells are reported to 
predominate in males and mucous cells in females, though cells of both types can be 
seen in each gender (Cook et a/., 1994). This variation in cell type may explain the 
differences in PG33 expression in the three major salivary glands, though there is no 
immediately apparent pattern of distribution, except that expression is highest in the 
predominantly serous parotid gland. In situ hybridization studies were not conducted 
on salivary gland tissue; consequently. the identity of the salivary gland cells expressing 
high levels of PG33 is currently unknown. 
To summarise, the expression of PG33 mRVA has been correlated with the 
location of the protein antigen recognised by the anti-chloride conductance monoclonal 
antibody in porcine small intestine. Of the porcine tissues investigated, PG33 was only 
detected in trachea and salivary gland in addition to the small intestine. While these 
epithelial tissues are secretory in nature, PG33 expression may not be a function of all 
secretory epithelia, since PG33 was not detected in exocrine pancreas. stomach, or large 
intestine. The PG33 message was not detected in liver, skeletal muscle, cardiac muscle, 
or kidney, nor was it detected elsewhere within the respiratory tract or pulmonary 
parenchyma. In both trachea and small intestine, PG33 was detected in surface 
epithelium; this transcript was hrthermore detected in tracheal submucosal glands. a 
location in which CFTR is also highly expressed. These findings are consistent with a 
role for the PG33 gene product in the secretory process in the tissues in which it is 
expressed. 
5.0 Comparison of the Tissue Expression of PG33 and the Bovine Chloride 
Channel Ca-CC 
5.1 Introduction 
Calcium-regulated chloride secretion functions as an important alternative 
pathway to the activation of chloride secretion via CAMP-dependent agonists. In some 
tissues, such as human sweat glands, the calcium-dependent pathway actually accounts 
for the majority of agonist-induced increases in chloride secretion (Sato & Sato, 1984: 
Reddy & Bell, 1996). In others, including human airways and murine pancreas, the 
magnitude of the two responses are nearly equal (Boucher et aL, 1989; Clarke et al.. 
1 994). 
Under circumstances where CAMP-dependent chloride secretion is absent or 
defective. the calcium-regulated pathway may be upregulated. The cftJnl"" (4) mouse. 
for example, shows an increased nasal epithelial response to ionomycin compared to 
normal littermates, indicating an upregulation of the calcium-activated pathway (Grubb 
et al.. 1994). A protective role has therefore been proposed for this alternative 
conductance in tissues affected by CF. Tissues in which this conductance can be 
demonstrated, such as pancreas and airways, are only mildly affected by the absence of 
functional CFTR in cfrr'""" mice (Clarke el al., 1994). In the small and large intestine, 
where this alternative conductance is absent, a much more severe disease phenotype 
manifests (Clarke et a l ,  1994). Multiple chloride conductive pathways, then, are at the 
very least useful in preserving transepithelial chloride secretion, and may in some 
circumstances be essential. 
In 199 1, a group of investigators reported the isolation of a chloride channel 
from bovine tracheal epithelium (Ran and Benos, 199 1 ). A candidate protein was 
isolated when apical membrane vesicle preparations were subjected to a series of 
procedures involving detergent solubilization and anion and cation exchange 
chromatography. The fractions showing the highest specific activity in a "'I-uptake 
assay correlated with the appearance of a 38 kDa protein species on SDS-PAGE; when 
this band was electroeluted and reconstituted into proteoliposomes, it continued to 
mediate the uptake of '151 across the liposornal membrane. This activity was inhibited 
by the potassium ionophore valinomycin, which eliminated the electrical gradient across 
the liposomal membrane, and also by the anion channel blocker DIDS. 
Because the specific activity of the eluted protein was enhanced only 12-fold 
compared to the total solubilized protein, milder isolation conditions were sought. 
lmmunopurification using a polyclonal antibody raised against the 38 kDa species 
allowed a further 24-fold increase in specific activity as measured by the rate of '*'I 
uptake across reconstituted proteoliposomes (Ran and Bcnos, 1992). 
Separation of the electroeluted protein on a polyacrylamide gel consistently 
demonstrated the presence of minor bands at 62,64, and 140 kDa as well as the major 
band at 38 kDa (Ran and Benos, 199 1, 1992). This was intriguing because the size 
range eluted was only 35-42 kDa. All of these bands were detected, however, by the 
anti-p38 antibody in a Western blot, leading to the hypothesis that the 62-64 kDa 
doublet and the 140 kDa singlet were somehow derived From the 38 kDa band (Ran and 
Benos, 1 992). 
Treatment of thc total solubilized protein with the reducing agent dithiothreitol 
(DTT) caused the larger bands to disappear, leaving only the 38 kDa band (Ran and 
Benos, 1992). The most likely interpretation of these results was that the 140 kDa and 
the 62-64 kDa species are, respectively, tetrameric and dimeric forms of the protein, and 
that DTT treatment reduced the disulfide bonds linking the subunits, leaving only the 38 
kDa monomer. Subsequent experiments appeared to confirm this hypothesis (Ran et al. 
1992). 
The single channel properties of p38 reconstituted into liposomes and planar 
lipid bilayers were investigated (Ran et al, 1992; Fuller el al, 1994). Based on its 
reversal potential in symmetrical KC], the membrane protein was found to be anion- 
selective, with an anion permeability sequence of I-> Br-> C1-. The single-channel 
conductance of the protein was 25-30 pS in symmetrical 150 mM KC1 and the current- 
voltage relationship was linear. Channel activity was only seen when the 140 kDa 
protein was present; neither the 62-64 kDa species nor the 38 kDa monomer appeared to 
function as a chamel. 
The native 140 kDa protein fused with planar lipid bilayers does not respond to 
PKA and ATP or to ATP alone, nor is it phosphorylated in vitro by PKA and ATP 
(Fuller er al, 1994). The protein is phosphorylated in vitro by CaMK 11. and while the 
channel does not respond to physiological-range increases in Ca2+ alone, the addition of 
0.5 to 1 pM CaL+ to the bath solution after the channel has been phosphorylated by 
CaMK I1 causes an increase in channel activity in planar lipid bilayers (Fuller et al. 
1994). High, nonphysiological levels of Ca2+ (above 3 pM) can also activate the 
channel (Fuller et al, 1994). 
The anti-p38 polyclonal antibody was used to screen a bovine tracheal 
expression library for the cDNA encoding the p38 protein. The full-length cDNA 
subsequently isolated was 3001 bp long, with an open reading frame from bases 19 to 
2730 (Cunningham er a/,  1995). This would code for a protein containing 903 amino 
acids with a predicted molecular mass of approximately 100 k D a  far larger than the 38 
kDa species used to raise the screening antibody. 
A labeled segment of the cDNA clone (now called Ca-CC) hybridized to a 3.1 
kb transcript in a Northern blot performed on bovine tracheal mRNA, which is in 
agreement with the length of the cloned cDNA (Cunningham er al, 1995). 
Amplification of internal sequences by RT-PCR confirmed the expression in bovine 
trachea, but showed no expression of the gene in bovine liver, lung, brain, or renal 
papillae (Cunningham et al, 1995). Ca-CC appears to be conserved between at least 
some species, as the cDNA probe cross-hybridized to mouse. rat, dog, rabbit, monkey, 
and human genomic DNA. though not to yeast or chicken DNA (Cunningham et a/. 
1995). 
Analysis of the predicted amino acid sequence of Ca-CC shows the presence of 
multiple protein kinase recognition sequence motifs. While there are only two 
consensus sequences for protein kinase A and three for tyrosine kinase, there are 10 for 
CaMK I1 and 15 for protein kinase C (Cunningham er al, 1995). These potential sites 
may not all serve as phosphoacceptors, since earlier experiments had shown Ca-CC is 
not responsive to PKA and ATP, though no in vifro or in vivo studies of in vifro 
translated Ca-CC phosphorylation have been reported. 
The major product of in vitro translation was a 100 kDa protein; when translated 
in the presence of pancreatic microsomes, which allows glycosylation of the core 
protein. the major product migrated at 140 kDa on SDS-PAGE (Cunningham et al, 
1995). However. neither the 100 nor the 140 kDa products could be reduced by 
treatment with DTT. unlike the immunopurified 140 kDa protein (Cunningham er a!. 
1995). Antibodies raised against a Ca-CC fusion protein did recognise the 3 8 kDa 
protein in a Western blot on bovine tracheal membrane vesicles (Cunningham et al, 
1995). 
Expression of Ca-CC in COS-7 cells correlated with the appearance of a linear, 
anion-selective current in the presence of the calcium ionophore ionomycin 
(Cunningham er nl, 1995). This increase in whole-cell current was inhibited by the 
addition of DTT. Likewise, injection of Ca-CC sense cRNA into ,Yenopus oocytes 
caused an increase in whole-cell current that was partially inhibited by both DIDS and 
by DTT (Cunningham er al, 1995). The current-voltage relationship in oocytes, 
however, was outwardly rectifying, unlike the channel activity in COS-7 cells. When 
vesicles from these Ca-CC-injected oocytes were fused with planar lipid bilayers. a 
calcium-regulated channel activity appeared that had a single-channel conductance of 2 1 
pS. This channel was also sensitive to DIDS and to DTT. 
Certain inositol phosphate metabolites have been shown to act as signalling 
molecules in a variety of cell types (Barren, 1997). In particular, D-myo-inositol 
3.4,5,6-tetrakisphosphate [Ins(3,4,5,6)P4 ] has been reported to inhibit calcium-activated 
chloride secretion in epithelial cells. This isomer was shown to inhibit Ca-CC activity 
in planar lipid bilayers (Ismailov et al, t996), which suggests the possibility of a direct 
interaction of Ins(3,4,5,6)P4 with the channel. 
The role of Ca-CC in airway fluid secretion has yet to be explored, but since the 
calcium-activated current is an essential component of net airway chloride secretion, 
Ca-CC may prove to be physiologically relevant in this tissue. Ca-CC is also the only 
DNA sequence with known homology to the cDNA clone PG33. While PG33 was 
isolated horn porcine small intestine, Ca-CC appears confined to bovine trachea. The 
studies on Ca-CC tissue expression were not exhaustive, however, and it was thought 
important to investigate whether Ca-CC might also be present in tissues which are 
known to express PG33 and which were not studied in the original reports. In addition, 
the ZooBlot performed using Ca-CC as a probe in the original study did not include 
porcine genomic DNA. It was also of interest, therefore, to discover if Ca-CC is 
expressed in pig tissues. and if PG33 is expressed in bovine tissues. Reverse 
transcriptase PCR using gene-specific primers was the simplest and most sensitive 
technique which would allow all of these questions to be answered. 
5.2 Methods 
5.2.1 Cell Culture 
Both T84 and HBE1 cells were a generous gift of Dr. Sherif Gabriel (University 
of North Carolina-Chapel Hill). 
T84 human colonic carcinoma cells were grown in a I : 1 mixture of Ham's F 12 
medium and Dulbecco's modified Eagle's medium (DME) containing 5% fetal bovine 
senun (FBS). CeIIs were maintained at 37OC in 95% 0,/5% CQ. Cells were fed every 
three days, and passaged every 4 weeks. 
Human bronchial epithelial cells (HBE I )  were grown in Ham's F12+7X medium 
(supplemented with I0 pg/mL insulin, 1 0-6 M hydrocortisone, 3.75 @mL endothelial 
cell growth supplement (ECGS), 25 ndmL epidermal growth factor (EGF), 3 x 10-' M 
triiodothyronine. 5 pg!mL transfemn, and 10 ng/mL cholera toxin.) Cells were 
maintained at 37°C in 95% 0 2 / 5 %  COz and fed even: three days. Polarized 
differentiation was induced by supplementing the medium 1 : 1 with DME containing 2% 
FBS which had previously been conditioned for 3 days in the presence of confluent 
human 3T3 fibroblasts. 
5.2.2 RNA Purification 
Postmortem tissue samples were taken from weanling pigs of mixed Yorkshire- 
Landrace breeding (obtained from the Prairie Swine Centre), and Jersey (obtained from 
WCVM Necropsy) or Holstein (through kind permission of Dr. Germain Nappert) 
cows. Total RNA was purified as earlier described (Chornczynski and Sacchi, 1987), 
then treated with 10 units DNase I/pg RNA to remove any contaminating genomic 
DNA. DNase 1 was removed by extraction with one volume of phenol:chloroform, 
followed by ethanol precipitation of the RNA sample. 
In the case of cultured cells, poIy A+ RNA was directly purified using a 
QuickPrep Micro mRNA purification kit (Pharmacia) as previously described. 
5.2.3 Reverse Transcriptase PCR 
Samples were reverse transcribed using either the bovine [CaCl: 5' 
TTTAGGATTTATTTACAAACGG 3'1 antisense primer or the porcine [105a: 5' 
AGCACGTCTTTGAGATTTTACG 3'1 antisense primer. The reverse transcription was 
carried out under conditions identical to those described earlier, with the single 
exception that the Superscript 11 reverse transcriptase enzyme (GibcoBRL) was used 
instead of the MMLV-reverse transcriptase enzyme. 
PCR amplification of porcine sequences (PG33) was also identical to protocols 
previously described. The sense primer used to amplify PG33 was 920s [5' 
ACGATGCAAATGGTCG.4TACAG 3'1, and the antisense primer was 105a [Y 
AGCACGTCTTTGAG ATTTTACG 3'1. The 83 8-base pair product generated under 
these reaction conditions could be visualised after 30 cycles of PCR amplification of 
cDNA from porcine tissue samples, and after 55 cycles if the cDNA had been reverse 
transcribed from T84 or HBEl mRNA. 
Amplification of the 766-base pair internal bovine Ca-CC sequence was camed 
out under similar reaction conditions, with two exceptions. First, because the bovine 
antisense PCR primer, CaCl [5' TTTAGGATTTATTTACAAACGG 3'1, has a lower 
melting temperature than the porcine antisense PCR primer 1 OSa, the anneaiing step of 
the reaction was carried out at 45°C instead of 52°C. Second, the Ca-CC product could 
not be visualised after 30 cycles of amplification. One pL of the first, 30-cycle round 
was therefore reamplified under the same conditions as the first round for a further 25 
cycles. The sense primer for PCR amplification of the Ca-CC product was 920s. 
Internal controls were performed on 5 pg total RNA samples reverse transcribed 
with a P-actin-specific antisense primer [5' TAGATGGGCACAGTGTGGG 3'1; PCR 
amplification of p-actin internal sequences was performed with the antisense primer and 
a P-actin-specific sense primer [5' GGCGTGATGGTGGGCATGG 3'1. Amplification 
conditions were as described above, except that a 54°C annealing temperature was used. 
Products were visible after 30 cycles of PCR amplification. 
All PCR products were visualised on 0.8% agarose gels containing 0.33% 
ethidium bromide as earlier described. 
5.3 Results 
Expression of PG33 appears to be restricted to secretory epithelial tissues such 
as the small intestine. the large airways, and the salivary glands. It  is not. however, 
expressed in all secretory epithelia. as evidenced by the lack of PG33 message in 
exocrine pancreas. The bovine calcium-activated channel Ca-CC. on the other hand, 
could be detected in bovine trachea, but none of the other bovine tissues originally 
screened (Cunningham at al, 1995). The investigators did not report the expression of 
Ca-CC in the tissues in which PG33 is strongly expressed. 
Reverse transcriptase PCR was performed on total cellular RNA from porcine 
ileum, parotid. and tracheal epithelia. and from bovine ileum, parotid, and tracheal 
samples. Gene-specific primers were designed to allow selective amplification of either 
the porcine PG33 message or the bovine Ca-CC message from a given sample. A 
template that had been reverse transcribed with a bovine primer could not be PCR- 
amplified with the porcine gene-specific primers, nor could porcine reverse-transcribed 
templates be PCR-amplified with the bovine gene-specific primers. The porcine PCR 
primers were designed to amplify an 838-base pair internal segment of PG33 
corresponding to bases 1355-2 193, and the bovine primers amplified a 766-base pair 
internal Ca-CC sequence between bases 2030 and 2796 of the bovine cDNA. 
The expression of Ca-CC in bovine trachea was confirmed (see Figure 5.1, lane 
2), demonstrating that our system can detect Ca-CC message as well as PG33 message. 
AmpIification of the Ca-CC internal sequences required a minimum of 2 rounds of 
PCR, and a total of 55 cycles of amplification. Ca-CC expression was not detectable in 
bovine parotid or ileal samples (Figure 5.1, lanes 4 and 6), nor could PCR products be 
amplified by the use of PG33-specific PCR primers on CaCl-reverse transcribed 
templates from these tissues (Figure 5.1, lanes 3, 5,  and 7). Integrity of the bovine 
RNA samples was demonstrated by the amplification of an internal sequence of a 
housekeeping gene, p-actin (Figure 5.1 C). 
Samples of tracheal. parotid. and ileal epithelia were taken from pig and 
screened for expression of Ca-CC. Expression of the bovine gene was not detected in 
any of these porcine tissues (Figure 5.2, lanes 2.4, and 6). Total R I A  from the porcine 
tissues was intact. however, since P-actin-specific sequences could be amplified from 
these samples (Figure 5.2C). Several small DNA fragments under 200 bp in size were 
amplified from the porcine samples. but there was no detectable expression of the 766- 
base pair product specific to Ca-CC. These small fragments were therefore considered 
to be nonspecific artifacts. Amplification of cDNA reverse transcribed with CaCl using 
PG33-specific PCR primers did not result in any discemable products (Figure 5.2, lanes 
3- 5, and 7). 
The same total cellular RNA samples were used to assess the expression of 
PG33. The presence of the PG33 message in porcine ileum, parotid, and trachea was 
confirmed (see Figure 5.3, lanes 2,4, and 6), in agreement with earlier studies (see 
Chapter 4: Tissue Expression). Unlike the Ca-CC product. the PG33 internal product 
could be amplified during a single round, 30 cycles in total, of PCR. cDNA reverse 
Figure 5.1. Expression of Ca-CC in bovine trachea, ileum, and parotid gland. A: 
schematic depicting mplification of 766-bp internal Ca-CC sequence. B: Five pg total 
RNA was reverse transcribed with the CaCl primer. cDNA was PCR-amplified for two 
rounds, a total of  55 cycles, with the sense primer 920s and either the Ca-CC internal 
antisense primer CaCl or the PG33 internal antisense primerl05a. Lane 1 : pRR322- 
BstN I standards (I 857, 1058,929,383, and 12 1 bp). Lane 2: bovine tracheal cDNA 
amplified with Ca-CC-specific primers. Lane 3: bovine tracheal cDNA amplified with 
PG33-specific primers. Lane 4: bovine ileal cDNA amplified with Ca-CC-spccific 
primers. Lane 5:  bovine ileal cDNA amplified with PG33-specific primers. Lanc 6: 
bovine parotid cDNA amplified with Ca-CC-specific primers. Lane 7: bovine parotid 
cDNA amplified with PG33-specific primers. Lane 8: no template control. C: p-actin 
internal controls. 
Figure 5.2. Expression of Ca-CC in porcine trachea, ileum, and parotid gland. A: 
schematic depicting amplification of Ca-CC 766-bp product. B: Five pg total RNA was 
reverse transcribed with the CaCl primer. cDNA was PCR-amplified with the sense 
primer 920s and either the Ca-CC-specific antisense primer CaCl or the PG33-specific 
antisense primer 105a for 2 rounds of PCR, a total of 55 cycles. Lane 1 : pBR322-BstN I 
standards (1857, 1058,929,383, and 121 bp). Lane 2: porcine tracheal cDNA amplified 
with Ca-CC-specific primers. Lane 3: porcine tracheal cDNA amplified with PG33- 
specific primers. Lane 4: porcine ileal cDNA amplified with CaCC-specific primers. 
Lane 5: porcine ileal cDNA amplified with PG33-specific primers. Lane 6: porcine 
parotid cDNA amplified with Ca-CC-specific primers. Lane 7: porcine parotid cDNA 
amplified with PG33-specific primers. Lane 8: bovine tracheal cDNA amplified with Ca- 
CC-specific primers (positive control). C: p-actin internal controls. 
Figure 5.3. Expression of PG33 in porcine trachea, ileum, and parotid gland. A: 
Schematic indicating amplification of 838-bp internal PG33 sequence. B: Five pg total 
RNA was reverse transcribed with thel05a primer. cDNA was PCR-amplified with the 
sense primer 920s and either the PG33-specific antisense primer 105a for 30 cycles, or 
the Ca-CC-specific antisense primer CaCl for 55 cycles. Lane 1 : pBR322-BstN I 
standards (1857, 1058,929,383, and 121 bp). Lane 2: porcine tracheal cDNA amplified 
with PG33-specific primers. Lane 3: porcine tracheal cDNA amplified with Ca-CC- 
specific primers. Lane 4: porcine ileal cDNA amplified with PG33-specific primers. Lane 
5: porcine ileal cDNA amplified with Ca-CC-specific primers. Lane 6: porcine parotid 
cDNA amplified with PG33-specific primers. Lane 7: porcine parotid cDNA amplified 
with Ca-CC-speci fic primers. Lane 8: PG33 amplified with PG33-specific primers 
(positive control). C: P-actin internal controls. 
transcribed with the PG33-specific antisense primer could not be PCR-amplified with 
primers specific for Ca-CC (Figure 5.3, lanes 3, 5 ,  and 7). 
PG33 message could not be demonstrated in bovine ileum. parotid. or trachea 
(Figure 5.4, lanes 2,4, and 6) ,  nor, iTthe cDNA had becn reverse transcribed with the 
PG33-specific antisensc primer, did PCR performed with the Ca-CC primers result in 
the amplification of the Ca-CC product (Figure 5.4, lanes 3,5, and 7). 
The presence of Ca-CC protein in the colonic epithelial cell line T84 has been 
demonstrated by immunoblot (Ran and Benos, 1992), and it has been suggested that 
Ca-CC may contribute to a calcium-regulated chloride conductance in these cells (Ran 
and Benos, 1992; Morris & Frizzell, 1994; Barren, 1997). It was of interest, therefore, 
to compare the potential gene expression of Ca-CC and PG33 in this cell line. 
Reverse transcriptase PCR shows that PG33 message can be detected in 
undifferentiated T84 cells, although amplification of specific product required 5 5  PCR 
cycles, rather than the 30 cycles necessary to amplify this product from porcine tissue 
samples (Figure 5.5, lane 3). The bovine CaCC message can also be detected in 
undifferentiated T84 cells (Figure 5.5, lane 6), confirming the observations of earlier 
reports (Ran and Benos, 1992). The product amplified with CaCC-specific primers, 
however, contained sevcral additional DNA products besides the target sequence. 
While some of these products were smaller than the expected 766-base pair product, one 
product was much larger, approximately 1600 base pairs in size. None of these 
products had been observed earlier during the amplification of Ca-CC from bovine 
tracheal cDNA. 
Because of these unexpected results in T84 cells, another human cell line was 
investigated for Ca-CC and PC33 expression. The HBEl human bronchial epithelial 
cell line is known to express both CAMP-dependent and Ca"-regulated chloride 
conductances (Yankaskas el a!., 1993). Like T84 cells, HBEl cells also express both 
PG33 and Ca-CC. but at very low copy numbers (Figure 5.6). Fifty-five cycles of PCR 
over two rounds were rcquired to amplify both the PG33 and Ca-CC internal sequences 
from HBEl cDNA. 
Figure 5.4. Expression of PG33 in bovine trachea, ileum, and parotid gland. A: 
Schematic indicating amplification of internal PG33 sequence. Fivc pg total RNA was 
reverse transcribed with the 105a primer. cDNA was PCR-amplified with the sense 
primer 920s and either the PG33-specific antisense primer 105a for 30 cycles or the Ca- 
CC-specific antisense primer CaCl for 55 cycles. B: Lane 1: pBR322-BstN I standards 
(1 85% 1058,929? 383, and 12 1 bp). Lane 2: bovine tracheal cDNA amplified with 
PG33-specific primers. Lane 3: bovine tracheal cDNA amplified with Ca-CC-specific 
primers. Lane 4: bovine ileal cDNA amplified with PG33-specific primers. Lane 5: 
bovine ileal cDNA amp1 i fied with Ca-CC-specific primers. Lane 6: bovine parotid 
cDNA amplified with PG33-specific primers. Lane 7: bovine parotid cDNA amplified 
with Ca-CC-speci fic primers. Lane 8: PG33 amplified with PG33-specific primers 
(positive control). C: p-actin internal controls. 
Figure 5.5. Expression of PG33 and Ca-CC in undifferentiated cells from the T84 
intestinal epithelial cell line. One pg poly A+ RNA was reverse transcribed with either 
the PG33-specific primer 1 O5a (lanes 2-4) or the Ca-CC-specific primer CaCI (lancs 5- 
7). cDNA reverse transcribed with 105a was PCR-amplified for 55 cycles with the 
antisense primer I O h  and the sense primer 920s. cDNA reverse transcribed with CaCl 
was PCR-amplified for 55 cycles with the antisense primer CaCl and the scnsc primer 
920s. Lanc 1 : pBR322-BstN I standards (1 857, 1058,929,383, and 12 1 bp). Lane 2: 
PG33 arnpli fied with PG33-specific primers (positive control). Lanc 3: T84 cDNA 
amplified with PG33-specific primers. Lane 4: T84 polyA+ RNA amplified with PG33- 
specific primers (genomic DNA negative control). Lane 5: bovine trachea amplilicd with 
Ca-CC-specific prirncrs (positive control). Lane 6: T84 cDNA amplified with Ca-CC- 
specific primcrs. Lane 7: T84 polyA+ RNA amplified with Ca-CC-specific primers 
(genomic DNA negativc control). Lane 8: no template control. 
Figure 5.6. Expression of PG33 and Ca-CC in differcntiated and undiffcrcn~iatcd I IBEI 
human airway epithelial cells. One ug poly A+ RNA was rcversc transcribcd with cithcr 
the Ca-CC-spcci fic antisense primer CaCl (lanes 2-3) or the PG3 3-spcci fic antiscnsc 
primer 105a (lanes 5-6). cDNA reverse transcribed with CaCl was PCR-amplified ibr 55 
cycles with the scnse primer 920s and the antisense primer CaCl. cDNA rcvcrsc 
transcribcd with 105a was PCR-amplified for 55 cycles with the scnsc primer 920s and 
the antisense primer 105a. Lane 1 : pBR322-BstN I (1 857, 1058,929,383. 12 1 bp). 
Lane 2: undifferentiated HBEl cDNA amplified with Ca-CC-specific prirncrs. Lane 3: 
differentiated HBE 1 cDNA amplified with Ca-CC-specific primers. Lane 1: bovine 
trachcal cDNA amplified with CaCC-specific primers (Ca-CC positive control). Lane 5: 
undifferentiated I-IBE I cDNA amplified with PG33-specific primers. Lane 6: 
di fferentiatcd I-IBE 1 cDNA amplified with PG33-specific primers. Lane 7: porcine ilcal 
cDNA amplified with PG33-spzcific primers (PG33 positive control). 
In addition to the expected 766-base pair product, the same larger product was 
observed when undifferentiated HBEl mRNA was reverse transcribed with CaCl, then 
PCR-amplified with primers specific for Ca-CC (Figure 5.6, lane 2). When the 
template cDNA was reverse transcribed from mRNA purified from differentiated HBE 1 
cells, however, only the target 766-base pair sequence was visible (Figure 5.6, lane 3). 
The quantity of product amplified from differentiated HBEl cells was also diminished 
compared to that amplified from undifferentiated cells. 
Amplification of PG33 internal sequences From I Oja-reverse transcribed cDNA 
from undifferentiated HBE 1 cells resulted in multiple products, up to and including the 
838-base pair expected product (Figure 5.6, lane 5). None of these products were 
present in large quantities. The same PCR reaction carried out on cDNA from 
differentiated HBE 1 cells also resulted in multiple products. but in this case the 
predominant product was the 838-base pair target sequence (Figure 5.6, lane 6). 
To summarise, expression of the calcium-regulated chloride channel Ca-CC was 
not detected in bovine tissues other than in tracheal epithelium. Expression of this gene 
could not be shown in other bovine secretory epithelia, such as the small intestine or the 
parotid salivary gland. nor was Ca-CC detected in any of these epithelia in pigs. PG33 
message, while expressed in porcine trachea, ileum, and parotid. was not detected in 
bovine trachea, ileum, or parotid. Both of these genes. however. appear to be expressed 
in the human cell lines T84 and HBE 1.  In the case of HBE 1 cells, expression of PG33 
and Ca-CC may depend upon the differentiation status of the cell. This may also be true 
of the expression of these genes in TSJ cells. but this could not be confirmed as T84 
mRNA from differentiated cells was not available. 
5.4 Discussion 
The bovine calcium-activated chloride channel Ca-CC is the only cDNA 
currently known with significant nucleotide and amino acid homoiogy to the PG33 
cDNA. Because PG33 may also be involved in the epithelial chloride secretory process, 
it was considered important to investigate whether the pattern of tissue distribution of 
mRNA for the two genes is similar or complementary. 
In bovine tissues, the Ca-CC gene product cart only be detected in trachea, the 
tissue in which it was first characterised. The original investigators reported that Ca-CC 
is not expressed in bovine brain, lung, liver, or kidney (Cunningham er al., 1995). 
Surprisingly, however, none of the other characteristically secretory epithelia tissues 
such as intestine or pancreas were examined. In addition, while the presence of the Ca- 
CC gene was demonstrated in a number of species. genomic DNA from pig was not 
included in the Southern blot (Cunningham ef a/., 1995). Several points therefore 
required clarification in order to assess a possible relationship between the bovine Ca- 
CC and the porcine PG33 gene product. 
Antisense primers for the reverse transcription reactions were designed from the 
3' untranslated regions of Ca-CC and PG33 (see Figure 5.7). The CaCl antisense 
primer bound specifically to the bovine Ca-CC cDNA. but was selected from a region 
of Ca-CC which had very little sequence homology to PG33. Likewise. the 1 O5a 
antisense primer bound with high fidelity to PG33 cDNA, but was chosen from an area 
with low homology to Ca-CC. Used separately, then. these two sequences should 
specifically prime the reverse transcription of only Ca-CC or PG33 mRNA, but not 
both. This was confirmed by a series of control PCR reactions in which PGX-specific 
primers were used on a cDNA template reverse transcribed with the bovine CaCl 
primer. A parallel set of reactions were camed our in which Ca-CC-specific primers 
were used in the PCR amplification of a cDNA template which had been reverse 
transcribed with the porcine 105a primer. In neither case was product of the appropriate 
size obtained. Hence, PCR reactions were amplifying one cDNA or the other, but not 
both if only one antisense primer was present in the same reaction. 
Reverse transcriptase PCR using the Ca-CC-specific primers confirmed the 
expression of Ca-CC in bovine tracheal epithelia. The standard 30-cycle PCR reaction 
conditions were, however, insufficient to amplify a visible product. Instead. it was 
necessary to amplify an aliquot of the first 30-cycle round for a subsequent 25 cycles 
before the 766-base pair internal sequence could be visualised on an agarose gel. Benos' 
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Figure 5.7. Primer binding sites for reverse transcriptase PCR of PG33 and Ca-CC. 
Stop codons, the PG33-specific antisense primer 105a, and the Ca-CC-specific antisense 
primer CaCl are in bold type. Asterisks indicate nucleotides that are identical in the two 
sequences. 
group reported successful amplification after 30 cycles of PCR (Cunningham el ui., 
1993, but these reactions required 200 ng of template cDNA. Despite the fact that the 
reverse transcription reaction was primed in their case with oligo-dT rather than a gene- 
specific primer, multiple reactions must have been pooled for a successful PCR 
amplification under the conditions described in this report. Taken together. these results 
suggest that the Ca-CC message is expressed in tracheal epithelial cells in an extremely 
low copy number. As a comparison, the PG33 message, which is estimated to occur in 
small intestinal cells at a frequency of 0.01 % or less, can be amplified from porcine 
tissues afier 30 rounds of PCR. 
Even under the reaction conditions which successfully amplified the Ca-CC 
message from bovine trachea, this message could be demonstrated in neither bovine 
ileum nor parotid salivary gland. The tissue distribution of Ca-CC is clearly different, 
therefore, from that of PG33, which is expressed in porcine ileum and parotid as well as 
in porcine trachea. This may indicate that Ca-CC is important to some specialised 
process of tracheal epithelial cells, while the PG33 gene product may be involved in a 
function common to several types of secretory epithelial cells. 
The Ca-CC and the PG33 gene may not be entirely conserved between species. 
Ca-CC cross-hybridizes with genomic DNA from rabbit, dog, mouse, rat, monkey, and 
human as well as cow, but not to DNA from yeast or chicken (Cunningham et ui., 
1995). Under these experimental conditions, Ca-CC message could not be 
demonstrated in porcine tissues, including ileum and parotid as well as trachea. 
Likewise, PG33 message could not be amplified by PCR from RNA pools from any of 
the bovine tissues investigated. While the tissue expression of the two genes in their 
respective species appears to be different, this lack of conservation between the two 
species may indicate that the two genes play similar roles in the tissues in which they 
are expressed. 
An alternative possibility exists that may explain the apparent lack of 
conservation of these genes between cattle and pigs. The antisense primers were 
selected from the 3' untrandated regions (UTR) of both genes, and there may be some 
species variation in the nucleotide sequences of these UTR. Should this be the case. 
attempts to reverse transcribe a bovine variant of PG33 or a porcine variant of Ca-CC 
might have been unsuccessful if the antisense primers were unable to bind these regions 
of the message. 
Message from both genes can, however, be demonstrated in one species. Both 
Ca-CC and PG33 are expressed in undifferentiated cells from the human colonic 
carcinoma cell line T84. PG33 is also presumably expressed in non-immortalized 
human intes t id  cells, since it has been isolated from a human infant intestinal cDNA 
library (see Chapter 3, Cloning Strategies). This suggests, therefore, that the sequence 
of the 3' untranslated regions may not vary to a large extent between bovine and porcine 
tissues, if the 3' UTR are not significantly different between these species and human 
tissues. 
Fifty-five cycles of PCR were required to amplify both the Ca-CC and the PG33 
message from T84 cells, suggesting that these transcripts are both present in a very low 
copy number in these cells. While a single product of the expected size appeared when 
PG33 cDNA was amplified from T84 cells, the amplification of Ca-CC cDNA resulted 
in multiple products in addition to the expected 766-base pair product Several of these 
products were smaller than 766 bases, but one was approximately 1600 bases in size, 
much larger than the expected product. These products had not been observed during 
the investigation of Ca-CC expression in bovine tissues. 
Several possibilities exist which may explain the appearance of these products. 
The low annealing temperature required may have caused non-speci fic amplification 
from the T84 template. Alternatively, the human Ca-CC may occur in one or more 
isoforms. and these bands may represent splice variants of Ca-CC. These products are 
also seen after Ca-CC amplification from undifferentiated human airway epithelial 
(HBE I ) cells. These extraneous products may therefore represent a transcript variant 
particular to human cells, or simply to cells in culture. 
Several investigators have also proposed that the differentiation status of a cell 
may affect the levels of mKNA and protein expression within the cell (Anderson & 
Welsh, 199 1 ; Anderson ef af., 1992; Morris er al., 1992). In particular, the expression 
of calcium-regulated (Anderson & Welsh, 199 1) and CAMP-regulated (Anderson & 
Welsh, 199 1 ; Morris el al., 1992) chloride channels in intestinal epithelial cell lines has 
been shown to depend upon the state of differentiation of the cell. Expression of 
CAMP-regulated chloride secretion in the intestinal epithelial cell line HT-29 is thought 
to require polarization of the cell monolayer (Moms rt al., 1992), while apical chloride 
channel activity attributable to calcium agonists is diminished after these cells become 
polarized (Anderson er al., 1992; Morris er ol., 1 992). Hence, the reorganization of the 
plasma membrane as apical and basolateral domains become established during 
polarization may result in changes in the chloride channel populations of these 
membrane domains. 
If this is the case, differentiation may affect the expression of Ca-CC and PG33 
in HBEl and T84 cells. This hypothesis is supported by the fact that in HBE 1 cells, the 
838-base pair PG33 target sequence is strongly amplified in differentiated but not in 
undifferentiated cells. In addition. the extraneous products seen during the 
amplification of Ca-CC from undifferentiated HBEl and T83 cDNA are not observed 
when Ca-CC is amplified from differentiated HBE I cellular mRNA. The amount of 
Ca-CC product also appears to be smaller in differentiated cells than in undifferentiated 
cells. Amplification of Ca-CC from differentiated T84 cells. therefore, might result 
only in the expected 766-base pair product, and possibly in smaller quantities of 
amplified product. mRNA from differentiated T84 cells was not available, however, so 
this hypothesis could not be confirmed. 
In summary, the expression of two closely related genes in bovine and in porcine 
tissues has been compared. Though Ca-CC and PG33 share a similar nucleotide and 
amino acid sequence, their pattern of tissue expression is different in their respective 
species of origin: Ca-CC could only be detected in bovine trachea, while PG33 is 
expressed in porcine trachea. small intestine. and parotid salivary gland. Expression of 
Ca-CC was not detected in the porcine tissues investigated. nor was PG33 detected in 
the bovine tissues examined. Ca-CC and PG33 are both expressed in the human cell 
lines T84 and HBE 1 ,  however, and the level of expression of these genes may depend 
upon the state of differentiation of these cells. 
6.0 General Discussion and Conclusions 
This thesis reports the use of an anti-chloride conductance monoclonal antibody 
to successfully isolate a cDNA from a porcine small intestinal expression library. This 
original cDNA, while not hll-length, was used to isolate a total of 2.3 kb of sequence 
through the use of conventional oligonucleotide and PCR-based screening of the porcine 
intestinal library and of a human infant intestinal library. Northern analysis of porcine 
parotid mRNA indicates that the size of the mature PG33 transcript is approximately 2.7 
kb. 
In addition to its expression in porcine small intestine, expression of the PG33 
gene was also demonstrated in porcine trachea and salivary glands through reverse 
tnnscriptase PCR. PG33 mRNA was not detected in several other epithelial tissues, 
such as pancreas and large intestine, nor was it detected in a number of non-epithelial 
tissues investigated. In situ hybridization studies confirmed the small intestinal and 
tracheal expression of the PG33 message. These studies further showed that expression 
of this mRNA is confined to the mucosal epithelium in the ileum, with particularly high 
levels of the message observed in certain isolated cells within the villi. In the trachea, 
PG33 expression was observed in the surface epithelium, and also in high levels in the 
underlying submucosal glands. The restricted localisation of the PG33 message appears 
to be consistent with a role in fluid secretion in exocrine epithelial tissues. 
The PG33 cDNA sequence is homologous to only two other reported gene 
sequences: the bovine calcium-regulated chloride channel Ca-CC, and the lung- 
endothelial adhesion molecule Lu-ECAM-I . The degree of homology between PG33 
and Ca-CC prompted a comparative investigation of their gene expression in bovine and 
porcine tissues. A previous report had indicated that Ca-CC is expressed only in bovine 
tracheal epithelium (Cunningham el al., 1995), which was confirmed through reverse 
transcriptase PCR studies. However, while PG33 is expressed in porcine ileum and 
parotid gland as well as tracheal epithelia, Ca-CC mRNA could not be detected in bovine 
ileum or parotid. The expression of these two genes therefore appears to be tissue- 
specific. Expression of the bovine gene was not, however, detected in porcine tissues, 
nor the porcine gene in bovine tissues. This may indicate either a species-specific 
expression of these two genes, or that the experimental techniques were insufficiently 
sensitive to detect low levels of gene expression. 
Expression of both genes was, however, detected in two human cell lines, the 
colonic carcinoma cell line T84 and the bronchial epithelial line HBEI. Preliminary 
evidence suggests that expression of the two genes may depend on the relative state of 
cell differentiation. Because PG33 cDNA was also identified in a human intestinal 
library, it may be inferred that this gene is expressed in intact human tissues as well as in 
cultured cells of human origin. 
The third member of this family, Lu-ECAM-1, was originally identified as a 
ligand potentially involved in the adhesion of metastasizing tumor cells to lung vascular 
endothelium (Zhu et a/., 199 1 ; Zhu et al., 1992; Zhu & Pauli, 1993). Lu-ECAM- I 
expression has been reported in bovine lung endothelium and in spleen, and this pattern 
of expression can be distinguished from that of the highly homologous Ca-CC genc 
(Elble et al., 1997). Chloride channel activity has not yet been reported for Lu-ECAM- 
1. Since all research efforts to date have focused on its function as a cell adhesion 
factor, its potential role in ion transport was not apparent, or even considered, until the 
gene sequence was characterised and the degree of homology to Ca-CC noted. 
Given the relationship between the two genes, a number of interesting questions 
can be raised concerning the physiological role of Lu-ECAM-I. Does this protein in fact 
exhibit chloride channel activity, and if so, under what circumstances? Furthermore, 
would such channel activity be associated with the role of Lu-ECAM-I in cell adhcsion 
and tumor metastasis? Only a few reports to date have linked ion transport and cell 
adhesion properties within the same protein (Isom el ul., 1995; Liu et al., 1996). 
Speculation as to the purpose of such functional coupling has, therefore, been limited. 
The homology of the PG33 cDNA to Ca-CC and Lu-ECAM-I is less marked but 
still significant. Regions conserved between the predicted protein products of PG33 and 
the other genes include the four potential transmembrane domains proposed by Benos' 
group for Ca-CC (Cunningham el ai., 1995). PG33 also contains a number of consensus 
sites for N-linked glycosylation, similar to those found in Ca-CC and Lu-ECAM-I, and 
consistent with the findings of  the immunoprecipitation studies conducted in this 
laboratory on intestinal brush-border membrane proteins (Racette ef al., 1996). Finally, 
like Ca-CC, PG33 contains multiple consensus sequences for phosphorylation by 
serine/threonine protein kinases. 
Do these conserved regions indicate conservation of chloride channel function 
between PG33 and the other two genes? Several lines of evidence would seem to 
support such a hypothesis. First, the expression of the PG33 gene appears to be 
restricted to porcine tissues of a classically exocrine nature, and can be specifically 
localised within these tissues to cells associated with chloride secretion. Second, the 
conservation of positively charged residues within thc potential transmembrane domains 
of the deduced PG33 protein sequence is consistent with the ionic requirements for a 
channel that would allow the passage of negatively charged chloride ions. Third, thc 
initial selection criteria for the PG33 cDNA were bascd on its identification by an 
antibody which inhibits chloride conductance in intestinal brush-border membrane 
vesicles. 
This final point raises several particularly interesting questions that will need to 
be addressed in the future. The monoclonal antibody used to select PG33 had been 
shown to inhibit nearly 100% of conductive 36Cl uptake into HEPES-TMA-equilibrated 
brush-border vesicles in functional assays (Racette el al., 1996). The population of 
chloride channels documented in the apical membranes of exocrinc cpithelial cells is 
complex, as are the regulatory mechanisms controlling the activity of these channels. 
That the binding of a single antibody can inhibit the majority of chloride conductivc 
activity is, perhaps, surprising, considering the presence in the brush-border of chloridc 
channels such as CFTR, the ORCC, and CIC-2. 
These findings can be reconciled with several different scenarios. If PG33 
encodes a chloride channel, it may account for a significant percentage of chloride 
conductance in the specific intestinal conditions under which conductive uptake was 
measured, though not nccessiu-ily conductance under all possible circumstances. The 
conductance pathway associated with PG33 has been shown to be activated by CAMP 
(Forsyth & Gabriel, 1989), which argues that PG33 is physiologically relevant to fluid 
secretion in exocrine epithelia. 
Altcmatively, the binding of the antibody to its epitope may physically block 
chloride conductance, whether through a channel encoded by PG33 or through other 
conductive pathways in the apical membrane. Many ion channels are known to maintain 
physical associations with other membrane proteins. An outwardly rectifying chloride 
channel from bovine tracheal epithelia, for example, copurifies with a regulatory G 
protein (Ismailov et a!., 1996), and CFTR has been shown to interact with both the 
ORCC and with ENaC (Jovov et al., 1995a; Jovov et al., 1995b; Stutts el a/., 1995b; 
Ismailov el al., 1996). Epitope binding by an antibody may therefore affect not only the 
activity of the protein to which it binds, but the activity of other proteins associated with 
that protein. 
Future investigations into the function of the PG33 gene product must necessarily 
address these and other questions. Is PG33 a chloride channel, and if so, what is its 
physiological role in the tissues in which it is expressed? Completion of the cloning 
project, and expression of the PG33 cDNA in a mammalian system should be undertaken 
to resolve this issue. Furthermore, in addition to a potential role as a chloride channel, 
docs PG33, like Lu-ECAM- 1, also function in cell adhesion? 
If electrophysiological studies do confirm chloride channel activity in PG33, will 
the single-channel kinetics correlate with any of the known epithelial chloride channels? 
Although the PG33 DNA sequence eliminates CFTR, Ca-CC, and CIC-2 as potential 
candidates, a number of other hnctiondly characterised channels are currently under 
investigation, but have not yet been cloned and sequenced. 
Othcr avenues of investigation include studies of potential regulatory mechanisms 
controlling PG33 activity. Ca-CC activity appears to be predominantly stimulated by 
CaMK 11, and D-myo-inositol3,4,5,6-tetrakisphosphate has been shown to inhibit Ca- 
CC activity (Fuller et  al., 1994; IsmaiIov et d., 1996). Whether PG33 is  under similar 
regulatory control will also need to be determined. As well, in addition to conventional 
regulation by protein kinases and phosphatases, the notion of coordinate activation of 
apical and basolateral membrane transport processes by cytoskeletal regulation is gaining 
prominence, and studies of protein regulation must reflect this. 
In conclusion, the process of epithelial chloride secretion, though apparently 
simple, is in fact the culmination of a highly complex series of events mediated by a 
cast of participating proteins under tight control, thereby allowing cells to respond 
appropriately to changing intracellular and extracelluiar environments. Knowledge c 
large 
)f the 
individual processes contributing to this response provides not only potential means o r  
therapeutically manipulating these events, but an appreciation of the exquisite 
redundancy built into the balancing act that maintains the health of a cell. 
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